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Résumé
Les dispositifs médicaux ont connu des gros progrès depuis leur apparition. Durant les dernières décen-
nies, on observe une tendance en direction des dispositifs implantables. Les avancées technologiques ont
permis de concevoir des dispositifs à plus long terme et moins invasifs. Aujourd’hui, plusieurs dispositifs
sont disponibles tant pour la détection de paramètres physiologiques que pour des actions thérapeutiques.
Ils facilitent la prise en charge du patient, tout en préservant sa qualité de vie.
Le but ultime d’un implant médical serait de conjuguer à la fois des mesures et des actions dans un
cycle d’asservissement, afin d’optimiser la thérapie. Un certain nombre de défis technologiques restent
à surmonter pour atteindre ce but, notamment dans le domaine de l’approvisionnement en énergie et
dans la miniaturisation. Le dépassement de ces limites pourrait ouvrir des horizons encore inexplorés
et permettre des applications dont on ne rêve pas encore : des mesures plus fréquentes et à long terme
permettraient des diagnostics plus détaillés dans des nombreux cas ; par exemple, des implants plus petits
et profonds permettraient la formation d’un réseau de capteurs et actionneurs. Des populations à risque
souffrant de certaines maladies pourraient être mieux suivies et prises en charge. De plus, des implants
minimalement invasifs sur le corps pourraient améliorer sensiblement la recherche médicale, grâce à une
observation et une compréhension plus précises des phénomènes physiologiques.
Ce travail de thèse décrit la contribution de son auteur au développement d’une nouvelle stratégie
pour un dispositif médical implantable, développé dans le cadre du projet européen FP7 ULTRAsponder.
L’auteur a œuvré à tous les niveaux de l’intégration du dispositif : l’établissement du cahier des charges
du système, l’identification des composants commerciaux adaptés, le placement et la fixation des circuits
dans le boîtier, le choix d’un matériau approprié pour l’enveloppe de protection et l’analyse de son effet
sur la transmission d’énergie.
Le but du projet est la conception d’un nœud générique dans un réseau de dispositifs (Body Sensor
Network), qui soit implantable à n’importe quel endroit, qui agisse sur le long terme et en autonomie.
Les principales caractéristiques du système proposé sont la télé-alimentation et la possibilité de com-
muniquer avec une unité de contrôle externe à travers une modulation par rétro-diffusion. A la fois
l’énergie et les données échangées sont véhiculées par une onde ultrasonique plutôt que par des vecteurs
plus usuels, telles que les ondes électromagnétiques. Ceci à cause de la compatibilité intrinsèque des
ultrasons avec l’imagerie par résonance magnétique, et pour éviter les interférences avec les émetteurs
d’ondes électromagnétiques présents dans l’environnement du patient, tels que téléphones portables ou
instruments électroniques. Aussi, les ultrasons ont démontré une meilleure efficacité que les émissions
radiofréquences ou l’induction magnétique dans le cas de dispositifs petits par rapport à la profondeur
d’implantation.
Les exigences de l’utilisateur et les contraintes techniques liées à son application ont été évaluées et
ont mené à la définition du cahier des charges du dispositif. Des composants commerciaux, ainsi que des
technologies émergentes, ont été identifiés pour mettre en œuvre le concept.
L’intérêt de ce travail consiste dans l’intégration de différentes technologies, composants et approches
scientifiques dans un dispositif novateur. En particulier, le défi spécifique de la transmission d’ultrasons à
travers un boîtier médical standard, composé de titane, a été abordé. L’excellente biocompatibilité du
titane en fait le matériau de référence pour la protection des dispositifs médicaux. Néanmoins, il interfère
lourdement avec la propagation d’ondes mécaniques telles que les ultrasons. La combinaison d’une
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transmission à ultrasons et d’un boîtier en titane constitue un point essentiel dans l’industrialisation et
commercialisation du dispositif développé.
Des démonstrateurs du dispositif implantable et de son unité de contrôle ont étés fabriqués, en se
focalisant sur la transmission d’énergie, le traitement du signal et la communication des données. Un
boîtier commercial a été exploité, pour prouver la compatibilité du système avec des matériaux et
procédés industriels.
Le concept de transmission d’énergie et de données entre le dispositif et son unité de contrôle, ainsi
que l’interface utilisateur, ont été validés par des essais in vitro. Des tests in vivo pratiqués sur des
cochons ont ensuite permis d’évaluer le système en conditions réelles. Sa fonctionnalité a été prouvée,
bien qu’à une distance de transmission réduite.
Le travail futur consiste à optimiser la transmission acoustique, à intégrer le capteur proprement dit, et
à miniaturiser les dispositifs.
Mots clés : Dispositifs médicaux implantés, Génie biomédical, Réseau de capteurs, Ultrasons, Modu-
lation par diffusion, Titane, Télémétrie, Récupération d’énergie.
ii
Riassunto
I dispositivi medici si sono evoluti considerevolmente rispetto ai loro albori. Negli ultimi decenni si è
potuta osservare una chiara tendenza verso i sistemi impiantabili. I progressi tecnologici hanno permesso
lo sviluppo di dispositivi a più lunga durata e meno invasivi per il paziente. Al giorno d’oggi, disponiamo
di una moltitudine di dispositivi utilizzati sia per il monitoraggio di parametri fisiologici che a scopo
terapeutico. Essi permettono una migliore gestione della cura, pur preservando la qualità di vita del
paziente.
L’obiettivo a lungo termine di un tale impianto medico è il connubio tra sensori e attuatori in un ciclo
di retroazione, in modo da ottimizzare la terapia. Per raggiungere tale scopo, alcune sfide tecnologiche
devono essere affrontate, in particolare nell’ambito dell’alimentazione e della miniaturizzazione del
sistema. Dare risposta a tali problemi apre la strada ad applicazioni ancora inesplorate dei sistemi
medici impiantabili: la possibilità di misurare frequentemente e a lungo termine dei parametri fisiologici
permetterebbe in molti casi diagnosi più precise; dispositivi più piccoli e impiantati più in profondità
sarebbero la base per una rete di sensori ed attuatori. Si potrebbero analizzare e trattare più efficacemente
le popolazioni a rischio per una certa malattia. Inoltre, degli impianti a basso impatto sul corpo
(minimamente invasivi) potrebbero migliorare sensibilmente la ricerca medica attraverso una più precisa
osservazione e la comprensione di specifici fenomeni fisiologici.
Questa tesi descrive il contributo dell’autrice allo sviluppo di una nuova strategia per un dispositivo
medico impiantabile, sviluppato nell’ambito del progetto europeo FP7 ULTRAsponder. L’autrice si è
concentrata sugli aspetti di integrazione nella progettazione e nella produzione del sistema proposto:
in particolare, si è occupata della definizione delle specifiche tecniche, della selezione di componenti
commerciali idonei, del loro posizionamento sul circuito stampato, della scelta di un materiale adatto per
l’involucro dell’impianto e dell’analisi del suo effetto sulla trasmissione di energia.
Lo scopo del progetto è lo sviluppo di un generico nodo in una rete di dispositivi (Body Sensor
Network), che sia impiantabile ovunque, che agisca a lungo termine e in autonomia. Le caratteristiche
principali del sistema proposto sono l’alimentazione a distanza e la capacità di comunicare con una unità
di controllo esterna attraverso una modulazione a radiazione di ritorno (backscattering). Sia l’energia
che i dati scambiati sono trasmessi tramite onde ultrasoniche, anziché tramite le più comuni onde
elettromagnetiche. La ragione risiede nella compatibilità intrinseca degli ultrasuoni con le tecniche di
risonanza magnetica e per evitare interferenze con gli emettitori di onde elettromagnetiche nell’ambiente
del paziente, come telefoni cellulari o strumenti elettronici. Inoltre, nel caso di dispositivi di piccole
dimensioni rispetto alla profondità di impianto, gli ultrasuoni si sono dimostrati più efficienti delle
tecniche a radiofrequenza o dell’induzione magnetica.
Le esigenze del paziente ed i vincoli tecnici alla loro applicazione sono stati valutati e ciò ha portato alla
definizione delle specifiche di un dispositivo di nuova generazione. Adeguati componenti commerciali e
tecnologie emergenti sono stati individuati per permettere la realizzazione di un prototipo che rispondesse
a tali caratteristiche e servisse da verifica del concetto.
L’originalità di questo lavoro consiste nell’integrazione di diverse tecnologie, componenti e approcci
scientifici in un dispositivo innovativo. In particolare, è stato affrontato il problema specifico della
trasmissione degli ultrasuoni attraverso un involucro di titanio omologato per impianti medici: la
biocompatibilità del titanio lo rende il materiale di riferimento per la protezione di dispositivi impiantabili.
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Tuttavia, esso interferisce pesantemente con la propagazione di onde meccaniche, come gli ultrasuoni. La
combinazione della trasmissione tramite ultrasuoni e di un rivestimento in titanio è un punto fondamentale
per l’industrializzazione e la commercializzazione del dispositivo sviluppato.
Si sono realizzati prototipi dell’impianto e della sua unità di controllo, con particolare attenzione alla
trasmissione di energia, elaborazione dei segnali e comunicazione dei dati. Un involucro commerciale è
stato sfruttato per dimostrare la compatibilità del sistema proposto con materiali e processi industriali.
In una prima fase, la trasmissione di energia e la comunicazione tra l’impianto e l’unità di controllo
sono stati dimostrati tramite test in vitro. Successivamente, test in vivo, eseguiti su maiali, sono stati
utilizzati per valutare il sistema in condizioni reali. La sua funzionalità è stata dimostrata, anche se ad
una distanza di trasmissione ridotta.
Il lavoro futuro sull’impianto comprende l’ottimizzazione della trasmissione acustica, l’integrazione
del sensore vero e proprio nell’impianto e la miniaturizzazione del dispositivo.
Parole chiave: Impianto medico, Ingegneria biomedica, Body Sensor Network, Ultrasuoni,
Backscattering, Titanio, Alimentazione a distanza, Energy Harvesting.
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Zusammenfassung
Die Medizintechnik hat einen langen Weg zurückgelegt hin zu immer häufiger genutzten und kom-
plexeren implantierbaren Systemen. Dank des technologischen Fortschritt verfügt man heute über die
notwendigen Kenntnisse und Technologien für die Entwicklung und Herstellung beständiger und weniger
invasiven Implantaten. Mehrere implantierbare Geräte für die Messung physiologischer Größen sowie zur
therapeutischen Behandlung sind heute bereits im Handel erhaältlich. Sie vereinfachen die Überwachung
des Therapieverlaufs und erhöhen so die Lebensqualität des Patienten. Ein ideales Implantat würde
sowohl Sensoren als auch Aktoren in einer Regelschleife integrieren, um eine optimale Therapie zu
gewährleisten. Um dieses Ziel zu erreichen, müssen einige technische Herausforderungen bewältigt
werden – insbesondere hinsichtlich Stromversorgung und Miniaturisierung.
Die Lösung dieser Probleme würde Anwendungen ermöglichen, die heute in dieser Form noch
nicht realisierbar sind: bessere Diagnosen könnten für jene Behandlungsfälle erzielt werden, für die
eine kontinuierliche, langfristige Überwachung von physiologischen Größen unter realen Bedingungen
erforderlich ist. Die Qualität der dazu nötigen Messungen könnte durch den Einsatz eines Netzwerks
aus mehreren kleineren und tiefer implantierten Geräten verbessert werden. Außer zu Therapiezwecken
könnten diese Implantate auch zur Überwachung von Risikopatienten eingesetzt werden. Darüber hinaus
würden minimalinvasive Implantate die medizinische Forschung voranbringen, indem physiologische
Mechanismen genauer beobachtet werden könnten.
Diese Arbeit beschreibt den Beitrag der Autorin zur Entwicklung eines neuartigen Körpersensor-
netzwerkkonzeptes, welches innerhalb des Europäischen FP7-Projektes ULTRAsponder vorgeschlagen
wurde. Die Autorin hat sich auf die Aspekte des Entwurfs und der Fertigung dieser neuen implantier-
baren Plattform konzentriert: Festlegung der technischen Spezifikationen, Auswahl der kommerziellen
Bauelemente, Einpassung der Leiterplatte in das Gehäuse, Wahl eines geeigneten Gehäusematerials und
Beurteilung dessen Einflusses auf die Energieübertragung.
Das Ziel war einen generischen und autonom arbeitenden Netzwerkknoten für ein Körpersensor-
netzwerk zu entwickeln, welcher vorbehaltslos implantiert und langfristig genutzt werden kann. Haupt-
merkmale des vorgeschlagenen Systems sind die drahtlose Energieversorung des implantierten Gerätes
und die bidirektionale Kommunikation über den Energieübertragungskanals durch Modulierung der
rückgestreuten Wellen (backscatter modulation). Für die Übertragung wurden Ultraschall- anstatt elek-
tromagnetischer Wellen gewählt, da diese die Kombatibilität mit wichtigen medizinischen bildgebenden
Verfahren, wie z.B. de Kernspintomographie, sicherstellen und Interferenzen mit anderen elektronischen
Geräten, wie z.B. Mobiltelefonen, vermieden werden. Ultraschall als Übertragungsmedium erwies sich
als effizienter als Radiowellen oder magnetische Induktion für den Fall, dass die Implantate tief im
Körper sitzen oder klein sind.
Die Nutzungsszenarien und technischen Randbedingungen für ein optimales Implantat wurden analy-
siert, um darauf aufbauend die Eigenschaften unseres neuen Systems festzulegen. Daran schloss sich
die Auswahl passender kommerziell erhältlicher Bauelemente sowie neuer Technologien an, die die
Entwicklung des Gerätes ermöglichten.
Die Neuheit dieser Arbeit liegt in der Integration verschiedener Technologien, Komponenten und wis-
senschaftlicher Ansätze in einem neuen, viel versprechenden implantierbaren Gerät. Ein Augenmerk lag
insbesondere auf der Etablierung einer zuverlässigen Ultraschallverbindung durch ein medizintechnisch
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konformes Titangehäuse. Titan ist das Standardmaterial für biokompatible Gehäuse in der Medizintech-
nik, wirkt sich allerdings negativ auf die Übertragung von Ultraschallwellen aus. Der im Rahmen dieser
Doktorarbeit erbrachte Nachweis der Realisierbarkeit einer sicheren Ultraschallübertragung zu einem
in Titan gekapselten Implantat ist die Voraussetzung für die medizintechnische Nutzung dieser neuen
Technologie.
Prototypen des Implantates und des externen Steuergerät wurden wurden hergestellt, um die Energie-
übertragung, Signalverarbeitung und Ultraschallrückstreuung zu untersuchen. Ein Titanstandardgehäuse
für medizinische Implantate wurde genutzt, um die mögliche Kommerzialisierung dieser neuen Techno-
logie zu demonstrieren.
Die Energieübertragung und Kommunikation zwischen Implantat und Steuergerät wurde durch auto-
matisierte in-vitro Tests validiert. Die Funktionalität unter realen Bedingungen wurde durch in-vivo Tests
an Schweinen nachgewiesen. Allerdings konnten nur kürzere Übertragunslängen realisiert werden.
Weiterführende Arbeiten könnten sich auf die Optimierung der Ultraschallübertragung, die Integration
eines Sensors sowie die Miniaturisierung der Elektronik konzentrieren.
Stichpunkte: Medizinisches Implantat, Medizintechnik, Körpersensornetzwerk, Ultraschall,
Rückstreumodulierung, Titan, Fernsteuerung, Drahtlose Energieversorgung.
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Resumo
Medicinaj aparatoj multe evoluis ekde ilia naskigˆo. Dum la lastaj jardekoj, la tendenco estis al enplantitaj
aparatoj – Implanted Medical Devices (IMDs). La teknologia evoluado havigis la necesajn ilojn por
longa dau˘ro, malpli invasivaj aparatoj. Pluraj arangˆaˆoj por malkasˆo kaj ekzekuto estas komerce haveblaj
kaj plibonigas terapian demarsˆon, konservante la kvalito de vivo de la paciento.
Ideala enplantaˆo ebligus ambau˘ malkasˆadon kaj ekzekutadon en fermita masˆo, tiel ke oni atingu
optimuman terapion. Por atingi tiun celon, pluraj defioj estas, cˆefe pri energia nutrado kaj miniaturigo.
Solvante cˆi tiuj temoj devus malfermi novajn eblecojn kaj permesi aplikojn kiuj ankorau˘ ne eblas:
oni povus atingi plej bonan diagnozon kien ajn estas bezonata kontinua, longtempa monitorado de
fiziologiaj parametroj en reala vivo kondicˆoj. Ekzemple, pli malgrandaj kaj pli profunde enplantitaj
arangˆaˆoj permesus disfaldi plurajn aparatojn en la korpo, sukcesante reton de sensiloj kaj agiloj – Body
Sensor Networks (BSNs). Apud terapio, oni povus uzi enplantaˆoj pro diagnozo en homoj riskantaj
malsanojn. Krome, minimume invasivaj enplantaˆoj povus multe plibonigi medicinan esploron, pro tio
ke ili permesas pli proksiman observadon, tiel helpante kompreni fiziologiajn mekanismojn.
Cˆi tiu tezo priskribas la au˘torinan kontribuon al la disvolvigˆo de nova IMD koncepto, proponita ene de
la Eu˘ropa FP7 projekto ULTRAsponder. La au˘torino plej laboris pri la integrigˆaj aspektoj en la dezajno
kaj la fabrikado de la nova enplantinda mekanismo: sˆi difinis la teknikajn specifojn; sˆi pritaksis tau˘gajn
komercajn komponantojn kaj la geometrian lokigon de la stampita cirkvito ene de la sˆelo; sˆi elektis
tau˘gan uja materialon, kaj pritaksis gˆian efikon sur la energia transdono.
La celo estas gˆenerala reta nodo, kiu povas esti enplantita kien ajn, kiu longe dau˘ras, kaj kiu povas
funkcii au˘tonome. Gravaj trajtoj de la sistemo proponita inkluzivas foran energian donadon a la enplantita
mekanismo kaj komunikadon kun ekstera komandilo pere de reflekta modulado - Backscattering. Por
ambau˘ energio kaj transporto de datumoj, oni preferas ultrasonajn ol elektromagnetaj ondoj, cˆar ultrasonoj
estas kongruaj kun magneta resono kaj ne malhelpas elektromagnetajn elsendilojn kiel posˆtelefonoj kaj
elektronika ekipaˆo. Gˆi ankau˘ pli efikas ol radiofrekvencaj ondoj au˘ magneta indukto kiam atingante
profundan enplantaˆon kaj kiam uzante malgrandajn sentilojn.
La uzantaj postuloj kaj la teknikaj limigoj al optimuma enplantaˆo estis taksitaj kaj la trajtoj de
la sistemo estis difinita. Tau˘gaj komercaj komponantoj kaj aperantaj teknologioj estis identigitaj, kiu
permesis disvolvigˆi la aparaton.
La originaleco de tiu verko trovas en la integrigˆo de malsamaj teknologioj, komponantoj kaj sciencaj
aliroj en nova, promesanta IMD. Krom tio, la defio de sukcese uzi ultrasonoj tra sˆelo farita de norma
medicina titano estis studita. Titanaj sˆeloj estas la nuna normo por aparatoj kongruaj kun la viva korpo,
sed ili forte influas al la ultrasona transporto. Sukcesa integrigˆo de ultrasona transdono kun titanaj sˆeloj
certigas ke oni povas fabriki la proponitan aparaton industrie kaj vendi gˆin.
Facsimilaj enplantaˆo kaj ekstera komandilo estis fabrikitaj, montrante la transdonon de energio, la
signalan traktadon, kaj la reflektan moduladon. Komerce havebla, suficˆe granda sˆelo estis uzita, pro pruvi
la industrian uzeblecon de la aparato.
In vitro esplorado validigis la transdonon de energio kaj la komunikadon inter komandilo kaj enplantaˆo,
tiel kiel la uzantinterfacon. Taksado en realaj kondicˆoj estis atingita pere de in viva provojn sur porkoj.
Funkcio estis pruvita, tamen je multe pli malgranda distanco ol oni intencis.
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Estonteca laboro inkludas optimumigo de la ultrasona transporto, integrigˆo de la sensila cirkvito, kaj
miniaturigo de la rezultanta aparato.
Gravaj vortoj: Medicina aparato, Biomedicina ingˆenierio, Reto de sensiloj, Ultrasono, Reflekta
modulado, Titano, Defora energia transdono, Rikolto de Energio.
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Abstract
Medical devices have gone a long way since their beginning. In the last decades, the trend has been
towards Implanted Medical Devices (IMDs). The technology evolution has provided the necessary
tools for longer-term, less invasive devices. Several devices for sensing and actuation are commercially
available and ease therapy management, while preserving the patient’s life quality.
An ideal implant would integrate both sensing and actuating possibilities in a feedback loop, thus
achieving optimum therapy. To reach this goal, several challenges remain, in particular concerning power
supply and miniaturization. Solving these issues would open new possibilities and allow applications
which are not possible yet: better diagnosis could be achieved wherever a continuous, long-term
monitoring of physiological parameters in real life conditions is required. For instance, smaller and
deeper implanted devices would allow deploying several IMDs in the body, achieving a Body Sensor
Network (BSN). Beside therapy, implants could be used for diagnosis in populations at risk. Furthermore,
minimal invasive implants would greatly improve medical research, by allowing closer observation, thus
helping to understand physiological mechanisms.
This thesis describes the author’s contribution to the development of a novel IMD concept, proposed
within the European FP7 project ULTRAsponder. The author focused on the integration aspects in the
design and manufacturing process of the novel implantable device platform: definition of the technical
specifications, assessment of appropriate commercial components, geometrical placement of the Printed
Circuit Boards (PCBs) inside the casing, choice of a suitable housing material, and assessment of its
effect on the energy transmission.
The target is a generic BSN node, which can be implanted wherever needed on a long-term basis and
which can operate autonomously. Key features of the proposed system include remote powering of the
implanted device and communication with an external Control Unit (CU) by backscattering modulation.
For both energy and data transfer, an ultrasonic carrier is used instead of Electromagnetic (EM) waves
because it is compatible with Magnetic Resonance Imaging (MRI) and does not interfere with EM
emitters like mobile phones and electronic equipment. It also proved to be more efficient than the use
of Radio Frequency (RF) waves or magnetic induction to reach deep implants and when using small
transducers.
The user requirements and the technical constraints towards an optimal implant were evaluated and the
characteristics of the proposed system were defined. Appropriate commercial components and emerging
technologies were identified, which allowed the development of the device.
The originality of this work lies in the integration of different technologies, components and scientific
approaches into a novel, promising IMD. In particular, the challenge of achieving an ultrasonic link
through a standard medical grade titanium casing is addressed. Titanium casings are the golden stan-
dard for biocompatible device housing, but they have a strong influence on ultrasonic energy transfer.
Successful integration of ultrasonic transmission and titanium casing ensures the ability of the proposed
device to be industrially exploited and commercialized.
A demonstrator implant and an external CU have been manufactured, focusing on energy transfer, sig-
nal treatment, and backscattering. A commercial, rather large housing was used, in order to demonstrate
the industrial viability of the device.
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In vitro tests validated the energy transfer and the communication between the CU and the Transponder
(TR), as well as the user interface. Assessment in real conditions is achieved by in vivo tests on pigs.
Functionality was proved, however at a much smaller distance than intended.
Future work includes optimization of the ultrasonic transfer, integration of the sensing circuitry, and
miniaturization of the resulting device.
Keywords: Implanted Medical Device, Biomedical Engineering, Body Sensor Network, Ultrasound,
Backscattering modulation, Titanium, Telemetry, Energy Harvesting.
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1 Introduction
1.1 Motivation
The technology evolution in the last decades has promoted the development of new sensing and monitor-
ing devices for health-care. Several promising prototypes for monitoring or treating patients with chronic
diseases are commercial reality or under development. Most common examples are pacemakers, glucose
monitor systems, and neurostimulators. The trend is towards Implanted Medical Devices (IMDs), which
show promising characteristics in continuous monitoring of physiological indicators, while preserving
the autonomy of the patient.
In particular, following categories may greatly benefit from IMDs:
• Patients suffering from chronic diseases. Early diagnosis in populations at risk and regular
monitoring of physiological parameters is a common goal for treating many diseases, in order to
prevent long-term complications. In many cases, an implanted system which would autonomously
measure relevant parameters and possibly raise an alert in case of need, would be a great improve-
ment for the patients. An IMD could also integrate an actuator to form a closed feedback loop,
that is able to autonomously deliver therapy (e.g., drugs, electrical stimulation) and monitor the
patient’s response to the treatment.
• Hospital patients. At present, hospitalized patients are monitored intermittently, intensively, or
continuously (e.g., in intensive care units). This monitoring consists in vital sign measurements
(e.g., blood pressure, heart rate, ECG, respiratory rate, and temperature), visual appearance, and
verbal response. The monitoring tends to be very labor-intensive. It requires manual measurement,
documentation, and it is prone to human error. The automation of this process would be therefore
advantageous for both the health-care provider and the patient in terms of costs, precision, and
patient’s quality of life.
• Elderly patients. The proposed monitoring system would also be of benefit to populations at
risk, such as the elderly whose life expectancy is continuously increasing. Identifying ways of
surveying in a minimally invasive manner this aging population in their domestic environment
is very important, especially during months of non-temperate weather. This would allow earlier
detection of any degradation in their condition, without requiring frequent visits at the hospital.
The development of IMDs gave rise to the creation of standards and best practices in the field. As
a relevant example for this work, titanium and its alloys are by far the most used casing materials,
because of their long-term biocompatibility and their lack of interaction with the Magnetic Resonance
Imaging (MRI) equipment.
However, a certain amount of technological challenges still need to be overcome. Limitations of the
currently commercial devices include their size and possible adverse interaction with the external world
(e.g., compatibility with MRI, interference with mobile phones and medical equipment).
A technological gap has to be filled in order to obtain smaller, longer term, deeper implantable devices
working in an autonomous way. Particular design issues for deeply implanted devices (5 to 10 cm)
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concern miniaturization and power consumption. In order to combine small size and long term, the power
required for the IMD operation must be minimized and the device must be able to be recharged from the
external world, through a Control Unit (CU). A transmission strategy able to reach the implant at deep
locations is required. Furthermore, the device must be as small as possible to fit the implantation site, in
order to be minimally invasive, minimize the implantation risks, and minimize possible discomfort to the
patient.
Current contact-less rechargeable devices rely on electromagnetic waves for the energy transfer,
either in the form of RF techniques or magnetic induction. Both strategies may not provide efficient
communication with deeply implanted devices, because of the dielectric nature of the body. To be able to
recharge the device wherever it is implanted, the nature of the source should be different.
Another important concern, always associated with radio communication, is the electromagnetic
compatibility. It is becoming more and more difficult to ensure a radio communication characterized
by a high immunity to external emitters. The ever increasing number of wireless hotspots associated
with the wide frequency spectrum of modern radio devices, render the use of electromagnetic waves for
energy transfer difficult.
1.2 Scope of the work
The European project ULTRAsponder, to which the author of this thesis work contributed, aims to
achieve a new generation of IMDs. To this end it proposes:
• The exploitation of ultrasonic (mechanical) waves as a carrier for energy and data transfer,
• A data communication based on backscattering technique, similar to Radio Frequency IDentifica-
tion (RFID),
• A design suitable for industrial mass-manufacturing, complying with current standards and safety
regulations.
Within the project, several technologies towards a novel IMD were developed and integrated into a
demonstrator.
The specific contribution of the author concerned the integration of the different parts manufactured
into a coherent device. This ranged from the definition of technical specifications in the early stage of the
product design to the choice of appropriate commercial components, e.g., for compatibility with MRI,
long operation life, and small device size. Further tasks were the geometrical placement of the Printed
Circuit Boards (PCBs) inside the casing, the choice of a suitable housing material, and the optimization
of the housing for good energy transfer to the transducer.
In view of this choice, the scientific challenge of the project, to which this thesis work tries to answer,
is the propagation of an ultrasonic wave through a titanium casing and in such a way that the adverse
bioeffects on the surrounding tissues are minimum.
To this end, the effect of the titanium barrier is simulated at several thicknesses and for slightly different
configurations of the implanted transducer.
Figure 1.1 schematically shows the target overall system. The contribution treated in this thesis work
is highlighted in blue.
2
1.3 Thesis outline
Modul
Batt
µC
FRAM
ADC
Tripler
Pwr Mng
Integration, connectors
In vitro and
in vivo tests
Study of Ti
influence on US
transmission
Choice of casing
and thinning
strategy
Choice/test of
components
Firmware and SPI
connection
TRANSPONDER
CONTROL
UNIT
T
R
A
N
S
Figure 1.1: Author’s contribution to the system proposed within the ULTRAsponder project.
1.3 Thesis outline
This thesis work is structured as follows.
Chapter 2 presents the state of the art in IMDs and in medical applications of ultrasound. The limitations
of the available devices are identified in Chapter 3, where a generic device concept is proposed, which
would address the challenges towards a new generation of IMDs. Chapter 5 relates on the device designed
within the ULTRAsponder project, based on that ideal device. The required technological tools and the
choices made in the conception of the product are described. Finally, the manufactured demonstrators
are presented in Chapter 6. The protocol and the results of in vitro and in vivo tests are detailed.
Chapter 4 shows the necessary theoretical tools to describe mechanical waves, and in particular ultrasound,
towards the goal of modeling the transmission of the energy and data carrier. In particular, the effect of
the titanium casing in the received transducer is addressed through simulation.
Conclusions and outlook are discussed in Chapter 7.
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2.1 Introduction
Medical devices are man-made instruments aiming to replace, support, or enhance a biological structure.
This chapter reports on the state of the art in active, implantable medical devices. Special focus is put on
the IMD power source, on the encapsulation and implantation strategy, as well as on the communication
with the external world.
The packaging exploited in commercial devices are for the most part titanium-based casings, because
of the excellent characteristics of this material [60].
Implantation methods are tending towards minimally invasive techniques, which is increasingly
possible because of the small size of the implants [31, 46, 84, 109]. Vice-versa, the planned implantation
technique influences the device design.
Autonomous power supply is a major challenge for IMDs. Wireless recharge of a local power storage
from an external unit is advantageous. Two main strategies are identified: magnetic induction and
ultrasonic energy transfer. This second method, known for years but still at its infancy, proved most
efficient for small and deep implants [22].
Besides, ultrasound is already widely used in medical domain for imaging and manipulation at cell
level, thus its exploitation as energy carrier is very promising.
2.2 Commercial Medical Devices
Medical devices are formally defined by the European Commission as follows [32]:
Medical Device means any instrument, apparatus, appliance, material or other article,
whether used alone or in combination, together with any accessories or software for its
proper functioning, intended by the manufacturer to be used for human beings in the:
• diagnosis, prevention, monitoring, treatment or alleviation of disease or injury,
• investigation, replacement or modification of the anatomy or of a physiological process,
• control of conception,
and which does not achieve its principal intended action by pharmacological, chemical,
immunological, or metabolic means, but which may be assisted in its function by such
means;
Medical devices range from extra-body machinery (such as glucose monitors, external insulin pumps)
to implanted devices. There again, IMDs can be divided into passive and active. The main example
of passive IMDs are implanted prostheses, such as knee or hips replacements. Active IMDs contain
electronics and are able to sense a particular parameter or deliver a treatment. Pacemakers, cochlear
implants, neurostimulators fall in this category. Figure 2.1 shows the different divisions in the medical
device family, and cites some examples of devices. An extensive review of commercial IMDs was
performed by Receveur et al. in 2007 [82].
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Figure 2.1: Types and examples of medical devices.
(a) First pacemaker prototype (around 1940)
© Canadian Heritage Information Network
[16].
(b) First implanted pacemaker (1958).
© Professor Marko Turina, Uni-
versity Hospital, Zurich [105].
(c) Victory™ SR 5610 device
(present). © Steven Fruitsmaak
[39].
Figure 2.2: Evolution in pacemaker devices.
Evolution of medical devices is well depicted by the treatment of heart anomalies. Artificial pacemakers
are devices that deliver electrical impulses in order to regulates the heart beating. They are employed
when the cells responsible for beat initiation (natural pacemaker) are not working properly, or when
the heart electrical propagation system is damaged, thus blocking the beating impulse. The concept of
artificial pacemaking is known since the beginning of the 20th century [64]. The first prototype was a
30 cm large machinery worn by the patient and connecting with the heart through wires coming out of
the skin. It was developed in the 1940s by Canadian surgeons Dr. Wilfred G. Bigelow and Dr. John C.
Callaghan at the Banting Institute in Toronto [8]. The tendency in the last decades has been to implant
medical devices, in order to avoid wires. Progress in microtechnology allowed the first implantable
pacemaker to be exploited in 1958 in Sweden. It had the size of a hockey puck (about 7.5 cm diameter
and 2.5 cm thick). Today pacemaker devices are much smaller, similar to Victory™ SR model 5610
(St. Jude Medical Inc., St. Paul, MN, USA), which has a size of 4.3 cm × 4.4 cm × 0.6 cm, and a device
life of ten years is standard for cardiac implants. In addition to resynchronization functionality, many
cardiac implants nowadays contain a cardioverter-defibrillator: this device intervenes in case of cardiac
arrhythmia (possibly leading to sudden cardiac death) and restores the normal rate and sequence of
contraction. Figure 2.2 shows the different evolution steps.
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Implanted Medical Devices make possible to sense more precisely, act where it is needed, and deliver
drugs on the exact spot to be treated, thus reducing the quantity of drug needed. The closer feedback
allows the adaption of the therapy to the patient reactions. Several promising prototypes for managing
patients (with acute diabetes, for treatment of epilepsy and other debilitating neurological disorders)
and for monitoring patients with chronic diseases have been developed. On medical research level,
IMDs allow monitoring unexplored mechanisms, such as long-term variations of a given parameter
(e.g., glucose concentration or blood pressure).
Important examples of IMDs are neural prostheses, such as cochlear implants, which translate the
sounds from the external world into an electrical stimulus, thus compensating for damaged hair cells in
the cochlea [113]; spinal cord simulators, based on the fact that pain transmission can be blocked by
stimulating large portions of nerves [57]; visual prostheses, that can create a sense of vision by electrically
stimulating neural cells in the visual system where photoreceptive cells fail to translate photons into
neural signal [112]. Functional Electrical Stimulation (FES), a particular type of neurostimulation
which aims to restore motion in people with disabilities, by injecting electrical currents to activate
nerves innervating extremities affected by paralysis, could greatly benefit from IMDs, allowing several
stimulation and sensing locations in the body [91]. Also, several devices have been developed to treat
heart anomalies, like the already mentioned pacemaker.
Commercial devices include for example the Activa® PC neurostimulator (Medtronic, Minneapolis,
MN, USA) 1, the cochlear implant HiRes 90K™ (Advanced Bionics AG, Stäfa, Switzerland) 2, or the
pacemaker Altrua™ (Boston Scientific, Natick, MA, USA) 3. Pacemakers and implanted defibrillators
are well assessed and implanted in about 200’000 persons every year in Europe [30].
IMDs can also be used to identify a patient and ease retrieving important medical information. VeriChip
(PositiveID, Delray Beach, FL, USA), achieves this exploiting a RFID tag and it is to date the only
microchip approved by the Food and Drug Administration (FDA) for implantation in humans.
This thesis work is focused on active, implanted, long-term medical devices. Figure 2.3 shows the
general schematics of an active IMD. A sensor/actuator block carries the functionality of the IMD. The
data sensed are kept in a non-volatile memory. A local power storage and an optional energy harvesting
block provide the required electrical energy to run the implant. A telemetry block allows communication
with the external world. Finally, a microprocessor is the core of the implant, as it manages the other
blocks.
Challenges in the product design are in particular related to device packaging and power supply [112].
Therefore, following sections will particularly detail the state of the art concerning those parameters.
2.3 Device packaging
To ensure long-term implant activity and safety for the patient, encapsulation of the electronics is
necessary, and several specifications must be met [56]. Main characteristic for the implant casing is
biocompatibility, which means the property of not eliciting immune response from the body. Conversely,
the implant should be resistant to corrosion, coming from the contact with body fluids. Indeed, in order
to avoid short circuits, major dysfunction, and injuries, the body fluids should not get in touch with
the electronics during the whole implant life. According to the application, the casing material should
1http://professional.medtronic.com/pt/neuro/dbs-md/prod/activa-pc/
2http://www.advancedbionics.com/com/en/products/hires_90k_implant.html
3http://www.bostonscientific.com/Device.bsci?page=HCP_Overview&navRelId=1000.1003&method=
DevDetailHCP&id=10103841&pageDisclaimer=Disclaimer.ProductPage
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Figure 2.3: Rendering of a generic active sensor IMD.
integrate in different ways with the surrounding tissues. For example, for hip or knee replacement,
the integration of the implant to the bones is very important, while for drug delivery systems the
encapsulation of the implant in a fibrotic, inert tissue needs to be avoided. The casing also protects the
device electronics from mechanical stress, which can be more or less important depending on the implant
site. The device needs to undergo sterilization before implantation. This requires a casing resistant to the
standard sterilization methods, including steam sterilization, Ethylene Oxide, or gamma rays [59, 73].
Finally, the entire above characteristic set should be maintained through the whole life of the implant.
Materials for IMDs are subject to different regulations in different countries. The biocompatibility
of the device components is a milestone for IMD development. Several materials used in Micro-
Electro-Mechanical Systems (MEMSs) were considered by Kotzar et al. [53], in order to assess their
exploitability in medical devices.
Several encapsulation methods are currently used for IMDs. The natural choice for long-term implants
is titanium, because of its excellent biocompatibility and interesting mechanical properties. At room
temperature titanium is resistant to tarnishing. Oxydation may occur at higher temperatures, but this
layer of titanium oxide will prevent further corrosion. Thus, titanium can be considered to be inert to
body tissues. It has a very low electrical and thermal conductivity, and it is paramagnetic. Medical grade
titanium, a 99% pure alloy, is widely used for medical prostheses [60] and instruments [58]. Through
coating with polymers [103], it is possible to encourage its reaction with bones (osseointegration),
thus making titanium an excellent candidate for orthopedics and dental implants. The biocompatibility
of titanium and its alloys is assessed by several standards and publications of the American Society
for Testing and Materials (ASTM) [2, 4, 7, 54]. Indeed, currently manufactured IMDs are almost
exclusively made of titanium and titanium alloys. Alternative materials are some polymers, such
as PolyTetraFluoroEthylene (PTFE), PolyEther Ether Ketone (PEEK), Poly(Methyl MethAcrylate)
(PMMA), polyethylene, and silicones. They are non-toxic, may be degradation resistant, and provide
good fatigue strength and wear resistance [80]. Nevertheless, they have tendency to be colonized by
microbes, thus requiring special treatment in order to be suited for long-term implantation [97, 107].
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Furthermore, polymers do not provide electrical shielding and strong mechanical protection for the
implanted electronics, as metals do.
In case of allergies against titanium, Medtronic applies a special coating of medical silicone or parylene
on its implant housings, and the device is then treated as a custom-made piece, to be followed-up in
particular ways.
Polymers may also be required for some parts of a specific device. As a recent and media-covered
example, Medtronic exploits Langley Research Center - Soluble Imide (LaRC-SI), developed by NASA,
to insulate thin metal wires on its Cardiac Resynchronization Therapy (CRT) devices [14].
The casing will have an influence on the energy and data transmission, which has to be taken into
account. Titanium is MRI compatible because of its paramagnetic properties. The specific issue of
heat production in the tissue surrounding the device is addressed by exploiting heat-absorbing materials,
which change state depending on the temperature [89]; they can be coupled with an internal algorithm to
further reduce the power supply and thus the heating produced.
2.4 Minimally invasive implantation
The goal is to reduce as much as possible adverse effects of the implantation, thus improving recovery
of the patient and reducing costs. Without complications, a patient undergoing minimally invasive
implantation can leave the hospital within 24 hours and visit the medical facility for follow-up [46].
This translates into minimizing damage of biological tissues at the point of entrance of the instruments.
Incisions will be as small as possible, and anatomical openings will be exploited to access the implantation
site.
A great step towards minimally invasive implantation techniques has been the development of the
catheter-delivered stent for angioplasty [27]. The motto of its inventor, which well resumes the aim of
minimally invasive implantation, is: “What can be accomplished without operative exposure should be.”
(cit. Dr Charles T. Dotter, 1969).
Since then, percutaneous approaches (through the skin) are widespread [31, 84, 109]. This involves a
needle catheter getting access to a blood vessel, followed by the introduction of a guidewire through the
lumen (pathway) of the needle. It is over this wire that surgeons can place other catheters into the blood
vessel, or implant a medical device. This technique is most used for implantation of stents in the blood
vessels, placement of artificial heart valves or heart pumps. For larger implants, more traditional methods
must be employed. As an example, pacemakers and cardiac devices in general are usually inserted in
the left shoulder area where an incision is made below the collar bone creating a small pocket. Once
the implant is in place, the leads are inserted through a large vein into the heart, and their insertion is
monitored using real-time X-Ray imaging (fluoroscopy).
In order to reduce the risk of infections, standard procedures require that the IMD is kept in a sterile
container or sterilized prior to introduction to the sterile implantation environment. In addition, drugs
may be administrated on the implantation site. Two methods for local drug elution have been disclosed
by Bischoff [9, 10]. The author proposes either to cover the device housing with a polymer layer
impregnated with drugs, or to insert a temporary, dedicated element next to the main implant. This
second method has the advantage to separate the actual IMD, which can have a long shelf life, from the
drug-impregnated element, which undergoes quicker deterioration.
Ideally, IMDs would be implanted through catheterization or similar transcutaneous implantation
techniques, in order to reduce the pain of the patient, avoid infections and save money. This influences
9
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Figure 2.4: Characterization of IMDs according to power supply method. Blue categories are not yet
commercial technologies.
the maximum size of the device: blood vessels range in diameter between 25 mm to some µm, while the
maximum size of currently used catheters is 14 F (about 4.5 mm diameter) [74].
2.5 Power supply
Active IMDs need an internal power supply, allowing autonomous operation over a certain amount of
time. Figure 2.4 resumes the different options for supplying the energy.
A first option is to use primary cell batteries as the source of energy of the IMD. This can be effective
for low power applications, such as pacing devices. However, high capacity batteries must be used in
order to supply the power required on a long term. The device size devoted to batteries can become very
large. Once the battery is depleted, the device needs to be explanted and re-implanted. This is not very
appealing to the patient, and it incurs costs to the hospital. For this reason, and given the trend towards
long-term implants, rechargeable batteries are increasingly used.
2.5.1 Energy harvesting from human body
An approach to reduce the need of energizing the implants from outside the body is based on the
observation that the human body produces a substantial amount of energy. It can take different forms
such as dissipated heat, inertia, muscle contraction, joint movement or heel strike. Several microsystems
are under development to harvest part of it. A piezoelectric energy harvesting system could potentially
power active IMDs [24]: a piezoelectric diaphragm could be placed in a blood vessel and translate the
mechanical quasi-static deflection caused by the blood pressure variation (about 2 Hz frequency) into
electrical energy. An alternative is to use the human body as a natural source of chemical and physical
energy [19]. Chemical energy could be extracted by implantable micro fuel cells (for example from
glucose); MEMSs could transform physical energy, such as body heat, blood pressure, breathing, and
body motions into electrical power.
Nevertheless, despite dynamic research and promising results in this field [6, 48, 62], body energy
harvesting is to date not ready to be used as a steady, reliable power source for IMDs [68].
A more developed approach consists in having an external power source, which transcutaneously
delivers energy. Wireless energy transfer is preferred: having electrical wires which perforate the skin is
disadvantageous due, in part, to the considerably elevated risk of infection. Both electromagnetic and
mechanical waves can be considered as wireless energy carriers.
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Figure 2.5: Spectrum of electromagnetic waves. Adapated from Philip Ronan [87].
2.5.2 Electromagnetic waves
Type and source of Electromagnetic (EM) waves are identified by their spectral band. Waves at different
frequencies have extremely different characteristics of penetration into the body, bioeffects, wave energy,
and dispersion. Figure 2.5 depicts the EM spectrum and identifies the different types of waves.
Some wave types can be immediately excluded as energy carrier candidates, because of their adverse
bioeffects. Waves at frequencies higher than the visible range (about 1014 Hz and beyond) are ionizing
radiations, that is to say they are able to create ions and free radicals in living tissue, thus damaging
the body even at low energy intensity. All frequencies of UV radiation have been classed as Group 1
carcinogens by the World Health Organization [44]. Ultraviolet radiation from sun exposure is indeed
the primary cause of skin cancer. It is therefore evident that Ultraviolet, X-rays, and Gamma rays cannot
be used as energization carrier for IMDs.
Also non-ionizing radiations (infrared, microwave, and radiofrequency radiation) act on the tissues with
an energy inversely proportional to their wavelength. Infrared and microwaves radiations induce heating
in the body by acting on the water dipolar molecules. Frequencies in the radio range, which possess the
lowest wave energy, are therefore the most suited for wireless energy transfer. Radiofrequency radiation
is suspected to be carcinogen, but with weak evidence [44].
The International Telecommunication Union (ITU) dedicated several bands to EM transmission for
IMDs [45]: 9-600 kHz, 30-37.5 MHz, 401-406 MHz (Medical Implant Communication Service (MICS)
[33, 34]), 2.4835-2.5 GHz. Furthermore, the Wireless Medical Telemetry Service 4 is defined in the USA
in the bands 608-614 MHz, 1.395-1.4 GHz, and 1.429-1.432 GHz.
To date, magnetic induction is the most widespread energization method for many devices, both
in medical domain5 [96] and in day-to-day life (e.g., wireless recharge of electric cars6, rechargeable
toothbrushes7).
Transcutaneous energy transfer by magnetic inductive coupling involves the placement of two coils
positioned in close proximity to each other on opposite sides of the cutaneous boundary. The internal
4http://www.fcc.gov/encyclopedia/wireless-medical-telemetry-service-wmts
5http://www.sjmneuropro.com/Products/US/Eon-Rechargeable-IPG-System.aspx
6http://www.pluglesspower.com/
7http://www.oralb.com/products/vitality-floss-action/
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coil, or secondary coil, is integrated in the IMD. The external coil, or primary coil, is associated with
an external power source. A current is induced in the secondary coil through inductive coupling. This
current can then be used to power the implanted medical device or to recharge the local battery, or a
combination of the two.
Primary and secondary coils can be adjusted to the target transmission to be achieved by acting on
their size, number of turns, and working frequency [42]. Several patents issued by Medtronic propose
technologies and methods to manufacture an IMD powered or recharged by magnetic induction. Using a
metallic casing as encapsulation for the IMD, a magnetic shield should be foreseen in the device design
[47], in order to improve energy transfer, and reduce the electromagnetic flux lines coupling with the
housing, thus reducing the eddy currents responsible for the heating around the device. Furthermore,
particular titanium-alloys can be exploited as suitable housing materials for IMDs, in order to ease
inductive coupling [58]. With respect to pure medical grade titanium, the alloys proposed exhibit greater
power coupling efficiency, thus improving the achievable transmission distance.
As the efficiency of the magnetic link is a crucial point in the device, it is not unusual that magnetic
emitters and receivers are custom-designed, in order to optimize the energy transfer in a particular IMD
[50, 85]. The best coil and signal characteristics are assessed based on target application and device
specifications.
In other cases, devices rely on RF transmission for wireless energy transfer: the implant is equipped
with a RF receiver and usually an internal power storage, conceived as a backup [5]. The RF emission
from an external control unit can power up the implanted device and/or recharge the local power storage.
The internal supply is able to autonomously power the implant for 24 hours continuous activity. The
carrier is an electromagnetic wave, like in previous method, but its frequency is higher, so that the
electric field is dominant with respect to the magnetic field. The boundary between magnetic coupling
and electromagnetic power harvesting is defined by d = λ/2pi, where, d and λ are the distance and the
wavelength of the signal, respectively [117]. For a chosen wavelength, if the distance between the coils
is smaller than d, the magnetic coupling gives more efficient wireless power transmission than RF.
Using EM waves, the presence of external electric and magnetic fields encountered by the patient
during daily activity, may expose the patient to the risk of false positives, i.e., accidental activation or
deactivation of the transponder. RF telemetry systems can interfere with other RF wireless systems, such
as mobile phones, home power tools, and aviation electronics.
Magnetic induction will in principle interfere with MRI, unless particular care is taken in the design.
Moreover, magnetic coupling requires accurate positioning for efficient energy transmission.
Finally, at a given working frequency, the EM energy transfer is strongly dependent on the shape and
size of the coil (antenna). Thus, the integration in small size IMDs can be cumbersome and results in
a trade off with respect to efficiency and penetration depth. Indeed, electromagnetic energy may only
penetrate into the body up to a distance equal to the size of the antenna, because of the dielectric nature
of the body [40]. Therefore it may not be able to communicate effectively with a transponder that is
located deep within the body and which has a small size.
For this reason all methods and devices presented in literature have a subcutaneous part, in which the
antennas/coils are placed, and a sensing/actuating part, in the same housing or connected with wires
to the energy harvesting part. The presence of wires between the implant and the receiver is of course
unwanted, but may be necessary to ensure sufficient energy transfer to a deep implant.
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2.5.3 Mechanical waves
Recent work shows how ultrasonic waves, that is mechanical waves at a frequency higher than the human
audible range (> 20 kHz), are emerging as an alternative way to transmit energy to IMDs [86]. This
technique exploits the ability of acoustic waves to penetrate deeper in the body tissue without being
significantly attenuated. A system consisting of an external CU and an IMD can be conceived, which
transfer energy and data by acoustic link [25]. An electrical signal is transformed into an acoustic wave by
a piezoelectric transducer contained in a CU external to the body. Then, this acoustic wave propagates in
the direction of the implanted device. Another piezoelectric transducer is integrated inside the implanted
device. It receives the acoustic wave coming from the CU and converts it to electrical energy, to be
stored in the internal battery. Special housing may ease intrabody ultrasonic communication among
implants, acting as an acoustic diaphragm to the underlining transducer [26]. With respect to EM waves,
ultrasound allows a lower working frequency keeping an efficient directionality [86]. Denisov et al. [22]
compared acoustic and electromagnetic wireless energy transmission. Although maximum efficiency of
ultrasonic energy transfer is only about 40%, while EM waves can achieve 80%, ultrasound scales much
better with the size of the transducer and with the penetration depth to the implant. For coil/transducer
sizes smaller than 10 mm and for implantation depth higher than 10 cm, ultrasound clearly outperformes
magnetic induction and RF transmission.
Transducer efficiency can be considerably improved by exploiting piezocomposite technology [29, 37],
in which an array of thin piezoelectric ceramic rods are embedded into a polymer material. E.g., piezo-
composite materials manufactured by IMASONIC (Voray-sur-l’Ognon, France) have a structure called
1-3, depicted in Figure 2.6. Their physical properties depend on the ceramic and polymer properties
and on the microstructure dimensions. Piezocomposites present interesting acoustic and mechanical
properties. Most importantly, piezocomposite materials have a high coupling coefficient, i.e., a high
capacity to convert acoustical energy into electrical energy, and vice-versa. The resulting transducer
has higher sensitivity and signal to noise ratio (10 dB to 30 dB compared to conventional technology).
The high coupling coefficient also contributes to enlarge the bandwidth while keeping a good sensitivity.
The acoustic impedance of the piezocomposite is always lower than that of monolithic piezoceramic
elements and can be adjusted by playing on the geometry of the rods. This allows better adaptation to the
transmission medium, in particular to water and therefore to body tissues, which acoustic impedance
is close to water (1.5 MRayl). The 1-3 structure of the composite attenuates lateral modes of vibration,
thus improving the beam pattern and keeping the cross talk among elements as low as -40 dB. Due to the
modular geometry and to the presence of polymer, piezocomposite materials can be mechanically shaped,
thus producing focused beams without using acoustic lenses. This avoids lens attenuation and allows
a more predictable beam pattern. Piezocomposite materials also have a higher mechanical resistance,
which confers to the transducers a higher resistance to mechanical shocks, vibrations, temperature, and
pressure constraints.
Acoustic telemetry methods and apparatus have already been reported and patented in the medical field
for heart pressure monitoring, insulin pump assisting [75] and cerebrospinal fluid draining in the case
of hydrocephalous disease [78]. From 1997 up to 2007, Remon Medical Technologies Inc. (Caesarea,
Israel, now Boston Scientific) has been one of the main actors developing systems in this field. Reported
systems include an external or implanted CU and one or several implanted Transponders (TRs) that can
wirelessly communicate, using acoustic transducers. These transducers are used either to exchange data
or for energy scavenging. These acoustic transducers are flexural mode transducers [79] working at a
low ultrasonic frequency, e.g., 40 kHz. These transducers are said to be omni-directional due to the low
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Figure 2.6: Piezocomposite structure 1-3. Source: O. Sigmund et al. [93].
operating frequency. Moreover, due to the use of low frequency acoustic signals, their system does not
suffer from significant attenuation in the surrounding medium.
2.6 Data communication
Implanted Medical Devices, and especially long-term devices, need to communicate with the external
world. Depending on the application, they need to inform a CU about a hardware problem [71]. Once in
a while, an implanted sensor may need to download the physiological parameters sensed. An actuator
may need to receive modified settings from the external world.
Telemetry capabilities allow conceiving a network of IMDs, each with an autonomous sensing or
actuating role [75, 76]. Intra-body communication is proposed, where an implant carries the role of
Control Implant, which activates the other implants. The link can also be used to switch on and off the
implant from the exterior world, in order to reduce its power consumption [77].
The medical Implantable RF Transceiver ZL70102 (Zarlink Semiconductor, now Microsemi, Aliso
Viejo, CA, USA) is used in most commercial IMDs. It operates in the frequency band 402-405 MHz,
which is the dedicated band defined by the MICS specification for bi-directional radio communication
with IMDs [33, 34].
In order to ensure miniaturization and autonomy, the communication strategy needs to consume little
power, so that the local battery lasts longer. This work exploits a communication concept in which the
data carrier is a wave coming from the external CU, which is reflected back by the implant according
to the message to be sent. The power needed to create the wave is provided by the external CU, where
power consumption is not an issue. The implant only spends energy to modulate that wave to transmit
the message. This process is based on the backscattering principle, which is best known in RFID
applications.
RFID is an automatic identification method, relying on storing data on devices called RFID tags, and
remotely retrieving those data by interrogating the tags from a RFID reader. As an example, that is how
badges control access to buildings.
A standard RFID tag is usually completely passive: it does not require a battery, as it is powered from
the wave supplied by the RFID reader. The reader sends an electromagnetic wave to the tag and the
tag answers, for example with its serial number. As illustrated in Figure 2.7, the working principle is
based on the fact that an electrical wave is reflected or absorbed by a device according to the electrical
impedance of the device itself. A device can be therefore recognized by how it reflects back an incoming
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Figure 2.7: Concept of Backscattering with RF waves.
wave. If the tag device is able to dynamically change its own impedance, for example by electrically
switching a component in and out, it can modulate the reflection of the wave received and, by this mean,
transmit information.
This process is called Backscattering Modulation, and it is a promising technique for communication
with IMDs. In principle, any kind of wave can be associated with backscattering technique. If a
mechanical wave (e.g., ultrasound) is exploited as a carrier, instead of an electromagnetic wave, the
modulation will occur by changing the mechanical (acoustical) impedance instead of the electrical one,
exploited by RFID [79].
2.7 Applications of Ultrasound
Ultrasound is already widely used in the medical domain.
The ability of ultrasound to differentiate tissues based on their acoustic impedance is the basis for
ultrasonic imaging (ultrasonography), which can be differentiated in many subtypes. Most important to
mention is the Doppler imaging, which renders tissue in motion, for example blood flow.
The ultrasonic image is created by first transmitting sound waves into the body and then interpreting
the intensity of the reflected echoes. The principle is very similar to the backscattering telemetry,
described previously. The ultrasonography is achieved using a hand held scanner, which contacts the
body. A water-based, acoustic adaptation gel is used to optimize the contact and to match the ultrasonic
impedance between the probe and the body. The data collected is then processed within the body of
the external scanner and displayed as a gray scale image. The frequency of the scanner beam directly
influences the depth of analysis: low frequencies (5-12 MHz) are well-adapted to image large, deep
elements, such as organs. Higher frequencies result in higher resolution images, closer to the transducer
surface. As an example, epidermis is best imaged with beam of 50 to 100 MHz.
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Dermatology exploits sonography in several ways, as overviewed by Kleinerman et al. [51]. Based
on the fact that skin echoes ultrasound according to its content in creatin, collagen, and water (among
others), the skin regions can be clearly recognized. Skin conditions can be diagnosed, for example
inflammations, skin cancer, cellulites, foreign bodies in wounds, etc. Evaluation of skin thickness by
ulltrasound is reported to provide better precision than using biopsy or palpation.
Ultrasound imaging has a strong relevance in regional anesthesia in infants and children [104], where
target nerves to be blocked are very close to critical structures. Being able to precisely image tissues
borders, the right injection point and quantity of anesthetic can be met.
Other than for imaging, ultrasound is widely used for their ability to manipulate matter at cellular scale.
High Intensity Focused Ultrasound (HIFU) exploits the bioeffects of ultrasound on tissues (thermal effect
and cavitation), which are normally avoided for other applications, in order to destroy tumoral masses
within healthy tissues. This technique allows a precise and less invasive treatment, because no incision
is required to reach the mass to be removed. Physiotherapy takes advantage of the heat produced by
ultrasound to speed up the healing process in injured tissues [108]. In cell therapy, Low-Intensity Pulsed
UltraSound (LIPUS) can improve cell properties prior to their injection as a therapy. As an example,
LIPUS increases angiogenic activity of cultured cells, i.e., their ability to build blood vessels. Those
"improved" cells can be later implanted in patients suffering from vascularization problems, such as
Critical Limb Ischemia [70]. Drug delivery at specific targets can be achieved by trapping drugs inside
microbubbles (e.g., liposomes, artificial vesicles made out of a double layer of lipides) and opening
them at the target location by ultrasonic vibration [35, 72]. In the same way, lithotripsy (disintegration
of kidney stones) and acolysis (disintegration of blood clots) are efficiently performed by ultrasound
[95, 118].
Finally, cosmetics has its fair share in ultrasound applications: exploiting the heat produced by the
acoustic beam in a well-confined region, cells composing the adipose tissue (adipocytes) can be destroyed,
improving the natural fat resorption; skin tightening can be performed in a less invasive way with respect
to standard surgical incision techniques, by destroying a cone of tissue under the epidermis; definitive
body hair removal can be obtained damaging the hair root with an ultrasonic beam.
2.8 Conclusion
Implanted Medical Devices are very promising tools for further development of minimally invasive
medicine. They allow new applications and better adaptation of therapies to the needs of the patient.
Table 2.1 gives an overview of the main methods and technologies used for IMDs, underlining their main
features and drawbacks. Minimally invasive surgery methods are ready or under development, which
allow implantation of the devices with minimal adverse reactions. Titanium keeps its place as principle
material for IMD housing, due to its excellent characteristics and biocompatibility.
Developments in IMDs tend towards autonomous devices to be implanted at long term. To achieve
this goal, an internal power supply must be provided, which in turn does not dramatically influence the
size of the device. A system composed of an external CU periodically sending energy to the implant
is the strategy privileged over integration of big batteries inside the implant or exploiting physical and
chemical energy of the human body. A method for communicating between implant and external world
is also an important requirement for active IMDs.
To date, magnetic induction performs very well as energy carrier to recharge an internal battery in
subcutaneous IMDs. It nevertheless shows limited propagation inside the body and interferes with
electromagnetic sources in the external world.
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Table 2.1: State of the art of technologies and materials for IMDs.
Technology Advantages Drawbacks State of Development
Titanium Biocompatible Obstacle for ultrasound Standard for IMDs
Polymers
Easy manufacture
Battery colonization Commercial
Hypoallergenic
Minimally Invasive
Implantation
Minimizes damages
Requires small IMD size Commercial
Cheaper
Ultrasound
Deep penetration Requires contact Commercial for imaging
Many applications Research for IMDs
Magnetic Induction Efficient energy transfer
Depth ∼ Receiver size
Commercial
Interference MRI
RFID Low power Proximity Commercial
Primary batteries
Reliable Size
Commercial
Assessed technology Needs replacement
Body Energy
Harvesting
On-site
Not steady source
Research for IMDs
Continuous Some commercial use
On the other side, ultrasonic waves are already extensively used in the medical domain, because of
their good propagation inside aqueous media and their ability to precisely recognize different tissues
based on their echo response. Ultrasonic energy transfer through small transducers and to deep implanted
devices proved more efficient than magnetic induction and RF waves. Therefore, this wave type is
investigated as a promising carrier for energization and communication in active Implanted Medical
Devices.
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3.1 Introduction
As described in Chapter 2, IMDs are promising tools for continuous monitoring of physiological
indicators. However, in many situations, a compromise has to be found between the desire of monitoring
a given parameter as frequently as possible and the resulting risks and constraints for the patient, in
terms of health, time, costs, and life quality. As an example, glucose monitoring in diabetic patients is
normally performed three to four times a day by peripheral blood analysis. Already this benefits from
portable devices, developed in the last few decades, which allow patients to perform the measurements
themselves. Ideally, patients would like to know more precisely their glucose level, in order to adjust the
medication accordingly. On the other hand, each sensing event costs time, money, and pain.
For this and others applications, an implanted system which would autonomously measure relevant
parameters, and possibly alert in case of need, would be a great improvement for the patients. The
long-term goal is a closed feedback loop, in which the same IMD contains a sensor, which monitors a
specific physiological parameter, and an actuator, e.g., a micro pump releasing a drug, which adjusts its
operation according to the sensor information.
This can be especially beneficial to elderly patients and in case of chronic diseases: the patient’s
condition could be monitored often and autonomously, without requiring frequent visits to the hospital,
thus preserving privacy and autonomy, as well as saving money.
The technology evolution in the last decade has promoted the development of new sensing and
monitoring devices for health care. The design issues for deeply implanted devices remain numerous,
especially regarding miniaturization and power budget.
Because of the body dielectric properties, energizing and communicating with implants that are located
deep within the body, using conventional techniques like Radio Frequency (RF) or magnetic induction,
may not work effectively. Another important concern is the compatibility with MRI and the interference
with other electromagnetic wave emitting devices, such as mobile phones, at home or in surgery rooms.
Finally, such implanted system should imply a minimum invasiveness to reduce the implantation risk
and the possible discomfort to the patient. Consequently, new roads need to be opened to overcome these
limitations and develop deeply implantable medical devices.
Ming-Li et al. [67] review several challenges in the development of IMDs.
This chapter presents a generic, modular device platform containing an IMD and an external unit for
power supply, control, and data communication. Such a medical system is intended to be the basis for
many applications, which will differentiate by the sensor or actuator connected. The devices, and in
particular the implant, are analyzed according to several requirements towards a new generation of IMDs
able to be more deeply implanted and to act on a longer term. The technologies and tools necessary
to achieve this goal are discussed and some potential applications of the resulting implant concept are
listed.
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3.2 Implant requirements
Several key points were identified in the design of the ideal IMD for chronic sensing / action:
• Implantability: the technology developed for the device should be highly flexible and modular, in
order to be easily adaptable to any kind of application. Implantation should be possible everywhere,
including in deep locations. The size plays therefore a major role: the implant must be small
and light, allowing being placed either by using open surgical or minimally invasive implantation
techniques.
• Long term implantation: the foreseen applications being monitoring of chronic illness and elderly
patients, the implant needs to stay in place at least 5 to 10 years. As the device could be potentially
deeply implanted, surgery to replace the implant or part of it could be not feasible. Furthermore,
the IMD must exhibit an excellent biocompatibility to allow long-term implantation.
• Autonomous sensing and action: in order to achieve a continuous monitoring, the device has to
work autonomously once implanted. A continuous drive and interrogation from the outside would
not address the need of independence of the patient. Connection periods with an external control
unit are necessary, but they will be kept as rare and short as possible. To this end, the local energy
stored in a small battery must be carefully managed: the implanted device must have an ultra-low
power consumption.
• Cost: finally, the whole device should ideally be cheap to produce, maintain, and operate.
3.2.1 Body Sensor Network
The implant proposed in this work is conceived as part of a bigger Body Sensor Network (BSN), as
defined by Yang [116]. Figure 3.1 depicts a BSN: an external Control Unit (CU) is secured to the patient’s
skin and able to energize and to communicate with a network of implanted nodes (Transponders). A
single TR may include one or more sensors for monitoring a variety of properties, such as temperature,
pressure, strain, or fluid flow, as well as chemical, electrical, or magnetic properties. It may also perform
therapeutic functions such as drug delivery, defibrillation, or electrical stimulation. The TR should
perform some (simple) steps regularly during the day, e.g., to sense a parameter and to store it into the
memory. To achieve the trade-off between long-term operation and size, i.e., acceptably small batteries,
the device should be rechargeable: once in a while, the implant will have to be connected to the CU.
During these sessions, both the battery will be recharged and the data sensed during the autonomous
period will be downloaded to the external world. This operation could be performed by the patient
himself, or by his physician. Obviously, wires coming out the skin are not acceptable for a long-term
implant. Therefore, a wireless energy transmission and telemetry must be used.
3.2.2 Implantability
The conception effort towards an innovative device should benefit different applications. The IMD should
be easily adaptable to different sensors or actuators, and be exploited at different locations and according
to different use patterns.
As an example, the requirements in terms of power consumption vary according to the application:
the device would ideally host a modular battery, in order to adjust its capacity (and size) to the optimum
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Figure 3.1: Concept of Body Sensor Network: several implants perform autonomous duties. An external
Control Unit manages the network and recharge the devices.
interval between recharge sessions and to the size allowed for the device. As a consequence, the casing
should as well be modular.
The fixation method, if any, also depends on the device application. For the most IMDs, the device
will be kept in place by the surrounding tissues. The housing can be treated with a coating increasing
biofouling, i.e., colonization of the casing surface by the surrounding tissue.
3.2.3 Deep Implantation
As the device should be exploited at different locations, it might be implanted in tissues far away from
the skin. If the device needs to interact with the external world, the link used must take into account
the implantation depth, overcome the distance between CU and TR, and deal with the characteristics
of the tissues on the path. Those parameters can be foreseen based on the Visible Human Project [98].
That project was run by the United States National Library of Medicine between 1989 and 1995 and
consisted in digitalizing the human body (female and male) for 3D visualization. Cadavers were frozen
and high-resolution photographs were taken, grinding away up to 1 mm from the top surface of the
specimen before each step. As a result, images of the body "slices" from head to toe are achieved. In the
perpendicular plane, computed tomography visualized the body from arm to arm.
Implant depth can range from some millimeters (for a subcutaneous device) to tens of centimeters
(e.g., for an implant in the abdomen).
3.2.4 Size
The target size of an ideal device is of course the smallest possible and the weight is as light as possible.
Its dimensions and weight are strongly dependent on the implantation location: the IMD must be small
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Figure 3.2: Thin electronics concept for reducing the Implanted Medical Device size.
compared to the surrounding organs, in order to not impact their performance. The implantation method
further affect the maximum allowable size of the device. The ideal implantation technique towards
minimal invasiveness consists in inserting the implant into a blood vessel through a catheter. The position
of the device can be monitored by X-rays, and the device is fixed at the intended site. According to the
application, the maximum acceptable size is also influenced by the device shape. In some cases, an
ultra-thin device could be an interesting option, as it could adhere to flat body structures.
Figure 3.2 visualizes this concept by an example of device. Keys of the thin-device strategy are
the choice of an ultra-thin battery, an ultra-thin PCB, and the clever choice and disposition of further
components. An appropriate casing, not shown in the figure, should be conceived.
Pushing the concept further, a flexible ultra-thin device could be imagined. This would impose that all
the device components are flexible, including the sensor or actuator, or small enough to not disrupt the
bending. Both solutions, on the other end, are not general approaches to IMDs. The best choice for a
general implant is therefore a stiff housing with the smallest dimensions. As a reference, the target size
of the IMD developed within the ULTRAsponder project was 2 cm3 for a weight of about 10 g.
3.2.5 Long-Term Implantation
Another crucial requirement towards the ideal IMD is a long-term implantation. Reason for this is the
potential implantation depth, which makes it unpractical to explant the device. In order to be competitive
with commercial devices, future IMDs must ensure at least ten years of maintenance-free implant life.
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To carry out device operations over a long period of time, internal batteries need to be sized accordingly.
To keep an acceptable device size, the device conception must focus on rechargeable batteries.
An ideal implant, and in particular a long-term implanted device, should also not interfere with the
external world, in order to avoid malfunctioning, and it should not prevent other medical treatments.
Finally, long-term implants require excellent biocompatibility over time, thus increasing the constraints
on housing materials.
3.2.6 Biocompatibility
The IMD must possess some characteristics in order to be compatible with the surrounding tissue.
Long-term implants are particularly concerned by these restrictions.
Biocompatibility is first of all conceived as the absence of adverse response from the body to the
implanted device.
For the integrity of the device itself, the packaging material should be resistant to chemical attack
by the surrounding tissues. In case of metallic materials, they should not be oxidized by the oxygen
dissolved in the blood and in other body fluids. They must be compatible with the wet environment,
containing acids (in gastric fluids for example) and salts.
Casing materials can be intrinsically resistant because of their chemistry, or they should undergo a
surface treatment, for example by coating on them a passivation layer, which should last for the entire
device life.
Intrinsically oxidation-resistant material are for example gold, platinum, magnesium, and zinc. Their
oxidized form is either chemically less favorable than their pure form, or the oxidation process takes
place at a very slow rate. Some other materials, such as titanium and stainless steel, do oxidize, but their
corrosion products form an ultra-thin passivation layer, which prevents further degradation. Contrary to
applied coating on corroding materials, this spontaneous passivation layer regenerates if damaged.
The chemical and physical reaction of the casing with the surrounding tissues also plays a very
important role. The IMD must be in contact with the tissue, in order to sense and/or deliver drugs. For
this reason, formation of a fibrotic, inert tissue around the implant must be avoided.
Also, for the protection of the living tissues, the casing should not release undesired chemicals into the
surrounding medium. As a particular example, leakage from the internal battery should not occur, and it
must be at least stopped by an hermetic casing.
The casing also protects the electronics from mechanical stress, which can be more or less important
depending on the implantation site.
Biocompatibility is also a matter of size and shape of the device. IMDs need to target a shape having
the smallest external surface and avoiding sharp edges, which could hurt the surrounding tissues. The
shape should be adapted to the natural movement of the surrounding organs. Also, the casing should not
offer attachment sites for bacterial colonies. The preferred shape is in many case a cylinder with rounded
endings.
Another constraint on the housing material is given by the sterilization of the IMDs prior to use.
Potentially infectious agents must be neutralized before the device is implanted, in order to avoid
immune reaction from the body. Sterilization relies on high temperature and high pressure. Currently
used methods are sterilization by autoclave, in which the device is held at 121-132 °C at 1-2 bars for
5-45 minutes, or sterilization in an ethylene oxide gas (EtO) environment, at a temperature of 25-75 °C
under 2 bars for 1 to 12 hours. The device housing must be able to withstand the sterilization without
degradation.
The casing will have an influence on the energy transmission, which has to be taken into account.
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Finally, all the characteristics mentioned above should be maintained through the whole life of the
implant.
3.2.7 Autonomy
The ideal IMD is an autonomous system carrying out both a sensing and an actuating role, in which the
sensor part adjusts the actuator delivering drugs or electrical impulses, in a closed feedback loop.
The device will autonomously evolve through a series of states, in order to complete its tasks. The
processing unit is therefore the core of the device: it drives the different components, treats the sensed
data, controls the actuation signals, if any, and manages the communication with the external world or
the rest of the BSN.
In order to be autonomous, the implant should possess a local energy source, for example a battery,
which should reliably supply power. The long-term requirement imposes an intelligent management
of the power consumption, in order to most effectively exploit that local energy storage. The internal
processor should shut down the components not required for the current task.
Even if the device works autonomously, it will need to connect wirelessly with the external CU for
data communication. The implant could for example alarm the CU when a physiological parameter
reaches a critical level; when a series of sensing have been acquired, the TR should communicate them
to the CU; the device could inform the CU about technical problems; the CU could reprogram the TR
according to new therapy requirements.
In order to keep the device as small as possible, but achieving long-term, autonomous applications, the
local battery could be recharged by the CU during the data transmission sessions.
Unfortunately, this approach may not be applied to lifesaving devices, such as cardiac implants as in
this case the power supply of the device cannot fully rely on an external recharge. The patient may tend
to forget to perform the recharge or perform it inefficiently.
A relevant choice in the device design is whether or not the implant will receive modulated instructions
from the CU. If this is the case, the TR must have a demodulation circuitry. This would allow
programming the device function from the external world, thus best targeting the therapy or sensing. On
the other hand, avoiding the additional circuitry would make the implant simpler, cheaper, less power
consuming, and increase the reliability of the system.
3.2.8 Connection to a Control Unit
As already stated, the autonomous device must interact with the external world, and more precisely with
the external CU. The internal state machine is partly autonomous and partly driven by inputs coming
from the CU. Connection to the CU is necessary to download the sensed data, and to monitor the working
state of the device. Also, the link between CU and TR is necessary to recharge the local energy source
of the implant. Figure 3.3 visualizes a general algorithm for an autonomous sensing device interacting
with a CU. When no external stimulus is received, the implanted device is in sleep mode (TR idle) and
wakes up at predetermined times (e.g., each 24 hours) to autonomously sense the required parameter
(TR senses). Once in a while , the CU is put in contact with the implant, in order to download the data
sensed and to recharge the TR. The CU sends energy wirelessly and the TR treats the incoming wave
to recharge its internal battery (TR under recharge). While recharging, the TR sends back its internal
battery level (TR sends Vbat level) at regular intervals (e.g., each 2 seconds). In this way, the CU has
a feedback on the successful wave transmission. As soon as the battery in the TR reaches a sufficient
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Figure 3.3: Example of an algorithm for an implanted sensor device.
level of charge (e.g., 4.1 V), the TR accesses its internal memory and sends to the CU the stored data
(TR sends data).
Acceptable duration of the connexion phase varies according to the application, to the device char-
acteristics and, if possible, to the patient’s requirements. A small device carrying out a particularly
power consuming task will need to be recharged more often than a device with less size constraints, and
thus with larger batteries. Based on informal discussions with surgeons and usual practice, a recharge
period of approximately 30 minutes each week seems acceptable for chronic measurement in human.
For devices implanted in animals for research purpose, it can be imagined to sedate the animal during
connection periods, or to take advantage of periods in which the animal is kept in a tight environment
or in a particularly still position (e.g., eating time or periodical medical check). The appropriate data
sensing frequency depends on the target application and on the available electric power.
The CU itself may need to be connected to the external world, for example in oder to raise an alarm
to a medical doctor when the physiological parameters are indicating a disease. This connection can
be performed by standard techniques relying on electromagnetic waves. It is therefore not a challenge
addressed in this work.
3.2.9 Ultra-low power consumption
In order to best exploit the internal power supply, and to keep the recharge events as infrequent as
possible, the implant should operate at very low power. The integrated microprocessor should be able to
efficiently power up and shut down components when needed and according to their power consumption
in normal, sleep mode, and during their wake-up time. During the idle state between two sensing events,
only a timer will be active,while the other components will be in sleep mode. In order to reduce power
consumption, each component must be chosen accordingly. The ability of placing each component in
hibernation, and their wake-up time, are particularly important.
As an example, Figure 3.4 represents the power consumption expected from a device containing a
microprocessor and a sensor. The microprocessor consumes about 2 mW when in full activity, and only
2 µW in sleep mode. The sensor consumes 1 mW when in activity and will be powered up only during
sensing time. Its wake-up time is 0.4 s. The device is programmed to perform a measurement each day
during 5 s.
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Figure 3.4: Chronograph of a possible device sensing 5 s per day.
It is important to notice that the power consumption during the idle state can account for almost
the totality of the power budget, even if the device consumes thousand times less when in sleep mode.
Indeed, the most relevant parameter in chronic sensor devices is the power consumption while waiting
for the next sensing event.
3.2.10 Cost
Finally, the IMD should be produced at a cost appropriate to the target application. Ideal IMDs,
as described in this chapter, are intrinsically cost efficient. Minimally invasive techniques ease the
implantation process and shorten the patient’s recovery, thus decreasing the hospitalization costs.
Long-term devices result in a lower quantity of implants for a single patient in a lifetime. Therefore,
the single implant can be amortized over many years.
Wireless recharge methods release from the need of explanting the device in order to change the local
batteries. This results again in less hospitalization and hardware costs.
A generic, modular device platform, such as developed within the ULTRAsponder project, can ideally
be the basis for many applications, which will differentiate by the sensor or actuator. The design costs of
a device would therefore be reduced.
Finally, the development of more performing, longer term, smaller, autonomous devices opens up new
application possibilities. The market of IMDs is just emerging.
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Table 3.1: Attenuation comparison of ultrasound, RF, and magnetic induction.
Attenuation @ 10-20 cm
Ultrasound 8-16 dB (@ 1 MHz) [28]
RF 60-90 dB (@ 2.45 GHz) [115]
Magnetic Induction 50 dB (@ 1 MHz, @ 13.5 MHz) [115]
3.3 Gap between the state of the art and the ideal implant
Technologies answering to the single challenges of IMD design partly exist. Nevertheless, a global
approach, integrating different technologies into an efficient device, still lacks. Following sections report
on some aspects which would improve an IMD.
3.3.1 Energy and communication carrier
In order to fulfill the requirements of deep implantation and size, a carrier must be chosen, which is able
to travel through the body.
3.3.1.1 Carrier type
Wireless transfer of energy is already exploited by many medical devices, both in medical domain and in
day-to-day life. Most of them rely on electromagnetic waves [96]. According to the application, either
the magnetic or the electric component of the wave is predominant.
Nevertheless, electromagnetic waves have some drawbacks, which jeopardize the achievement of the
key characteristics of an ideal implant. Mechanical waves, specifically ultrasound, are hereafter proposed
as an alternative wireless carrier, because of their very promising characteristics.
Energy transfer efficiency in deep implanted device: ultrasound propagates very well in body soft
tissues, which have similar characteristics to water. Proof of this fact is the wide use of ultrasonic
waves for prenatal imaging. The acoustic intensity varies on the distance according to a diffraction
inverse-square law, and undergoes an attenuation of about 0.3 dB/cm due to the absorption on the tissues.
Radiation at depth up to 20 cm can be achieved.
On the contrary, electromagnetic waves can only penetrate a few cm into the body, because of tissue
dielectric nature. Deep implants can therefore not be achieved.
Both RF and magnetic induction proved to be less efficient than ultrasound for implant distances bigger
than 10 cm and for antenna sizes smaller than 10 mm, as described by Denisov et al [22]. Table 3.1
summarizes the attenuation constants retrieved from the works of Duck [28] and Yamada et al [115].
Furthermore, the transmission efficiency in magnetic coupling strongly depends on the alignment
of the primary and secondary coils. An accurate positioning and a sufficiently big coil dimension are
required for efficient energy transmission. The penetration depth is linearly dependent on the coil size.
This is a major obstacle to reduced implant size and deep implantation.
Ultrasonic transmission relies on piezoelectric materials, i.e., on materials having the ability to translate
an electrical flow into a mechanical strain, and vice-versa to create an electrical potential when submitted
to a mechanical stress. The efficiency of the process depends on the material piezoelectric coefficients,
and on its thickness, which is in the order of magnitude of the wavelength.
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Several small piezoelectric elements allow beam-forming, which compensates the diffraction effect for
long distance transmissions. The dimension of the elements depends on the working frequency chosen.
As a result of its properties, ultrasound allows conceiving small transducers and radiation deep into
the body, which fulfills the requirements of small size and deep implant.
Compatibility with MRI: the proposed implant is intended to be a long-term device, and it addresses
chronic diseases. The compatibility of the device with MRI is very important, because a patient carrying
the implant should not be automatically excluded from using this diagnosis tool.
Ultrasound is intrinsically compatible with MRI, because it exploits a different physical carrier
(mechanical vibration) which is not affected by the magnetic field produced in the MRI facility.
Electromagnetic waves on the contrary are strongly affected by MRI equipment, possibly inducing
high currents in the device. Especially magnetic induction may therefore not be compatible with MRI.
Compatibility with external radiators: the long-term IMD will be part of the patient’s everyday
life. It must therefore be as inconspicuous as possible. Given the wide distribution of mobile phones,
electronics, and wireless devices, the interaction of an IMD with those radiators is a pertinent question.
Ultrasound is immune to external electromagnetic radiation, because it is a different type of wave.
Ultrasound will not interfere with mobile phones or medical machinery. This is a big advantage with
respect to recharge systems based on electromagnetic radiation or magnetic induction. EM waves surely
can be exploited for energization and communication with an implant, but particular care must be taken
and particular exposure must be avoided. Ultrasound on the contrary is natively compatible with external
electromagnetic sources.
Hacking prevention: as for today, wireless driven medical devices have no particular protection
protocol regarding the CU. The risk exists for IMDs to be maliciously controlled or deactivated, by
communicating on the same frequency as the CU [43]. Even though no attack has been carried out
until now, the risk is concrete and the potential effects of the attack are frightening, e.g., for implanted
drugs pumps, on which the life of the patient depends. This is no blocking point on the use of wireless
communication strategies, but may require in the future the development of a more complex implant
electronics, providing wireless security for the communication [23].
An advantage of ultrasound compared to electromagnetic waves, which propagate in air, is that
mechanical waves require a non-gaseous medium in order to be efficiently propagated. Therefore, no
malicious intervention can occur without contact with the patient’s skin.
Patient safety: any kind of energy transfer between an external CU to the IMD has an effect on the
patient’s body. In case of electromagnetic wave, this consists essentially in a current flow induced in
the tissues. For ultrasound, it is a cyclic displacement of the tissue particles around their initial position.
For both carriers, the main result is heat production inside the tissues, which should not exceed a certain
limit. For both electromagnetic and mechanical waves, regulations set the maximum intensity that can be
safely sent to the implant without adverse bioeffects [1, 94].
Given the low electrical impedance of tissues and the spherical wave front of EM, the beam will highly
spread into the body, and the "useful" intensity reaching the implant will be a small part of the power
originally sent. The most part of the electrical power will contribute to the heating of the surrounding
tissues.
On the contrary, ultrasound in soft tissues essentially propagates in the longitudinal direction and
undergo small attenuation on the propagation path, so that the implant receives a bigger share of the
acoustical power sent by the CU, thus affecting less the surrounding tissues.
This is beneficial to the patient, as (almost) only the power required for the implant needs to be sent,
and the adverse bioeffects are reduced.
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For all these reasons, the exploitation of ultrasonic waves is preferred over magnetic induction for the
application targeted in this work, i.e., small, deep implanted, long-term medical device.
3.3.1.2 Carrier frequency range
Given the choice of ultrasound as a carrier for energy transfer between the external CU and the implanted
TR, the choice of the working frequency is very relevant.
The influence of the wave frequency on the characteristics of ultrasound is presented in more detail
in Chapter 4, and it is shown that an appropriate frequency for the application can be chosen, which
minimizes adverse bioeffects.
The system presented in this work exploits wireless transmission to two different aims: energy
transfer from the CU to the implanted TR, and communication of the data from the TR to the CU by
backscattering. In both cases, the carrier is generated by the CU. In principle, a lower frequency could
be used during energization, in order to face less attenuation and more efficiently recharge the implant.
Conversely, higher frequency is advantageous during data transmission, in order to increase the data rate
of the backscattered signal and achieve shorter communication sessions.
3.3.2 Ultra-low power consumption
In order to optimize the power consumption during autonomous operation of the implanted device, low
power components must be chosen.
Moreover, as the system will be in idle state most of the time, an intelligent strategy for switching
the components on and off should be elaborated. Therefore, the microprocessor is a key element of the
system. Its power consumption when inactive should ideally be in the order of magnitude of few µW.
The power budget for the whole system, i.e., when all components are switched on, should remain below
10 mW.
Further action can be taken in order to reduce the energy spent during communication with the CU.
The energy required to create the wave on which the information will travel accounts for most of the
power consumption. This is reduced by the backscattering principle exploited in the ULTRAsponder
project, as it lets the CU create the communication carrier (e.g., the ultrasonic wave) and the carrier on
TR side is modulated by varying its input impedance. This requires little power, to basically switch on
and off an additional circuit element. This mismatches the power transfer, thus reflecting the incoming
wave to different extents.
3.3.3 Casing
Among the biocompatible materials, titanium is the most suited option for long-term devices.
Unfortunately, titanium has a non-negligible effect on ultrasonic waves, which will be exploited as
energy and data carrier. Titanium acoustic impedance (22.5 MRayl) is about 20 times bigger compared
to that of the human body (about 1.5 MRayl). It will therefore induce an acoustical mismatch and will
act as a barrier: ultrasound will be partially reflected off it. The energy transfer will be inefficient.
An appropriate impedance matching layer in the transducer can adapt the acoustic transmission and
compensate the effect of titanium.
From another perspective, the influence of the titanium layer on the ultrasonic transmission depends
on its thickness. Therefore, an ideal implant exploiting ultrasonic link would ideally have a casing as
thin as possible.
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On the other hand, the casing should protect the electronics inside the device, both from chemical and
mechanical degradation agents. A housing-less device is not (yet) conceivable.
An important technological challenge to overcome for the next generation of IMDs will therefore be
the development of a housing layer compatible with ultrasonic energy transfer while ensuring sufficient
protection to the electronics of the implant. This basically means to have a housing which is as thin as
possible, at least in the region of the transducer.
Thin layers of titanium can be either manufactured by deposition, maybe even directly on the piezo-
electric transducer, or locally thinning a thicker titanium plate on the position of the transducer.
Thinning down appears most advantageous when transducers are small with respect to the housing
size. This allows the preservation of the thickness, therefore the mechanical strength, in the rest of the
casing.
3.3.4 Choice of electronic components
Each component of the implant electronics plays an important role towards meeting the characteristics of
the whole device. All components should be MRI compatible: the metals contained in them must be
non-ferromagnetic, i.e., not sensitive to the fixed magnetic field created in the MRI equipment. Also,
all of the electronics must be able to stand the chosen sterilization procedure (e.g., high temperature),
which depends on the target application. In addition to that, the different components have their own
requirements. An overview is hereafter presented.
Battery: A very crucial component of the targeted device is the rechargeable battery. The size plays
a major role, as well as the form fitting the casing geometry. In order to allow long-term implants, the
battery should be able to be recharged as many times as possible. Ideally, the battery should not contain
biohazardous materials. At least, liquids should not leak from the electronics into the body. For these
reasons, ultra-thin solid state batteries are the ideal solution.
Memory: A non volatile memory is required inside the implanted device, in order to store both
the instructions needed by the microprocessor to perform its actions, and the data coming from the
sensor. For a given size, the more data that can be stored, the better the choice. The memory chip, like
the other components of the implant, should be non-ferromagnetic, in order to preserve compatibility
with MRI. This leads to the choice of Ferroelectric Random Access Memory (FRAM) devices, which
store the data into a ferroelectric layer instead of a dielectric layer. The ferroelectric layer reacts to an
electric field according to a hysteresis loop. Similar to ferromagnetic materials, which are constituted of
semi-permanent magnetic dipoles, ferroelectric materials contains semi-permanent electric dipoles in
their crystalline structure: when an external electric field is applied across the storage cell, the dipoles
tend to align themselves with the field direction. After the charge is removed, the dipoles retain their
polarization state. Binary "0" and "1" are stored as one of two possible electric polarizations in each data
storage cell. Due to the ferroelectric layer, and contrary to other memory types based on a ferromagnetic
layer, FRAM is insensitive to magnetic fields, thus compatible with MRI. Power consumption is reduced,
because FRAM does not require DC-DC converters like other non-volatile memories. FRAM has an
extremely high endurance, which is well suited for long-term implants. Its speed is much higher than
other non-volatile memories.
Microprocessor: the microprocessor will be the core of the implanted device: it will manage the
power management circuitry, enable the recharge of the internal battery or the use of the stored power
for sensing/actuation operations. It will drive and set up the sensor/actuator and store the sensed data.
During connection periods with the CU the microprocessor will retrieve the data stored in the memory,
condition them into a modulated message, and drive the backscattering circuitry. The microprocessor
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contributes to the power budget of the implant in several ways. It contributes directly with its own power
consumption, which must therefore be as low as possible. As an indirect contribution, the microprocessor
drives the implant components, wakes them up or shuts them down according to the chosen power saving
strategy, thus reducing the power consumption to the minimal needed for the operation.
Sensor/Actuator: the sensor or actuator is the component differentiating the devices according to the
application, while the rest of the implant is conceived to be as generic as possible and able to adapt to
many sensors/actuators. In itself, the component should be as low power as possible. An appropriate
connection between this active block and the TR electronics must be foreseen. A front-end circuit will
care about the exchange of data and operation commands. A necessary part of this interface is an Analog-
to-Digital Converter (ADC), which will convert the sensed parameter (analog) into a digital signal. The
microprocessor can then interpret that signal into a data to be stored in the memory. Vice-versa, in the
case of an actuator, it will drive the actuator in an efficient way.
3.4 Scientific and Technological impact
If the described challenges can be overcome, uncountable new possibilities for diagnostics, therapy,
and research can be conceived. Better diagnosis could be achieved, wherever a continuous, long-
term monitoring of physiological parameters in real life conditions is required. In this domain, future
applications of next generation IMDs may include:
Congestive Heart Failure (CHF): Heart failure is a condition in which the heart is not able to
efficiently deliver blood to the body. In many cases, fluids are accumulated inside tissues, and cause
swellings in the lungs (pulmonary edema) or in the legs. This particular case is called CHF. The heart
tries to compensate its inefficiency by beating more often and stronger. Therefore, the heart walls thicken.
At the same time, the kidneys retain more salts, in order to increase the blood quantity at disposal. This
causes even more fluid accumulation, thus leading to a chronic condition and a sure weakening of the
kidneys. Ability to monitor the change in size of the heart would be a very precious tool to predict heart
failure. Also, the size would indicate the level of heart congestion, so that the therapy can be tailored to
the patient’s need: the exact amount of drug could be delivered, and the moment of major need could
be chosen. Ambulatory monitoring is costly and greatly impairs the patient’s autonomy. Continuous
monitoring [12] and home-monitoring [15] would be very beneficial.
Myocardial Ischemia: This disease is generally associated with increasing Left Atrial Pressure (LAP).
At the moment, no efficient mean is available to monitor LAP. Ritzema-Carter et al. [83] presented
a LAP monitoring device able to detect Myocardial Ischemia. Challenge for future IMDs is to be
implanted directly inside the atrium for a long term, deliver the necessary information to diagnose
ongoing Myocardial Ischemia, and possibly give an alarm before irreversible damages occur.
Hypertension: An IMD small enough to allow intra-vascular pressure monitoring would ease the
diagnosis of hypertension and its therapy. As an example, the precise shape of the blood pressure
variation could be obtained, instead of a minimum and maximum value. The peaks of blood pressure
could be detected and treated, and links between blood pressure and external environment may be
assessed. Schmitz-Rode et al. [90] developed an IMD for telemetric intra-vascular blood pressure
monitoring. Refinements of the transmission technology are needed to extend the transmission distance
between capsule and reader antenna.
Smaller and deeper implanted devices would also allow several IMDs in the body. This would be
extremely beneficial in neural stimulation, for example for chronic pain treatment. Nerves in several
locations could be stimulated, for a more efficient effect. Also, the diagnosis of back pain and its
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evolution could be better understood. As an example, Brisby et al. [13] proposed a system to investigate
the concentration of nitric oxide in the joints between the vertebrae in patients with chronic low back
pain.
Finally, optimized IMDs would boost the medical research possibilities, by allowing closer observation,
thus helping understanding physiological mechanisms. Some examples of mechanisms, which surgeons
would like to explore are:
Arterial pressure variation over 24 hours: The human body behaves according to a circadian
rhythm, that is to say its physiological parameters display oscillation of about 24 hours. It would be very
interesting to study the variation of arterial pressure over the course of a day, and to understand which
external or internal cues influence it. In order to do this, long-term, easily implanted, and self-expelled
IMDs should be developed.
Another aspect to be improved concerns the type of measurement performed. Currently, blood pressure is
measured at the circulation periphery (e.g., on the arm). There the pressure variations, corresponding to
the heart beat phase, are dumped according to the blood vessel compliance, which is related to personal
morphology, size of the vessels, and atherosclerosis. Therefore, only the maximum and minimum
pressure value can be exploited. On the contrary, a sufficiently reactive sensor could retrieve information
about the blood pressure dynamic as well (i.e., its instantaneous changes), which would give more insight
into heart activity. To do this, the measurement must be performed right inside the heart. Therefore, the
IMD must be very small and easily reach and stay in the heart chambers. Wang et al. conceived a soft
catheter [111] inserted in the heart of laboratory mice, in order to test the effect of different drugs and
external factors on heart activity during the day [110].
Diabetes evolution: The causes of diabetes mellitus type 2, which arises with age, are not yet
understood. A genetic predisposition was observed, but external cues surely intervene, such as lack of
physical activity and alimentary habits. Minimally invasive IMDs could be deployed in healthy subjects,
both with familiar history of diabetes or with none. This could allow observation of the disease in its
early stages and understand its evolution. Also, larger screening for diabetes in people at risk would be
beneficial, because this disease has a prolonged asymptomatic phase [106]. Detection at an early stage
would prevent complications.
Idiopathic Pulmonary Arterial Hypertension (IPAH): Pulmonary hypertension is a condition in
which the blood vessels around the lung progressively thicken and eventually leak fluids inside the lungs.
This pathology leads to irreversible damage in the lungs, heart failure [100], and early mortality. The
disease can be an effect of pre-existent vascular diseases or be congenital. IPAH is a particular form of
pulmonary hypertension, which arises spontaneously. Its underlying causes and risk factors could not
yet be defined. IMDs offer a promising tool for better understanding the evolution of the disease and
thus develop a better treatment. Ideally, a serial monitoring of hemodynamics should be performed in
affected patients. Karamanoglu et al. [49] proved the link between right ventricular pressure and IPAH.
For research purpose, clinicians may also want to monitor healthy cavies and try to induce the disease.
3.5 Conclusion
Implanted Medical Devices have played an increasing role in health care in the last decades and
expectations have risen for less invasive therapies, more precise sensing, and continuous monitoring.
Despite the remarkable technological advances, among others in device miniaturization, several technical
challenges still need to be overcome towards a new generation of IMDs.
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Table 3.2: Technical challenges towards a new generation of IMDs.
Challenge State of the art Proposed solution
Power supply Permanent battery Recharging
Energy transfer Subcutaneous Deep implant
Carrier type RF, magnetic induction Ultrasound
Battery Li-Ion Solid-state electrolyte
Memories Flash, EEPROM FRAM
In this chapter, a set of requirements for a new generation of implants were identified. The long-term
aim is an autonomous device containing both sensing and actuating capabilities, to be chronically
implanted. To achieve this, several aspects of the device must be taken into account, and a good trade-off
must be found. Biocompatibility on the long term, small size, connection to the outside world, and very
low power consumption are some key parameters.
A particular system was discussed, composed of an external CU and an implanted TR. Solutions
for the communication carrier, the biocompatible casing, and the power consumption were proposed,
which can be exploited together. Most important, the compatibility between the ultrasonic carrier and the
titanium casing was questioned, and plans for the adaptation were conceived.
Chapters 5 and 6 describe in more detail the device concept and the demonstrators manufactured.
Table 3.2 overviews the main challenges that the new generation of IMD needs to overcome. The
ULTRAsponder project, to which the author of this thesis contributed, addresses some of those challenges.
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4 Physics of Ultrasound
4.1 Introduction
Ultrasonic waves are a promising carrier for communication to an IMD from the external world. They are
especially advantageous with respect to magnetic induction for deep implanted and small devices [22].
For this and other reasons, the system presented in this thesis work exploits ultrasound as a carrier for
both energy and data transfer. Another very important feature of the implant proposed is its biocompatible
casing, made of medical grade titanium. This material has a strong effect on ultrasound. It is therefore to
investigate if an ultrasonic link can be established through a titanium casing, and under which conditions.
The main goal in this chapter is to demonstrate that ultrasonic propagation through titanium can be
achieved, given an adapted design of the casing. As a related topic, the characteristics of the wave are
defined, which best suit the intended application in human body. The physics governing ultrasound
is presented, both for application in fluids and in solids. Significant characteristics of the ultrasonic
transmission are explicitly calculated, such as the wave intensity and the acoustical impedance of the
material. The effects of ultrasound on tissues are presented and the wave characteristics are adjusted
in order to minimize the adverse bioeffects. The theory presented follows the procedure and the
demonstrations of the book “Basics of biomedical ultrasound for engineers” by H. Azhari [3].
A model of the proposed transmission chain between the Control Unit and the Transponder is
developed, including two piezoelectric transducers and a medium representing the body soft tissues. The
propagation of ultrasound through the receiving transducer is simulated using a MATLAB® function,
based on the Krimholtz Leedom Matthaei (KLM) model [55]. Particular focus is set on the effect of the
titanium casing in the ultrasonic path.
4.2 Definition
Ultrasounds are mechanical waves traveling at a frequency higher than the human auditive range
(f ≥ 20 kHz). They exert a pressure on the medium, cyclically compressing and rarefying the particle
network in the direction of propagation. The physical unit of measurement for mechanical waves is the
Pascal (Pa), defined as a force (Newton, N) per unit surface (square meters, m2): Pa = N/m2.
Like any kind of wave, mechanical waves can be classified according to their propagation direction
(longitudinal or transversal waves) and their wave front (planar or circular waves).
When an object is subject to an ultrasonic wave, several physical characteristics have a wave-like
variation: the local particle displacement, the particle velocity, and the material density for example.
4.3 Mathematical description
An ultrasonic wave can be represented by the general wave function (in one dimension) u(x ± vt) where
v is the wave velocity, x the propagation axis and t the time. The complete form in three dimensions
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substitutes x with nˆ, the unit vector defining the direction of wave propagation, and ~r, the spatial location
vector.
u(nˆ · ~r ± vt) (4.1)
The function complies with the general wave equation
∇2u = 1
v2
∂2u
∂t2
(4.2)
The Fourier’s theorem demonstrates that any periodic function of period T can be written as the sum
of infinite sine and cosine terms, which angular frequencies are ω = 2piT and its multiples 2ω, 3ω and so
on. The lowest frequency (ω) is referred to as the fundamental frequency, and its higher multiples are
known as harmonics.
Therefore, the wave function (in one dimension) can be written as u = A cos(ωt − kx + φ), where A is
a scaling factor accounting for the amplitude of the wave, ω is the wave frequency, and k the so called
wave number. The parameters ω and k take the place of the previously mentioned wave velocity and are
linked to it by the relation v = ωk . By definition, k is linked to the wavelength λ by the relation k =
2pi
λ ,
and the wavelength is the displacement of the wave at velocity v after a period (T = 1f ): λ = v · T .
Euler’s formula e jx = cos x + j sin x allows exploiting either the exponential or the trigonometric
formulation, as best suited for the calculations. In trigonometric form, the wave behavior is expressed
by both the real and the imaginary part. Therefore, it is sufficient to keep either sin x or cos x in the
calculations.
u = A · e j(ωt−kx) (4.3)
4.3.1 Ultrasonic wave in fluids
Mechanical waves, and thus ultrasound, in fluids can be described by the pressure variation inside the
medium, due to the change in fluid density. The pressure variation is by definition
∆p = −1
β
· ∆V
V
(4.4)
where V is the volume and β the compressibility of the fluid at a given temperature.
The displacement of a given point in the fluid under the effect of the ultrasonic pressure can be
calculated by considering an infinitesimal volume V = dx1 · dx2 · dx3, as depicted in Figure 4.1 and
applying Newton’s law linking force and acceleration
F = m · ∂
2η
∂t2
(4.5)
where m indicates the mass of the considered volume and η is the displacement along the propagation
axis x2.
The change in volume ∆V/V , caused by the pressure applied, can be developed as
∆V
V
=
dx1 · dx3 · ∂η∂x2 · dx2
dx1 · dx2 · dx3 =
∂η
∂x2
(4.6)
The sum of the forces acting on the volume is
F =
[︃
p −
(︃
p +
∂p
∂x2
dx2
)︃]︃
· dx1 · dx3 = − ∂p
∂x2
· V (4.7)
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Figure 4.1: Effect of a mechanical wave on a fluid element of infinitesimal volume. Adapted from Azhari
[3].
and the mass, given the fluid density ρ, is
m = ρ · V (4.8)
From this and by removing the volume from both sides, the Newton’s law results in
− ∂p
∂x2
= ρ · ∂
2η
∂t2
(4.9)
Introducing the notion of velocity potential ϕ, defined as
∂ϕ
∂x2
=
∂η
∂t
(4.10)
the equation can be rewritten as
− p = ρ · ∂ϕ
∂t
(4.11)
Now, substituting eq. 4.6 in eq. 4.4, the expression of the pressure variation ∆p as a function of
displacement η is obtained
∆p = −1
β
· ∂η
∂x2
(4.12)
Noting that p = ∆p + p0 (with p0 constant) and therefore
− ∂p
∂x2
= −∂(∆p + p0)
∂x2
= −∂∆p
∂x2
=
∂
∂x2
·
(︃
1
β
· ∂η
∂x2
)︃
=
1
β
· ∂
2η
∂x22
(4.13)
The wave equation can finally be developed as
∂2η
∂x22
= (β · ρ)∂
2η
∂t2
(4.14)
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from which can be derived the wave velocity of the ultrasonic radiation
v =
1√
β · ρ (4.15)
To sum up, in an isotropic fluid medium, the behavior of the ultrasonic wave can be completely
described by the velocity potential ϕ, and by the associated particle velocity η˙, acoustic excessive
pressure ∆p, and density variation ∆ρ
η˙ = −∇ϕ (4.16)
∆p = −ρ0 ∂ϕ
∂t
(4.17)
∆ρ = −ρ0
η˙2
∂ϕ
∂t
(4.18)
It is important to keep in mind that soft tissues are very similar to fluids when exposed to ultrasound.
Hence, the analysis of ulltrasound in fluids apply in first approximation also to the propagation inside the
body.
An important characteristic of fluids and soft tissues is the strong attenuation of shear waves, because
of the mobility of different fluid layers within the medium. Therefore, almost exclusively longitudinal
waves are expected in fluids (and in soft tissues).
4.3.2 Ultrasonic wave in solids
Solid materials, contrary to fluids and gases, support the propagation of both longitudinal and transversal
waves. The external forces acting on the volume are measured as a stress, defined as the ratio between
the force applied and the surface on which the force is applied. In that sense, stress has the same physical
dimension and meaning as the (e.g., ultrasonic) pressure. Stress values are defined by both the direction
of the force, and the plane on which the force is applied. Stress coefficients σi j are therefore identified
by two subscripts, the first indicating the surface on which they act, and the second the propagation
direction. Figure 4.2 depicts the stress vectors acting on a volume element and Equation 4.19 develops
the stress tensor σ into its different individual coefficients.
σ =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎝σ11 σ12 σ13σ21 σ22 σ23
σ31 σ32 σ33
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎠ (4.19)
Every stress coefficient generates a force trying to displace the material. It is therefore intuitive that for
every stress σi j there must be a stress σ ji in the opposite direction, and that those two stresses must be
equal: σi j = σ ji.
As a reaction to stress, the material deforms according to its elastic coefficients C. The strain ε
measures this deformation and the strain coefficients are indicated as εkl. The effect of ultrasound in solid
materials is a linear-elastic wave, complying therefore with Hooke’s law stating that strain is directly
proportional with stress. The strain-stress relation can be described by
σi j = Ci jkl · εkl (4.20)
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Figure 4.2: Effect of a mechanical wave on a solid element. Adapted from Azhari [3].
where σ is the stress, ε the resulting strain, and C is the matrix of elastic coefficients of the material. The
accepted approximated definition of the strain coefficients for small displacements (which is the case for
ultrasound) is
εkl =
1
2
[︃
∂ηk
∂xl
+
∂ηl
∂xk
]︃
(4.21)
where η indicates as usual the displacement. It is clear from this equation that εkl = εlk. Figure 4.3
depicts a two-dimensional deformation.
Both σ and ε have 9 elements (every combination of the three axis), so that their relation possesses
81 parameters in total. Fortunately, the independent parameters can be strongly reduced keeping in
mind that εi j = ε ji and σi j = σ ji, and in many cases they can be even further reduced. A particularly
advantageous case are isotropic materials, for which the independent parameters are only two, so called
Lamé parameters.
The elastic properties of a material can be expressed by a series of coefficients, which are linked to
each other:
Young’s modulus E is the ratio between tensile stress and strain in one direction, and under the
conditions of validity of Hooke’s law. Given that the strain is dimensionless, the Young’s modulus has
the units of the stress, a pressure (Pa). It can be expressed as
E =
1D stress
1D strain
=
σ
ε
=
F · L
A · ∆L (4.22)
where A is the medium surface perpendicular to the wave propagation and L the length when no wave is
applied.
Poisson’s ratio ν indicates the cross-influence of strains in perpendicular directions. It is based on the
observation that an extension of the material in one direction results in a contraction in a perpendicular
direction. Poisson’s ratio is defined as
ν = −dεtrans
dεaxial
(4.23)
Bulk modulus B measures the material resistance to an uniform pressure in all directions of a certain
volume V . It can be expressed both according to the density variation ∆ρ, or the volume variation ∆V
B = −V dp
dV
= ρ
∂p
∂ρ
(4.24)
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Figure 4.3: Deformation of a 2-dimension shape, evidence of the strain coefficients. Adapted from
Sanpaz [88]).
Shear modulus G or modulus of rigidity indicates the ratio between a shear stress (i.e., a stress in
a direction perpendicular to the wave propagation), and the resulting shear strain. Assuming a wave
acting on a surface A on the xy plane of a volume element of length L, and a resulting strain ∆x, the shear
modulus is by definition
G =
σx1 x2
εx1 x2
=
F · L
A · ∆x1 (4.25)
In case of homogeneous, isotropic materials, these coefficients are not mutually independent, but linked
by conversion relations, so that two coefficients fully determine all others.
As previously done for the displacement in fluids, the wave equation for the displacement in one
direction (e.g., along x2) can be obtained applying Newton’s second law on an element of infinitesimal
volume, shown on Figure 4.4.
The Newton’s law applied to this case states
ΣFx2 = m · η¨2 = ρ · dV · η¨2 (4.26)
where each contribution to the force will be a function of σi2
Fi2 =
∂σi2
∂xi
· dV (4.27)
ΣFx2 =
(︃
∂σ12
∂x1
+
∂σ22
∂x2
+
∂σ32
∂x3
)︃
· dV (4.28)
and expressing the stress σ by the elastic coefficient C and the strain ε (Equation 4.20), and expressing
the strain ε by the displacement η (Equation 4.21), the resulting wave equation for the displacement is
Ci jkl
∂2ηk
∂xi∂xl
= ρ0
∂2η j
∂t2
(4.29)
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Figure 4.4: Set of stresses on an element of infinitesimal volume. Adapted from Azhari [3].
where the indexes i jkl indicate the plane and the direction of the stress and the strain. This equation is of
course generally valid for each axis, not only for the example given x2. Writing explicitly the indexes, a
system of equations arises.
Now, keeping the assumption that the wave propagation direction lies on the xi axis (which does not
reduce the generality of the notation), the displacement can be described by the general wave function
ηi = ηi0 · e j(ωt−~k~r) (4.30)
and the wave equation simplifies to
−Ci jkl · k j · kl · ηk0 = −ρ0 · ω2 · ηi0 (4.31)
Or, introducing the notation
ηi0 = δik · ηk0 = δi1 · η10 + δi2 · η20 + δi3 · η30 (4.32)
where δik (Kronecker’s delta function) is equal to 1 if i = j and equal to 0 otherwise,
(Ci jkl · k j · kl − δik · ω2 · ρ0) · ηi0 = 0 (4.33)
Exploiting the delta function, this equation develops into a system of only three independent equations
according to the three axes.
The terms Ci jkl are the elastic coefficients of the material, they are therefore known. The unknown are
the wave numbers k1, k2, and k3 along the three axes. The solution of the previous system of equations
determines the behavior of the displacement wave η(xi, t).
4.3.3 Wave energy and intensity
In order to analyze the energy of an acoustic wave, the medium material should be considered as a
matrix of particles, with a certain mass, linked together by spring-like interparticle connections. The
incoming wave displaces the particles, therefore "stretching" and "pulling" the interconnections. A purely
longitudinal wave is considered, traveling along axis x2. The kinetic energy associated with a mass m
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traveling at a speed v is known by classic mechanics to be Ekin = 12 ·mv2. In the case of an acoustic wave,
following the usual notation for the particle velocity η˙, it can be written as
Ekin =
1
2
mη˙2 =
1
2
ρ · dV
(︃
∂η
∂t
)︃2
(4.34)
The wave function for the displacement in its trigonometric form being η = η0 cos(ωt − kx2), its velocity
is therefore
∂η
∂t
= −η0ω sin(ωt − kx2) (4.35)
The kinetic energy per unit volume will be
E′kin =
Ekin
dV
=
1
2
ρ
(︃
∂η
∂t
)︃2
=
1
2
ρη20ω
2 sin2(ωt − kx2) (4.36)
The kinetic energy in a specific point x2,0 is equal to the energy at the time t0 in which the wave passes
through that point. By definition, t and x2 are such that sin(ωt − kx2) = 1. From that it can be concluded
that the wave energy is
E′ =
ρη20ω
2
2
(4.37)
The wave intensity is by definition the amount of energy per unit time and unit volume
I =
E
dV · dt =
E′ · dV · dl
dV · dt (4.38)
where the length l traveled during dt can be expressed, knowing the wave velocity v, as dl = v · dt.
Therefore, the intensity of the wave will be
I =
E′ · v · dt
dt
= E′ · v (4.39)
and using Equation 4.37, it results that
I =
ρ · η20 · ω2 · v
2
(4.40)
It is interesting to note that the intensity of the wave is proportional to the square of the angular
frequency ω.
4.3.4 Acoustical Impedance
Now that the general behavior of ultrasonic waves in homogeneous media is defined, it is interesting
to analyze the effect of a wave crossing different media. In order to do this, the concept of ultrasonic
impedance Zac of a medium must be defined, and from that the reflection coefficient R and the transmission
coefficient T can be calculated.
An ultrasonic wave is a pressure gradient acting on the volume element. This pressure gradient will
induce strain and therefore displacement in the medium particles. In analogy with Ohm’s law for electric
circuits, the pressure gradient p = p − p0 can be considered as a potential differential, and the resulting
particle velocity η˙ as a current. The acoustic impedance Zac is therefore by definition
Zac =
p
η˙
(4.41)
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The ultrasonic pressure effect was previously analyzed in both a fluid (Equation 4.9) and a solid
(Equation 4.26). The equations can be rearranged into
− ∂p
∂x2
= ρ0 · η¨ (4.42)
This equation should be expressed in a way that underlines the relation between p and η˙. To that end,
both sides are integrated along the wave propagation axis (e.g., x2) and η¨ is further integrated along the
time. The equation becomes
− p =
∫︁
ρ0η¨ dx2 (4.43)
Given the general form of the displacement wave
η(x2, t) = η0e j(ωt−kx2) (4.44)
each derivative in time is equal to the function multiplied by jω. Its second derivative is therefore
η¨ = jω · η˙ (4.45)
and the integral of η˙ along x2 is∫︁
η˙ dx2 =
∫︁
η˙0e j(ωt−kx2) dx2 = η˙0 · (− 1jk )e
j(ωt−kx2) = − 1
jk
η˙ (4.46)
A more detailed and rigorous calculation can be found in Azhari [3].
Equation 4.43 can therefore be rewritten as
p = −
∫︁
ρ0η¨ dx2 = −ρ0 · jω
∫︁
η˙ dx2 = ρ0
ω
k
· η˙ (4.47)
which finally results in
Zac =
p
η˙
= ρ0
ω
k
= ρ0c (4.48)
This relation is valid both for planar and circular ultrasonic waves, under certain conditions. The unit
of measurement of acoustic impedance are mega Rayleigh (MRayl), corresponding in the Système
International d’unités (SI) base units to
Rayl =
kg
s · m2 (4.49)
Table 4.1 presents the main acoustical parameters for some common materials, for biological tissues,
and for some materials used in the manufacture of transducers. Characteristics are retrieved from Zhu
[119] and from manufacturer datasheets [41].
The definition of the acoustic impedance links the excessive pressure p to the wave intensity I. It is
known by Equation 4.40 that I = 12ρ0cη˙
2, and that Zac = ρ0c. It is therefore valid that
I =
1
2
Zac
(︃
p
Zac
)︃2
=
p2
2Zac
(4.50)
It is important to note a small break in the analogy between the electrical and the acoustical world:
while the electric power is by definition the product of voltage and current (Pel = V · I, expressed in [W]),
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Table 4.1: Acoustic characteristics of various materials.
Material ρ [kg/m3] B [GPa] v [m/s] Zac [MRayl]
Blood 1025 1570 1.61
Muscles 1070 ∼ 2.5 1542-1626 1.65-1.74
Bone 1380-1810 ∼ 10-30 2700-4100 3.75-7.4
Air (0°C) 1.2 330 0.0004
Water (25°C) 988 1497 1.48
Aluminum 2875 ∼ 100 6260 18
Gold 19290 ∼ 200 3240 62.5
PZT-5A 7750 ∼ 150 4350 33.71
Rubber 950 ∼ 2.5 1550 1.472
Titanium 4500 110 ∼ 5000 22.5
the product of the corresponding parameters in the acoustical world (applied pressure p and particle
velocity η˙) gives the acoustic intensity Iac = p · η˙ in
[︁
W
m2
]︁
.
The factor 1/2 appearing in Equation 4.50 comes from the trigonometric expression of both pressure
and velocity. The same factor appears in the electrical power, when voltage and current are expressed
by sinusoidal waves. Given a pure sinusoidal wave of amplitude A, its effective value is equal to A√
2
.
Therefore, the product of two effective values will carry a factor 1/2.
The acoustical power is by definition the product of force (pressure · surface) and particle velocity,
and of course the product of wave intensity and surface:
Pac = p · η˙ · A (4.51)
4.3.5 Piezoelectric materials
Piezoelectric materials are various solids having the property of reacting to an exterior pressure with
an electric potential, and which viceversa generate an internal mechanical strain in response to an
external electric potential. Such materials include for example crystals (e.g., S iO2, LiNbO3, LiTaO3)
and particular ceramics such as BaTiO3 and Lead Zirconate Titanate Pb(Zr1−xTix)O3 (PZT). Plastic
polymer PVDF (polyvinylidene difluoride) has a piezoelectric behavior beyond 100 MHz. Strictly
speaking, even several biological materials exhibit a certain degree of piezoelectricity, for example DNA
molecules, tendons, and bones.
The piezoelectric characteristics of the material can be described by linear relationships between
stress σ and strain ε on mechanical domain, and electric induction (electric charge density displace-
ment) D and electric field E on electrical domain.
Several piezoelectric coefficients can be defined. The most relevant are the direct piezoelectric
coefficient d, measuring the variation in charge displacement due to the applied stress, and the inverse
piezoelectric coefficient h, measuring the variation in mechanical stress in the material due to the electric
induction:
d =
∂D
∂σ
⃒⃒⃒⃒⃒
E=const
(4.52)
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h = −∂σ
∂D
⃒⃒⃒⃒⃒
ε=const
(4.53)
Both the charge displacement density D and the mechanical strain ε will be the combined effect of
both a mechanical stress σ and an electric field E. Therefore, the "extended" Hooke’s law becomes
σ = c · ε − h · D (4.54)
The electric field E, which in absence of piezoelectric mechanism is simply proportional to the induc-
tion D by the material permittivity , takes now into account a term due to the mechanical strain:
E =
1

D − h · ε (4.55)
As a reminder, the electric current I is linked to the electric induction D by the relationship
I =
"
A
D dx1 dx3 (4.56)
which for harmonic waves becomes I = jωD · A, where A is the material surface in the x1x3 plane, as
opposed to the wave propagation direction x2.
PZT ceramics are the most used piezoelectric materials for medical purposes, mainly because of their
very high piezoelectric and electromechanical coefficients. Care has to be taken when handling ceramics,
that the temperature does not overcome their Curie temperature, over which the polarization of the
material is damaged. For PZT, Curie’s temperature is approximately 150 to 400 °C. This property has an
influence on the implants containing PZT material: device sterilization at higher temperature cannot be
taken into consideration.
4.3.5.1 Composites and multiple elements
In order to better exploit the piezoelectric behavior of materials, and adapt their characteristics to the
target application, particular geometrical structures have been developed.
Piezocomposites are matrix structures of thin rods of piezoelectric material in a polymer ground. A
piezoelectric block is cut along its thickness (keeping a common ground) and a polymer is flown in the
resulting lines between the rods.
Piezocomposites offers superior piezoelectric characteristics due to the piezoelectric material, but
lower Zac and larger bandwidth, due to the influence of the surrounding polymer. The effective density,
acoustic impedance, and wave speed in composite depends on the percentage of piezoelectric ceramic
[29, 37].
Multielements transducers follow the same concept but at higher scale: instead of a single thin
piezoelectric layer, the active part is constituted of several piezoelectric elements. This optimizes the
angular acceptance in reception.
It is important that the pitch between adjacent elements is on the order of magnitude of the wavelength,
in order to avoid crosstalk. The effective coupling factor is as high as the free ceramic, because the
surrounding polymer is allowing vibration in lateral direction.
Multielement transducers further allow beam forming by commuting the elements used. Different
electric signals can be sent on each element, in order to focus the beam. Spatial sweep in a region
is possible by varying the input to the elements, according to a sequence. For penetration in very
inhomogeneous media, which attenuate the wave by scattering in various directions, time reversal
techniques can be exploited: the input on the single elements is adapted based on the backscattering
[17, 36, 114].
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Piezop1 p2
v1 v2
(︃
p1
v1
)︃
= T ·
(︃
p2
v2
)︃
(4.57)(︃
p1
p2
)︃
= Z ·
(︃
v1
v2
)︃
(4.58)
Figure 4.5: Schematics and equation of an acoustic transmission line.
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·
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(4.59)
Figure 4.6: Schematics and equations for cascading of two quadrupoles.
4.3.5.2 Network notation
As already seen, the mechanical wave transmission can be described by an acoustic pressure (stress)
producing a particle displacement (strain). The mechanism is analog to electrodynamics, where a
potential difference (a voltage) displaces electrons and thus produces a current. Acoustic waves can
therefore advantageously be described using the network notation.
A passive material in which an acoustic wave travels is a transmission line, which can be modeled as a
two-port network element, depicted in Figure 4.5. Their behavior is associated with a 2x2 square transfer
matrix T , which links the input parameters (p1 and v1) with the output (p2 and v2), and an impedance
matrix Z, which links the pressures to the particle velocities.
This representation is particularly useful to describe the transmission through a stack of different
materials. Using matrix calculation, the total effect can be expressed by the multiplication of each single
matrix.
An acoustic line of transmission, that is to say materials without piezoelectric characteristics, possesses
a transmission matrix T defined as
Tpassive =
1
zp
(︃
zp + zs −(z2s + 2zpzs)
1 −(zp + zs)
)︃
(4.60)
where
zp = − j Zacsin k (4.61)
zs = jZac tan
k
2
(4.62)
being k the wave number, depending on the material thickness, and Z is the product of the acoustic
impedance Zac of the material, described in section 4.3.4, times its surface S .
The piezoelectric material behavior in one direction can be described by a three-ports linear element,
containing one electric port (injected current I, resulting voltage U), and two mechanical ports (char-
acterized by pressures p1 and p2 and corresponding particle velocity v1 and v2). Figure 4.7 shows the
hexapole schematic and Equation 4.63 resumes the relations between mechanical and electrical domain.
The KLM model [55] decomposes the piezoelectric hexapole in three quadrupoles, as depicted
in Figure 4.8. The two acoustical output ports represent the backing and the radiation faces of the
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Figure 4.7: Schematic and equation of a piezoelectric element.
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Figure 4.8: Equivalent KLM model of a piezoelectric element.
piezoelectric element. The two passive quadrupoles "1/2 piezo" account each for a half thickness of the
material, and are described by the matrix Tpassive presented in Equation 4.60.
The active quadrupole accounts for the electric-mechanical transformation, and its transmission
function, as modeled by Krimholtz et al., is equivalent to the series of a capacitor C0, a capacitor C and a
transformer N. The capacitor C0 accounts for the losses and for the permittivity in the piezo material,
while C and N are the piezoelectric constant.
The material parameters are listed in Table 4.2.
From the mechanical parameters, the piezoelectric coefficient h, the wave speed v* under the effect of
losses ∆, and the acoustical impedance Z can be extracted [55]:
h =
kt · v
(1 − j · tde)
√︂
ρ

(4.64)
∆ = (1 − kt2) · tdm + kt2 · tde (4.65)
v* = v
√︀
1 + j∆ (4.66)
Z = Zac · A = ρv*A (4.67)
Finally, the circuit parameters are defined as follows:
C0 = 
A
d
(1 − j · tde) (4.68)
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Table 4.2: Parameters of a piezoelectric material.
Transducer surface A
Thickness d
Density ρ
Permittivity (r · 0) 
Coupling coefficient kt
Wave speed d
Tangent of electrical losses tde
Tangent of mechanical losses tdm
Total losses coefficient ∆
Wave speed (with losses) d
C = − ω · Z
h2 · sin
(︁
ω·d
v*
)︁ (4.69)
N =
2h
ω · Z sin
(︃
ωd
2v*
)︃
(4.70)
The resulting transmission function is described by(︃
U
I
)︃
=
(︃
N C+C0jNωCC0
0 − 1N
)︃ (︃
p
v
)︃
(4.71)
This model allows the description of the transducer block as a series of homogeneous layers with
different acoustic characteristics. Passive layers, such as backing, impedance matching layers, electrodes,
and casing, will contribute with a transmission matrix of type Tpassive as described in Equation 4.60.
Piezoelectric material will contribute with a transmission matrix according to Equation 4.71. The model
holds valid if the layer surface is much larger than the layer thickness, so that the vibration along the
propagation direction (longitudinal wave) is predominant with respect to shear waves.
4.3.5.3 Reflection and transmission
Different materials have different acoustic impedances. Consider two elements of different material, put
in contact along one edge, as shown in Figure 4.9, and a purely longitudinal wave propagating along the
stack, perpendicularly to the boundary. The incoming wave experiences a medium discontinuity on the
boundary between the two materials, it will therefore be partly transmitted and partly reflected, according
to their acoustic impedances. In order to fulfill the continuity on the boundary, the resulting pressure on
both medium must be equal on the boundary, that is to say
pI + pR = pT (4.72)
Also, the particle displacement on both sides of the boundary must be equal. Being the displacement
equal, the particle velocities must also be equal, which is described by
η˙I − η˙R = η˙T (4.73)
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Figure 4.9: Wave propagation between two materials of different acoustic impedance.
If the wave is not perpendicular to the boundary, as assumed until here, the continuity relation becomes
η˙I cos θI − η˙R cos θR = η˙T cos θT .
The particle velocity is linked to the pressure by the definition of the acoustic impedance, so that the
equation can be rewritten by
pI
ZI
− pR
ZR
=
pT
ZT
(4.74)
Now, remembering that the incident and reflected wave are in medium 1, and the transmitted wave is
in medium 2, the acoustic impedances can be written as ZI = ZR = Z1 and ZT = Z2.
By definition, the amplitude transmission coefficient T is defined as the ratio between the transmitted
pressure pT and the incident pressure pI . In the same manner, the amplitude reflection coefficient R is
the ratio between the reflected pressure pR and pI . Developing according to equations 4.73 and 4.74, it
results that
T =
pT
pI
=
2Z2
Z1 + Z2
(4.75)
R =
pR
pI
=
Z2 − Z1
Z1 + Z2
(4.76)
It is equally interesting to define the reflection and transmission coefficient of the wave intensities.
This is achieved exploiting the link between pressure and intensity I = p2/2Zac, and results in
IT
II
=
Z1
Z2
T 2 = T ′ (4.77)
IR
II
=
p2R
p2I
= R2 = R′ (4.78)
The expression of transmission and reflection coefficients as a function of the acoustic impedances
gives very relevant information for the medical application of ultrasound. Soft tissues and water have
an acoustic impedance of approximately 1.5 MRayl. On the contrary, gases have a very low acoustic
impedance (approximately 400 Rayl for air), so that the reflection coefficient between soft tissues and
gas-filled organs will tend to 1 and the transmission coefficient tends to 0. Therefore chest, lungs, bladder
are not good for transmission.
When an ultrasonic probe is applied on the skin, the air layer trapped between the probe and the skin
strongly reduces the efficiency of the transmission. For this reason, a so called acoustic gel is applied
on the region to be imaged with the aim of matching the impedance of the probe to the skin. However,
microbubbles of gas can successfully be used as a contrast agent, for better visualizing an organ or a
tissue among similar soft tissues.
Bones possess an acoustic impedance of approximately 7.75 MRayl, that is 5 times the acoustic
impedance of soft tissues. Therefore, a wave traveling from soft tissues to bones will be mostly reflected.
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4.3.6 Attenuation
Waves in a medium undergo absorption (leading to local heat increase in the medium) and scattering. The
two effects can be resumed in an attenuation coefficient α, which affects the wave propagation following
an exponential term.
Considering an ultrasonic beam in an homogeneous medium, the pressure wave is described by
p(~r) = p0e−α~re j(ωt−
~k~r) (4.79)
and the acoustic intensity, being I = p2/2Z, is
I(~r) = I0e−2α~re j(ωt−
~k~r) (4.80)
For ultrasonic waves at frequencies around 1 MHz, the attenuation is described by
α = α0 · f b (4.81)
where b is equal to 1 for soft tissues. The amplitude attenuation coefficient α0, solely dependent on the
material, is measured in [dB/cm/MHz].
The previous expression of the attenuation underlines an important characteristics of ultrasonic waves,
usually referred to as beam softening: ultrasound at high frequency will be attenuated faster in the body
than low frequency waves.
4.4 Biological effects
4.4.1 Thermal effects
The main effect of ultrasound on tissues is heat generation due to absorption of the wave energy by the
tissue. The rate of absorption contributes to the attenuation coefficient of the medium together with the
scattering effect. It therefore varies according to the tissue type. As a general rule, soft tissues have an
attenuation coefficient on the order of 0.5 dB/cm/MHz while bones can reach 20 dB/cm/MHz. Of course,
the ability of tissues to evacuate heat is equally important.
For the same tissue, the thermal effect depends on the ultrasonic beam intensity and on the duration of
the radiation. From literature, it is accepted that a local increase of 1.5 °C does not damage the tissue
independently on the exposure duration. However, an increase of 6 °C causes immediate tissue damage
and an increase of 20 °C leads in most tissues to immediate necrosis. Within those boundaries, damages
accumulate proportionally to temperature and exposure time.
The temperature elevation can be more precisely estimated by calculating the amount of heat generated
by the ultrasonic radiation Qin and the heat Qout removed by blood perfusion. The relation between
temperature increase over time and heat amount is given by the BioHeat Transfer Equation (BHTE)
ρC
∂T
∂t
= k · ∇2T + Qin − Qout (4.82)
where ρ is the tissue density, C the the tissue specific heat, and k the the thermal conductivity of the
tissue.
The heat removed from the irradiated spot due to blood flow is
Qout = CB · ρB ·WB · (T − TA) (4.83)
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where CB is the specific heat constant of blood, ρB the blood density, WB a coefficient of perfusion in the
tissue, and TA is the temperature of the arterial blood.
Following the calculations done by Azhari [3] , and supposing that the whole attenuation is due to
absorption, the heat absorbed by the tissue from the incoming acoustic wave is
Qin = 2αI(x) (4.84)
Given the direct dependency of the attenuation coefficient from the wave frequency, it is worth noting
that the thermal effect will be bigger for higher frequency as well.
The temperature increase over time is
ρC
∂T
∂t
= k∇2T + 2α · I −CB · ρB ·WB · (T − TA) (4.85)
Two safety indexes are widely exploited, which take into account the variations in the beam intensity
both in spatial and temporal domain. They are the spatial peak temporal average intensity (IS PT A) and
the spatial peak pulse average intensity (IS PPA). The FDA defined the limit values IS PPA = 150 W/cm2
and IS PT A = 720 mW/cm2 for non-opthalmologic applications.
4.4.2 Cavitation
Ultrasonic waves propagate compressing and stretching the medium, e.g., the body tissues. The distance
among molecules varies with the wave, oscillating around its mean value. An excessive negative pressure
can pull the molecules apart by a distance which is bigger than the maximum distance required to keep
the medium intact. In that case, cavitation occurs. Microbubbles are created, which size evolves with the
amplitude of the pressure wave. In case of inertial cavitation, associated with high ultrasonic amplitude,
the size can reach a critical value, usually more than ten times the equilibrium size of the microbubble.
Shortly after reaching the critical size, the cavity implodes. This can result in extremely high temperature
and a local pressure as high as a thousand times the atmospheric pressure [21], thus damaging the
surrounding tissue. The implosion can be the result of a single, high intensity pressure cycle. On the
contrary, non-inertial cavitation results in oscillation of the bubbles below their critical size, therefore
without risk of collapsing.
The risk of cavitation is associated with the maximum negative pressure and also depends on the
inverse of the square root of the wave frequency. The Mechanical Index (MI) expresses this ratio. It is
defined by
MI =
max(pnegative)√︀
f0
(4.86)
where max(pnegative) is the peak of negative pressure (expressed in MPa) and f0 is the center frequency
(expressed in MHz).
An ultrasonic wave with a MI lower than 0.7 is accepted by all regulatory entities as having negligible
effect on cavitation. The FDA fixed its maximum value at MI = 1.9 for biomedical applications.
Equation 4.86 shows that the risk of cavitation is higher at lower frequencies.
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4.4.3 Radiation force
Apart from cavitation, other non-thermal effects can be caused by ultrasound, due to the transfer of
momentum from the ultrasonic field to the tissue. The force exerted on the tissue is equal to the total
acoustic power emitted divided by the speed of the beam:
Frad =
Pac
c
(4.87)
Dalecki [21] overviews several effects based on radiation forces, such as radiation torque, acoustic
streaming, acoustic levitation, and fountain effect.
4.5 System Modeling
The models presented until now allow the description of the ultrasonic generation, transmission, and
reception between two devices. The system proposed in the ULTRAsponder project consists of an
implanted device (TR) and a external CU, conceived for being placed on the patient’s skin.
Figure 4.10 depicts the main parts of the acoustic generation and transmission. A TR is depicted on
the right side, which will be implanted in the body. An external CU is depicted on the left. Both the
external CU and the TR are composed of a piezoelectric transducer (shown in red) and some electronics
(in green). The transducers can be composed of a single element, or of an array of elements. In principle,
both TR and CU can send and receive the carrier. Depending on the carrier and on the modulation
algorithm, the same transducer may be used for emission and reception, or portions of it.
On the CU side, a power generator produces the energy that will be sent to the transducers in order to
recharge and communicate with the TR. A wave generator block gives the suitable form to the signal
to be emitted and drives the transducers accordingly. On reception mode, the dedicated transducer (or
transducer section) translates the incoming message, which is then demodulated and converted to a
digital signal.
The generation and propagation of the ultrasonic wave in the transducers can be described by the
theory on ultrasound through solids and by the KLM model for the piezoelectric materials. The wave
travel in the medium can be well described by the model for ultrasonic propagation in fluids.
The whole system can be modeled in several steps. On CU side, the electric power generator feeds the
emitting transducer. The KLM model allows the calculation of the resulting acoustic power generated
Pacs . The variation of the ultrasonic wave in the medium will be calculated according to the Rayleigh
propagation model. It will link the acoustic pressure generated on the CU to the acoustic pressure Paci
impinging on the TR. This pressure is then propagated through the transducer. The KLM model again
allows calculating the behavior of the different layers and the resulting electrical power Pelout translated,
which then feeds the implant electronics and recharges the internal battery. The other way around, the
TR circuit board actively changes its electric impedance, causing a variation of acoustic impedance of
the transducer. An acoustic backscatter wave arises on the surface of the TR. The acoustic power Pacr
can be calculated by the KLM model and its propagation back to the CU follows again the Rayleigh
model. Finally, the backscattered acoustic power received on the CU is translated into electric power and
the resulting signal is demodulated.
4.5.1 Acoustic propagation
The medium between the CU and TR transducers will be composed of soft tissues and of an ultrasonic
gel for impedance matching and avoidance of air bubbles at the interface. For simplicity, it is assumed
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Figure 4.10: Schematics of the system to be modeled.
that the medium is quite homogeneous and that no hard tissues (e.g., bones) are present on the acoustic
path. Indeed, bones have such a high acoustical impedance, that it is safe to assume them as blocking
elements. The propagation therefore occurs either through soft tissues, or not at all.
The emitting transducer, having an active surface A, can be considered as a series of spherical sources.
If the beam is not focused, the propagation follows therefore an inverse-square law. For each source,
given the acoustic power Pac, the resulting intensity in the radial direction at a distance r from the center
of the source is:
I(r) =
Pac
A
=
Pac
4pir2
(4.88)
Taking into account the attenuation of the wave, which appears in the power as an exponential term e−2αr,
the intensity becomes
I(r) = Pac · e
−2αr
4pir2
(4.89)
From there, knowing the implantation depth L and knowing the surface of both the CU and TR transducers
(ACU and ATR), it is possible to relate the acoustic power Pacs emitted by the CU with the acoustic power
Paci received on the TR.
Paci = I(L) · ATR = Pacs ·
e−2αL
4piL2
· ATR (4.90)
Vice-versa, once the backscattered wave sent by the TR is determined, the model predicts the backscat-
tered wave reaching the CU.
More precisely, the Rayleigh propagation model addresses the wave transmission through the skin and
into the body, between the CU and the TR.
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Figure 4.11: Generic transducer layers and acoustic power at different locations.
The aim is to receive on the TR surface the maximum possible intensity within the FDA range
(IS PT A = 0.7 W/cm2), and to define which acoustic wave is required to be generated on CU side.
4.5.2 Transducers
Both on CU and TR side, transducers make the link between the ultrasonic wave and the electrical
signals.
The typical structure of a medical piezoelectric transducer contains at minimum the active piezoelectric
material and the electrodes relying the piezoelectric to the electronics. The electrodes are very thin
metallic layers, which do not disrupt the acoustic transmission. Usually, passive impedance adaptation
layers are present on the sides of the piezoelectric layer. On the exposed side of the transducer, the
adaptation layer matches the active layer with the propagation medium, lowering the impedance difference
at the interface. On the internal side of the transducer, a backing layer ensures mechanical strength to the
otherwise fragile piezoelectric material, and acts as an acoustic damping layer. This also increases the
bandwidth of the transducer and allows a better spatial resolution. On the contrary, the backing absorbs a
part of the incoming energy. The presence of backing and its characteristics are therefore very much
dependent on the target application. Typical materials for a backing layer are based on epoxy resin.
Figure 4.11 depicts the structure of a generic receiver transducer. The power on the interface between
medium and casing are indicated: incoming power Paci , reflected power Pacr , and transmitted power Pact .
The electric power Pelout , produced by the piezoelectric layer under the effect of the acoustic power, is
also indicated.
The device circuitry (not shown) is connected to the electrodes and the whole implant is encapsulated
in a housing, which represents a further acoustic layer. A requirement of the proposed system is the
encapsulation of the transducer into a titanium casing. Indeed, titanium is the golden standard for
biocompatibility in long-term IMDs. The demonstrator proposed in this work is conceived as a prototype
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Figure 4.12: Wave propagation between three materials of different acoustic impedance.
for a future industrial device. Therefore, it must have a comparable casing in order to prove its concept.
The presence of titanium on the acoustic path can greatly affect the acoustic transmission, because of its
high acoustic impedance (22.5 MRayl) with respect to that of body tissues.
For the proposed system, the transducer active surface was arbitrarily chosen to be 5 mm × 10 mm,
divided into six elements of 5 mm2 each with a pitch of 1.5 mm, equal to the wavelength in water.
4.5.2.1 Impedance matching layers
The several materials required in the sandwich have different acoustic characteristics. Impedance
matching layers are therefore essential towards an efficient transmission. Ideally, the whole energy
emitted by the external CU should arrive to the electronics of the TR, without being absorbed by the
transducer layers. This also prevents heating in the transducers, which would cause damages to the
piezoelectric polarized material.
In particular, the acoustic impedance of piezoelectric materials very much differs from the one of soft
tissues. A matching layer is particularly useful when the piezoelectric layer is in direct contact to the the
propagation medium. This is less true for transducers embedded in a housing, as the one proposed in this
work. In that case, the active layer and the casing are expected to have a similar acoustic impedance.
Usual matching layers exploited in transducer design are polymers, sometimes impregnated with metal
particles to adjust their acoustic properties. Their acoustic impedance is in the order of magnitude of 1 to
10 MRayl.
Consider the three-layers structure depicted in Figure 4.12. Azhari [3] reports the solution of the
energy transfer among three layers of different acoustic impedance
Υ =
I3
I1
=
4Z1Z3
(Z1 + Z3)2 · cos2(k2L2) + (Z2 + Z1Z3Z2 )2 · sin2(k2L2)
(4.91)
This drives the design of a matching layer for the transducer sandwich. Provided that the acoustic
impedances do not fulfill the condition Z2 ≪ Z1Z3, the transmission relation is independent on the
matching layer acoustic impedance in two particular cases:
• if the thickness of the matching layer L2 is very small with respect to the wavelength in the layer:
L2 ≪ λ24
• if the thickness is a multiple of the half wavelength L2 = nλ2
Υ =
4Z1Z3
(Z1 + Z3)2
(4.92)
The perfect impedance layer has a length equal to L2 = (2n − 1)λ2/4 and an acoustic impedance
Z2 =
√
Z1Z3. In that case, the energy transmission coefficient is equal to 1, that is to say all energy
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incoming into the first medium is transferred to the third medium, which was the aim of the impedance
matching layer.
4.6 Simulations and parameters chosen
The aim of the ULTRAsponder project was to assess the feasibility of a system, in which an IMD receives
energy from an external CU by ultrasonic link and in which the two parts communicate by the same
carrier. The most suited propagation conditions have to be defined, in order to efficiently send energy
while complying with the FDA regulation. This includes the choice of the working frequency, such
that the adverse bioeffects are minimized, and the choice of a suitable ultrasonic path, which does not
attenuate too drastically the beam from the CU to the TR. Nevertheless, the main focus of the author is
on the reception of the beam by the TR and its propagation through the transducer to the electronics. In
particular, the effect of the titanium barrier on the wave propagation is assessed.
In the transducer model, only vibrations in the wave propagation direction will be considered, because
the layers are thin compared to the surface of the transducer.
4.6.1 Working frequency
The appropriate working frequency for the system results from a trade-off among different characteristics
of the wave. The beam attenuation linearly increases with the frequency, and the wave energy increases
with the square of the frequency. On the contrary, the cavitation risk is inversely dependent from the
square root of the frequency.
α = α0 · f b (4.93)
E′ =
ρη20ω
2
2
= 4pi2ρη20 f
2 (4.94)
MI =
max(pnegative)√︀
f
(4.95)
Working at low frequency allows a very reduced attenuation. However, low frequency encounters
other limitations and induces safety issues due to cavitation. The lower the frequency, the more the
transmitted energy spreads in the body, so that only a small part can be recovered by the implanted TR.
Also, the beam intensity is less homogeneously distributed: regions on hot spots can experience tissue
damages, while energy transfer and communication is inefficient on cold spots.
Higher frequency contributes in decreasing the cavitation risk. The use of ultrasonic frequencies in the
MHz range is particularly attractive because the wavelength will be in the mm range, i.e., smaller than
the transducer elements. It is therefore possible to steer and focus the beam, thus increasing the intensity
at target. This compensates the increased attenuation, thus providing a higher energy transfer, a better
signal-to-noise ratio, and higher data flow during communication.
A review on ultrasonic propagation was recently performed by Roes et al. at Eindhoven University
[86]: the successful use of ultrasound was shown, both to remotely power deeply IMD and to transmit
power through a metal wall. The frequency used ranges from 0.5 to 2.25 MHz.
Ultrasonic Imaging usually exploits 2 MHz waves and reaches tissues down to 10-15 cm. Also,
applications in which cavitation is aimed, may exploit 1 MHz waves, but at a much higher intensity.
Within the ULTRAsponder project, it was decided to work at 1 MHz. For the same reasons, a center
frequency of 1 MHz will be considered for the simulation presented in this chapter.
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4.6.2 Location
The medium between the CU and the TR is considered to be a soft tissue and its thickness is assumed to
be 15 cm. This mimics the conditions of a deep implant accessible through an acoustic path [20].
The ultrasonic propagation in the medium is not simulated in this thesis work.
4.6.3 Titanium thickness
A key point in the ultrasonic transmission is the ability of overcoming the titanium barrier. As the
titanium casing is a mandatory element of an IMD, the proposed system could not claim to be feasible
for industrialization if the transmission through titanium would not be achievable. A strong attenuation
of the wave due to mismatch in the acoustic impedance is expected, given the high acoustic impedance
of titanium (Z2 = 22.5 MRayl) compared to the acoustic impedance of soft tissues (close to that of water,
Z1 = 1.5 MRayl).
A rough estimation of the transmission coefficient for the acoustic power is given by Equation 4.77,
assuming semi-infinite media:
T ′Ti =
Z1
Z2
(︃
2 · Z2
Z1 + Z2
)︃2
= 0.23 (4.96)
Less than a quarter of the incoming energy should enter the transducer due to the titanium barrier.
In reality, the titanium barrier is thin with respect to the wavelength, therefore its effect will be less
important. Given this loss of energy at the surface of the device, it is important that the transmission
inside the transducer (through the titanium, the adaptation layer and the piezoelectric material) would
not generate further losses.
Simulations must be performed to assess the optimum thickness at which the acoustic wave can be
transmitted through the enclosure and under which conditions. According to the results of the simulations,
it may be necessary to thin down a small region of the casing. The amount of thinning required will be
determined according to the results of the simulations.
A MATLAB® routine was developed, based on the work of Martinez [61]. A sandwich is considered,
containing a piezocomposite structure and a titanium layer. Figure 4.13 visualizes the structure taken
into account. Compared to the transducer depicted in Figure 4.11, the electrodes were neglected (because
they are very thin) and the backing layer was not considered. The backing layer plays the role of a buffer
for the piezoelectric vibration, thus enlarging the transducer bandwidth. However, this attenuates a part
of the incoming wave and reduce the performance. In order to preserve the incoming wave as much as
possible, the transducers manufactured within the ULTRAsponder project avoided backing layers. An
impedance adaptation layer is at first considered, but the calculations will show that it is useless.
The incoming acoustic power Paci , resulting from the CU emission, is considered to fulfill the FDA
rating on the intensity Iaci = 0.7 W/cm
2.
The electrical power effectively transmitted to the device largely depends on the electrical impedance
matching of the transducer with the electrical load of the PCB. The electric load seen by the transducer
will correspond mainly to the internal battery of the device. This impedance is difficult to measure, as it
varies in time according to the level of charge in the battery. A rough estimation gives 500 and 1000 ohms
for the real part and the same for the negative imaginary part (capacitive circuit). Therefore, the electronics
contribution to the power transfer was taken into account by a fixed charge ZPCB = (750 − 750 j) Ω.
Objective is to determine the transducer behavior at the original casing thickness and, if ultrasound
cannot be transmitted through that thickness, to estimate the amount of thinning required. The simulations
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Table 4.3: Characteristics of the piezoelectric layer.
Piezoelectric element
Bulk Modulus [GPa] 77.9
Density [kg/m3] 6050
Longitudinal speed [m/s] 3590
Coupling coefficient 0.58
Relative permittivity 2170
Electrical losses 0.04
Mechanical losses 0.04
were performed for the original thickness of the titanium casing (0.3 mm), for a thickness of 0.2 mm and
0.1 mm, and for a transducer without casing.
The following parameters were calculated:
• Electric impedance of the transducer.
• Acoustic impedance of the transducer.
• Power budget: Acoustic power available, acoustic power consumed, electric power consumed.
4.6.3.1 Characteristics of the Transponder materials
Piezoelectric layer: several piezoelectric materials can be used. For our simulation, it was assumed to
use a piezocomposite structure based on PZT material [66]. A high permittivity piezoceramic with a
high electromechanical coupling coefficient and a ceramic volume fraction sufficiently high was chosen,
in order to decrease the electrical impedance. The resulting acoustic characteristics were given by the
transducer manufacturer and are listed in Table 4.3.
The material properties define the thickness of the piezoelectric element. The most efficient thickness
is indeed equal to the half of the wavelength, so that the impinging and reflected power have the same
phase, i.e., their interference is not destructive.
Given the frequency f , and remembering that the wave speed c depends on the material Bulk modulus
B and density ρ, the thickness is defined by the relation
dpiezo =
c
2 f
=
1
2 f
√︃
B
ρ
(4.97)
Choosing the material with the characteristics listed in Table 4.3, and given the working frequency
f = 1 MHz, the layer thickness must be 1.795 mm.
The acoustic impedance of the piezoelectric layer can be calculated from its density and wave speed:
Zpiezo = ρ · c = 24.2 MRayl (4.98)
Titanium layer: The housing of the implant will be made of medical grade titanium, that is to say
very pure titanium. Therefore, the characteristics of the pure material were taken into account [41]:
material density ρTi = 4500 kg/m3 and Bulk modulus BTi = 110 GPa. This results in a wave speed
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Figure 4.13: Transducer structure taken into account in the simulation.
vTi = 4.95 km/s and an acoustic impedance ZacTi = 22.5 MRayl. The thickness of this layer can vary
from 0.3 mm, which is the original thickness of the casing walls, down to 0.1 mm, which was defined
by experts as a safe limit to ensure the mechanical stability of the housing. Different thicknesses are
simulated, in order to assess the influence.
Adaptation layer: Placed between the titanium casing and the embedded piezoelectric material,
an adaptation layer matches their impedances, so that the incoming acoustic power on the titanium
propagates into the piezoelectric layer. According to the transmission coefficient calculation in the
three-layers structure, assessed in section 4.5.2.1, the best acoustic impedance matching layer has a
thickness equal to a multiple of λmatch4 and an acoustic impedance linked to those of its two neighbor
materials.
Zmatch =
√︀
Zpiezo · ZTi (4.99)
dmatch = (2n − 1)λmatch4 (4.100)
Given the previously specified acoustic impedance of pure titanium and piezoelectric material, the
adaptation layer should possess an acoustical impedance Zacmatch = 23.3 MRayl.
Several materials can have similar acoustical impedance, from a combination of material density
and wave speed. Once the required material is identified, its elastic and physical characteristics can be
exploited to determine the wavelength in the material, and therefore the series of possible thicknesses of
the matching layer, according to Equation 4.100.
From the small difference between the three acoustical impedances, it is evident that the matching
layer would not improve in a significant way the ultrasonic transmission. Therefore, it was decided to
avoid the adaptation layer in the simulation, and the system reduces as depicted in Figure 4.13.
4.6.3.2 Results
Aim of the performed simulation is to assess the influence of a titanium layer on the ultrasonic transmis-
sion, and to find an appropriate design for the transducer, which allow efficient ultrasonic propagation for
the medical application.
The resulting acoustic impedance of the whole sandwich is ideally equal to the impedance of the
medium in which the wave should propagate. In the present case, approximating the acoustic impedance
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of soft tissues to that of water, the target equivalent acoustic impedance Zac is about 1.5 MRayl, without
an imaginary part at the working frequency. This will be the first index of a good propagation.
On electrical domain, the best energy transfer is given for a transducer electrical impedance having
the same active part as the PCB impedance, and an opposite reactive part. That is, the ideal transducer
electrical impedance is (750 + 750j) Ω.
Figure 4.14 shows the simulated behavior of the transducer for different thicknesses of the titanium
layer. The effect of titanium thickness, at a given thickness of the piezo layer, is that the peak of both
electrical impedance Zel and acoustical impedance Zac slightly increases and shifts towards a lower
frequency. The thicker is the titanium, the bigger will be the shift and the increase in peak.
The higher peak is due to the slightly lower acoustical impedance of titanium (22.5 MRayl) with
respect to the chosen piezocomposite (24 MRayl). The lower resonance frequency is due to the increased
thickness of the sandwich.
It is evident that the value of the electrical impedance at 1 MHz is not even close to the ideal one,
Consequently, the power budget at 1 MHz is poor (7.5 mW over the 35 mW available). The peak of
transmission is around 850 kHz.
That required frequency shift can be obtained by using a thinner piezo layer, i.e., adapting the material
resonation to a higher central frequency. Figure 4.15 shows the variation of thickness in the piezo layer,
for a fixed titanium layer of 0.1 mm.
On the contrary, an increased thickness of the piezoelectric material has a slightly beneficial effect on
the power budget.
4.7 Conclusion
In this chapter, the theory underlying the generation and the propagation of mechanical waves is
presented, both for solid and fluid propagation media. The theory is in particular applied to the system
under development. The acoustic transmission from an external CU to a TR is modeled. The ultrasonic
link between the two transducers, i.e., in the body, is associated with a Rayleigh propagation.
The reception of an acoustic power on the receiving transducer, its propagation through the different
layers of the transducer sandwich and its translation into electrical power is modeled based on the
KLM model, assuming planar, longitudinal waves. Particular focus is reserved to the effect of the
titanium barrier on the power transmission in the transducer. A thickness of 100 µm and an appropriate
piezocomposite material proved to allow acoustic propagation at 1 MHz: this configuration is therefore
acceptable for the proposed system.
Within the project ULTRAsponder, the design of the transducer sandwich was performed by an
industrial partner, which performed more precise simulations and tests than the ones presented within
this thesis work. Both transducers for use in direct contact with water and to be integrated in a titanium
casing were produced. Different materials and geometrical characteristics were taken into account for
the piezocomposite and the impedance matching layers, in order to compensate the titanium effect and
achieve the best transmission at the chosen frequency. The glue joint between titanium and piezoelectric
material was taken into account, which has a very low acoustic impedance, but also a very reduced
thickness, thus not disrupting the acoustic link.
Nevertheless, an important result could already emerge from those simplified simulation: titanium
encapsulation can coexist with ultrasonic propagation, given an appropriate matching layer, an appropriate
piezocomposite design, and a locally thinned layer of titanium. This opens the way to a new generation
of long-term biocompatible IMD, based on ultrasonic power transfer and communication.
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Figure 4.14: Simulated effect of a titanium layer at different thicknesses.
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5.1 Introduction
The European FP7 project ULTRAsponder, to which the author of this thesis contributed, aims to develop
a generic Body Sensor Node structure that would adapt to different applications. The demonstrator
manufactured is conceived to serve a cardiac application aiming to measure impedance at long-term.
Due to inefficient use of electromagnetic waves and their crippling limitations to recharge the implant,
ULTRAsponder proposes to exploit acoustic waves (ultrasound) for communicating with, and efficiently
energizing a network of transponders that could be deeply implanted in a human body (i.e., 5 cm to
10 cm).
An intelligent data communication strategy is proposed, based on backscattering technique.
A commercial titanium housing is taken into consideration, mostly because of its biocompatibility.
Strategies for adapting the casing to the application are discussed.
The components of the system are carefully chosen to meet the requirements of the whole system.
Custom, low-power microprocessor, ADC, energy harvesting, and backscattering circuitry are designed
and manufactured within the project, as well as the electro-mechanical transducers. A FRAM device
is chosen for data storage, because of its high operation speed, low power consumption, long life, and
MRI compatibility. Ultra thin-film, solid-state batteries are exploited, which carry an integrated power
management unit.
5.2 Functional Demonstrator
In the vision of the project, the IMD should act within a Body Sensor Network. The complete system
could consist of several TRs implanted in the body, dedicated to the measurement of various physiological
parameters, such as temperature, pressure, strain or fluid flow and chemical or electrical properties. They
may also perform therapeutic functions such as drug delivery, defibrillation or electrical stimulation. A
CU secured to the patient’s skin is able to energize and to communicate with them, and can relay the
recorded data from the transponders network outside the patient’s environment via Global System for
Mobile communications (GSM™), Universal Mobile Telecommunications System (UMTS), Plain Old
Telephone Service (POTS), or Internet Protocol (IP) based networks.
The TR must be small and light, allowing its placement either by open surgery or minimally invasive
techniques. Furthermore, it must exhibit an excellent biocompatibility to allow long-term implantation.
Figure 5.1 shows the general schematics of the proposed system. A TR is depicted on the right
side, implanted in the body. An external CU is depicted on the left. Both the TR and the CU contain
piezoelectric transducers, which convert ultrasound into exploitable electric power and vice-versa. Both
TR and CU can send and receive the carrier. Depending on the application, the same transducer or
portions of it can be used for emission and reception.
The transducers of the CU are in contact with the body skin through an acoustic gel for impedance
adaptation, while those of the TR are at an undefined position inside the body. To be general, it should be
assumed that the device is deep implanted. On the TR side, a power management unit receives and treats
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Figure 5.1: Overview of the proposed system.
the acoustic power coming from the CU, provides the necessary power supply to the microcontroller, and
recharges an internal battery. A sensor unit is driven by the microcontroller through an ADC and is able
to collect and store the sensed data or to perform some action. Communication from the TR to the CU is
coordinated by the microcontroller through a modulation stage, which prepares the digital message that
will be translated by the transducers and will be sent on the acoustic carrier backscattered to the CU.
On the CU side, a power generator produces the energy that will be sent to the transducers in order to
recharge and communicate with the TR. A wave generator block gives the suitable form to the signal to
be emitted, and drives the CU transducers accordingly. On reception mode, the dedicated transducer
(or transducer section) translates the incoming backscattered message, which is then demodulated and
converted to a digital signal. To complete the system, the CU should also be equipped with a user
interface to the implant, in order to use manipulation by surgeons and medical staff. This aims to ease the
seeking of a good position to recharge the TR, and to allow the interpretation of the message received. A
USB link serves as bridge between the electronics and the user interface.
5.2.1 Application
Even if the development of the device wants to be generally valid and independent from a particular
IMD, a specific application was chosen as a concrete case, and the demonstrator was designed based on
that. The selected application is monitoring changes in cardiac function in patients at risk of heart failure.
Those patients would greatly benefit from autonomous, long-term monitoring: their condition can stay
stable for many years, thus not calling for daily visits at hospital, but changes are life-threatening and
must be therefore rapidly detected.
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Figure 5.2: Proposed application: heart impedance measurement. The electrodes are not shown.
In order to assess cardiac function, three parameters are of interest: Electrocardiography (ECG), heart
impedance (and particularly the impedance of the left ventricle), and the heart pressures.
Focus is put on left ventricle measurement, because it cannot be easily measured without invasive tech-
niques. At the very best, a rough estimate could be made based on indirect blood pressure measurement
performed by an external device. A regular monitoring of small differences may help in adjusting medical
therapy. Information from the ECG complement the impedance measurement in order to establish the
cardiac output [101]. Previous examples of cardiac monitoring through IMDs are reported by Ohlsson et
al. [69], by Wong et al. [52], and by the COMPASS-HF Study Group [11].
Within ULTRAsponder it is proposed to deploy the developed IMD to measure the cardiac impedance.
Being able to compare readings at different moments, the system can detect variations in the heart and
reacts, e.g., warning the patient, the caregiver, or the medical staff during the next connection to the CU.
A TR will be implanted on the external heart wall, and from there four electrodes will be placed on
different locations on the heart. The target method of implantation is a percutaneous procedure, e.g
through the femoral vein into the left ventricle, the subclavian vein, or the femoral artery into the right
ventricle. Flexibility of catheters for percutaneous procedure and size of sensor are most important.
Two electrodes send a current and the other two measure the resulting voltage in the same location.
The CU is occasionally manually held on the patient’s skin, it energizes the TR and communicates with
it. It contains a power generator, the circuitry to drive the transducer, and a demodulator to interpret the
message coming from the TR. Everything is directed by a user interface on a laptop: the user can turn on
or off the input wave to the CU transducers, switch between a continuous emission and a transmission of
groups of peaks (burst mode), and monitor on screen the received backscattered message.
The proposed application for chronic heart impedance measurement is depicted in Figure 5.2. The
rough locations of TR and CU devices are shown, but the sensor electrodes are not depicted.
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5.2.2 Carrier choice and implantation location
As discussed in Chapter 4, EM waves have several disadvantages in long-term, deep IMD, and therefore
cannot be used as a carrier in the target application for this work.
Instead, it was decided to exploit ultrasound as energy and communication carrier.
A key factor of the system is the relative position of the CU with respect to the implanted TR. An
appropriate acoustic path must be chosen, in order to have minimum attenuation between the transducers.
Cotté et al. [20] simulated several acoustic paths between the CU and the TR, based on the inner
organs segmented data of the Visible Human Male Project [98]. This dataset enables to identify the
tissue layers along the paths. Simulations of ultrasonic propagation and temperature rise were performed,
and verified by in vitro experiments. Two suitable paths for the applications were identified, along
which a safe and efficient acoustic transfer of energy can be obtained, while limiting the acoustic power
radiated in order to minimize adverse bioeffects. The results validated the choice of an ultrasonic working
frequency around 1 MHz, which offers a good trade-off between cavitation risk and efficiency.
5.3 Algorithm
The objective of the implanted system is to allow autonomous sensing of some physiological parameter
during few seconds every day, and to store them in the internal memory for later download during
recharge sessions. Measurement will be performed every 24 hours during 5 seconds.
The microprocessor is the core of the implant, as it coordinates its operations. A code must be
developed and stored into the microprocessor memory, to be executed autonomously. The main operations
performed by the TR are:
• Once a day, configure the sensor, perform a measurement, and store the result into the memory on
board.
• Recognize when a wave is coming from the CU.
• During the recharge session, send the battery level at regular intervals as a feedback to the CU.
• When the internal battery is recharged, start the backscattering communication of the sensed data.
According to the data rate chosen for the sensing and the interval between two recharges, it may be
necessary to reduce the power consumption of the implant through signal compression before storing
the data sensed into the memory. Since signals resulting from the measurements of relevant physical
parameters in the human body are highly correlated in time, compression prior to transmission can
significantly reduce the bit-rate and thus the power consumption.
A potential strategy for removal of temporal correlation was suggested by Oslo University Hospital
within the project [38]. It is based on Differential Pulse-Code Modulation (DPCM), which is known
to provide significant compression at low complexity for correlated data . In their paper, Floor et al.
show that a simple 2nd order predictor (a 2nd order Finite Impulse Response filter) gives significant
compression of ECG signals. Moreover, the cost in terms of computational complexity is relatively low.
The key result from the paper is shown in Figure 5.3: when measuring typical physical parameters of the
human body, DPCM reduces the amount of bits required to achieve a certain fidelity compared to direct
quantization. As an example, DPCM requires half so many bits per source sample to compress an ECG
signals sampled at 250 Hz, compared to conventional quantization technique.
However, this compression method was not implemented in the system demonstrator.
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(a) Original signal. (b) 8 bit direct quantization.
(c) 4 bit DPCM. (d) 4 bit direct quantization.
Figure 5.3: Compression of a Electrocardiography signal: DPCM technique requires half so many bits
as direct quantization.
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Figure 5.4: Message produced by the microprocessor
5.3.1 Backscattering
The transponder must work at low power to keep an acceptably long time between two recharge periods.
In particular, a low power transmission strategy is necessary. Ultrasonic backscattering is a promising
technique for this, as the power required to create the carrier is provided by the CU.
The reader is the CU and the tag is the TR. The communication is unidirectional: the CU provides
the energy for the carrier wave, which illuminates the TR. The TR modulates this carrier by impedance
modulation and scatters it back to the CU. Finally, the CU receives the backscattered wave and
demodulates the message. Demodulation occurs only at CU level and modulation only at TR level.
This helps reducing power consumption on TR, as the implant won’t have to demodulate instructions
coming from the CU. Ultrasonic backscattering relies on ultrasound instead of electrical waves, and on
acoustic impedance instead of electrical impedance: the implanted tag modulates the signal by changing
its acoustic impedance, which is related to the stiffness of the transducer. The TR modulates the acoustic
impedance of the transducer element(s) used for transmission, in one of two possible states:
ON: closing the piezoelectric element over a short circuit; this makes it mechanically stiff and therefore
reflective to an incident ultrasonic wave. The reflected amplitude will be high (logical “1”).
OFF: open-circuit; this makes it mechanically soft, it can freely vibrate and is therefore absorbent to
ultrasound. The reflected amplitude will be low (logical “0”).
In the demonstrator developed within the ULTRAsponder project, the message generated by the
microprocessor is fixed. A firmware was written for this task and stored into the FRAM memory on the
TR. In an infinite loop, the message is prepared, coded and sent to the backscattering switch on the TR
electronics. During the communication of the sensed data to the CU, synchronization tokens have to be
added to the message, so that the CU recognizes the beginning and the end of the message sequence.
Also, if the channel is noisy, the message should be coded and some error detection strategy has to be
implemented. It was decided to exploit a Manchester code [99], a very simple technique in which a level
is coded as a transition (e.g., “0” becomes “01” and “1” becomes “10”). This allows synchronizing the
message between reader ( CU) and tag ( TR), and detecting some errors. A message packet is composed
of a preamble, a Start sequence (i.e., a violation of the Manchester code, e.g., “000”), the actual message
word, and a Stop sequence (again, a violation of Manchester code).
The resulting signal is shown in Figure 5.4.
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Figure 5.5: Conversion by the custom ADC of a DC voltage between 0 and 1.5 V.
5.3.2 Connection to the Analog-to-Digital Converter
A custom ADC was manufactured within the project by IMST GmbH (Kamp-Lintfort, DE), providing a
test-platform for the assessment of the chip and the development of the interface to the microcontroller. A
Serial Peripheral Interface (SPI) protocol was chosen. Figure 5.5 shows the successful digital conversion
of a constant analog voltage sweeping between 0 and 1.5 V.
5.3.3 Graphical User Interface
A Graphical User Interface (GUI) for the CU has been developed within the project, in order to better
manage the signal sent by the driver and to decode the backscattered signal.
The interface is based on a MSP430F22x4 microprocessor, manufactured by Texas Instruments (Dallas,
TX, USA). It allows:
• the access to the CU electronics through Inter-Integrated Circuit (I2C) protocol and the control of
the channels and the power supply relay setting.
• the visualization of Received Signal Strength Indication (RSSI) and other internal voltage.
• the decoding of the message at the output of the CU. Incorrect messages are not displayed.
• the display of the decoded message.
The GUI is connected to the PC through a USB serial COM port. A commercial terminal soft-
ware (free Docklight version) is used to send commands and to read messages produced by the
micro-controller. The summary of the commands is given in Table 5.1. The command format is
<0x02><ASCII_CMD><PARAM><0x03>.
5.4 Materials and components
Figure 5.6 shows the general schematics of the implanted device.
One of the biggest challenges of the proposed device concerns the physical size and on-board compu-
tational resources in terms of power and processing capabilities.
69
5 ULTRAsponder project
Table 5.1: Command summary for the GUI.
<ASCII_CMD > <PARAM > Description
RST - Reset the microprocessor
EPR - Enable power relay
DPR - Disable power relay
E1C - Enable 1 kHz carrier
D1C - Disable 1 kHz carrier
E1M - Enable continuous 1 MHz carrier
D1M - Disable continuous 1 MHz carrier
ERS - Enable RSSI monitoring
DRS - Disable RSSI monitoring
SIV [0x00...0xFF] Set I2C value
Figure 5.6: Concept of the transponder electronics. © Eric Meurville.
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Figure 5.7: Kinetra® casing before adaptation to the project requirements. Adapted from
Medtronic Inc. [65]
5.4.1 Casing
The demonstrator proposed in this work requires long-term biocompatibility; it was therefore a natural
choice to use titanium, which is by far the most exploited material for IMD casing.
In order to prove the industrial viability of the implant, it was decided to integrate the electronics into
an existing casing of a commercial device. This should assess the feasibility of the integration of the
proposed system in standard manufacturing facilities. Furthermore, the surgeons being familiar with
such casing, this will help for the in vivo assessments. Given the achieved size of the electronics, the
neurostimulator Kinetra® produced by Medtronic was chosen (Figure 5.7). It is composed of two halves
of Grade 1 titanium, which underwent homologation for biocompatibility. Each half is 300 µm thick.
Figure 5.8 shows the assembly of the device. In particular, it shows the bottom half of the titanium
casing, thinned down in a small region, where the transducer will be later placed. The casing has eight
pins (feedthrough) connecting the interior of the housing with the external world. They ensure waterproof
connection to the leads, i.e., the cables going to the stimulation location. In the demonstrators presented
in this work, which do not include a sensor, a modified version of the commercial leads is used to monitor
some key parameters of the implant electronics.
The influence of a titanium casing on the ultrasonic transmission is of course not negligible. Because
of its high acoustic impedance (22.5 MRayl) compared to the human body (∼1.5 MRayl), titanium will
induce an acoustical mismatching and will act as a barrier: the ultrasound will be partially reflected on
it. As discussed in Chapter 4, a titanium layer of 100 µm allows ultrasonic transmission for the target
application. A small region on the casing wall is thinned down and the transducer is glued inside.
The electronics are placed inside the casing, connected to the transducer and to the feedthroughs of
the casing, for monitoring of the electronics behavior from the outside. The casing is then closed in a
reversible way, in order to operate the TR device in water.
The thinning of the casing must lead to a clean end result, avoiding particles which could damage the
electronics, or disturb the hermetic closing of the housing. The surface should be appropriate to glue the
transducer to it, in order to transfer the ultrasonic vibration.
Wet etching consists in chemically attacking the material. The object to be etched is immersed in an
etching solution, whose composition depends on the material chemical properties. Titanium is usually
etched by chlorine- or fluorine-based chemistries (e.g., Hydrofluoric acid (HF)).
A disadvantage of this method is the immersion of the whole casing into the etching bath. This can
be problematic when the casing already contains components (e.g., connectors) which would be more
attacked by the etchant than the casing material.
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(a) Implant electronics. (b) Casing region thinned down. Trans-
ducer not shown.
(c) Connection of the electronics to
the casing feedthrough.
(d) Exploded view of the parts. (e) Closed casing, with connector placed.
Ready for implantation.
Figure 5.8: Assembly of the transponder device.
A localized etching furthermore requires masking of the remaining surface, thus introduces manufac-
turing steps. Finally, the chemicals used are highly polluting and toxic. Therefore, their use in IMDs
imposes particular care and a strict protocol of post-etching cleaning.
Plasma etching relies on mechanical attack of high-energy ionized gas particles. For etching on
titanium, Boron trichloride (BCl3) is normally used.
The definition of the area to be etched can occur by coating the surface with a photo-resist, and
exposing it to UV light through a mask having the target geometry. The exposed regions will softens and
can be washed away. The remaining parts will protect the underlying casing regions from the etchant.
The process is called in that case photochemical etching.
Both techniques require clean room facilities, which complicates the manufacturing process.
A far less clean technique consists in electric discharge machining: there, the metal is attacked by
sparks (electrical discharges) between the tool-electrode and the metallic workpiece. This technique
requires a dielectric material, normally oil-based. Disadvantages of this technique are the low speed and
the contamination of the casing by oil, which needs then to be removed.
Another technique is abrasive blasting, in which the material to be thinned is bombarded by particles
propelled at high pressure, such as coal slag, bauxite beads, or zirconia alumina crystals. This method is
disadvantageous as it induces mechanical stress on the casing. Especially for thin material layers, the
etching particles would deform the surface.
Finally, in laser ablation technique, material removal is achieved by hitting the surface by a laser
beam. Normally, the beam reaches the surface by pulses rather than as a continuous beam. This allows
a lower beam intensity. The etching characteristics, linked to the material properties, can be precisely
adjusted by modifying the beam wavelength and pulse length.
A very high resolution can be achieved exploiting the fact that material to be etched quickly sublimates
due to the high laser intensity, and therefore the surrounding material does not heat up. Further advantages
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(a) Electric discharge machining. (b) Laser ablation.
Figure 5.9: Thinning result on a titanium sheet.
of laser ablation include absence of chemicals, ease in automation of the process, and precise control of
the etching.
Preliminary tests are performed on titanium sheets of 300 µm thickness, manufactured by Good-
Fellow Sàrl (Lille, France). Figure 5.9 visualizes the difference in surface condition between electric
discharge machining and laser ablation. Laser ablation is the technique of choice for the manufactured
demonstrators.
5.4.2 Transducers
The piezoelectric transducers for both the TR and the CU were designed and manufactured by IMA-
SONIC. Both transducers are made of piezocomposite material realized using a dice-and-fill process,
in which a bulk PZT material is shaped in rods and the resulting empty spaces among rods are filled
with a polymer material. As seen in Chapter 4, the transducer material and the geometrical design of
the piezocomposite were custom designed according to the project specifications. The piezocomposite
thickness was chosen with regard to the 1 MHz working frequency. Copper electrodes were placed on
both sides of the transducers.
5.4.2.1 Transponder transducer
The main role of the transducer in the TR is to receive the incoming acoustic waves. The TR is likely to
move in the final application (because of the heart motion) and this will change the incidence angle of the
ultrasonic waves on its surface. In order to optimize the angular acceptance in reception, the receiving
area of a single element should be decreased. Therefore, the total transducer surface of 5 mm × 10 mm
was divided into 6 elements of 1.2 mm × 5 mm each, for a total active surface of equivalent to 36 mm2.
The pitch of the array was set to 1.5 mm, corresponding to the wavelength at 1 MHz. The single element
of the transducer array are separated by a soft polymer, in order to minimize the coupling between
neighboring elements.
The TR transducer is either integrated on the thinned region of the Kinetra® casing or plugged in an
aluminium prototype box. The most reliable method to connect the transducer to the Kinetra® casing
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(a) Control Unit: 32-elements array. (b) Transponder: 6-elements array.
Figure 5.10: Transducers exploited in the final demonstrator (not to scale).
is gluing: epoxy-based glues provide a flexible joint, which allows vibration of the transducer without
creating fatigue in the glue. Appropriate glues can withstand the transducer operating temperature.
Figure 5.10 shows the 32-elements transducer of the CU and the 6-elements TR transducer, covered by
titanium and inserted in a plastic housing for integration in the aluminum casing. The same transducer,
without the housing, was glued on the titanium casing.
5.4.2.2 Control Unit transducer
Two version of transducers were developed for the CU: in a first design, a shaped transducer was
manufactured, consisting of 64 independent channels. The round shape intrinsically focuses the acoustic
beam at around 15 cm. Each element of the CU transducer has an area of 30 mm × 1.55 mm, the pitch
between each element is 2.05 mm and the whole transducer bandwidth at −6 dB is 65%.
In a further development, a flat transducer was preferred, in order to obtain a broader focus point. A
smaller array was manufactured, which contains 32 elements.
Both CU transducers are equipped with a temperature sensor, in order to monitor the heat produced
during emission and avoid excessive temperature, which could depolarize the transducer.
5.4.3 Power storage
For the system proposed, ultra-thin batteries were used (Thinergy® series by Infinite Power Solutions,
Littleton, Colorado, USA). They possess a thin form factor (170 µm thickness) and are available in
several surface dimensions and capacities, up to 1 mAh for 6.5 mm2. Their very low thickness makes
them particularly suitable for small size devices, as the battery can be fit under the printed circuit board
and contributes very little to the device size. If needed, several cells can be stacked to reach higher
capacity.
IPS batteries are all-solid-state batteries, containing non-combustible and non-reactive electrolytes
(e.g., LiPON). This is advantageous for implantation to avoid leakage. They have a very high discharge
rate capability and an ultra-low self-discharge rate, which makes them suitable for long-term operation.
Their recharge occurs at constant voltage with no current limitation, thus allowing a rapid and easy
recharge. Finally, they are RoHS compliant.
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The battery needs a stable DC level to be recharged, between 4.1 V and 4.5 V. Moreover, the battery
must not be discharged lower than 2.2 V; otherwise it will not be able to be recharged again. For this
reason, IPS batteries come with an integrated interface between the battery, the recharging signal and the
load: the MAX17710 power management chip (by Maxim Integrated, San Jose, CA, USA).
5.4.4 Digital Signal Processor
To coordinate the operations of all components of the device, a microprocessor is required. Within
the ULTRAsponder project, a custom, very low-power Digital Signal Processing (DSP) processor
called icyflex has been designed by the Centre Suisse d’Électronique et de Microtechnique SA (CSEM)
(Neuchâtel, Switzerland).
The processor shows low power consumption with respect to competitor products [18]. As an example,
Texas Instruments MSP430 (by Texas Instruments, Dallas, Texas, USA) draws at least 1 µA when in
low power mode and 150 to 290 µA/MHz when in standard operation [102], in both cases under a 3 V
supply voltage. Icyflex operates on an internal voltage as low as 1.8 V, but is able to generate on its
pins regulated voltages ranging from 1 to 3.6 V. Average power is in the range of 150 µW/MHz when in
operation and only 1 µA quiescent current in hibernation. A set of voltage regulators allow advanced
power management features and different power modes [92]. The input/output pads are grouped into
4 supply banks. Each bank is powered with a separately selectable voltage, from 1 to 3.6 V, in order
to supply external components from 0.9 to 2.7 V and 1 to 5000 µA. This allow switching off external
components and parts of the chip, e.g., using General Purpose Input/Outputs (GPIOs) as power switches.
The main voltage of the chip has to remain between 1 and 1.8 V because of the 0.18 µm Complementary
MOS (CMOS) technology used for the Digital Processing chip. The microprocessor offers 4 possible
clock sources: an internal RC oscillator at 16 MHz, a 32 KiHz quartz, a 48 MHz quartz, and an external
pad. Frequency dividers allow adjustment of the clock period. The switch between clocks occurs without
glitches.
The microprocessor offers three modes of operation:
A normal mode, where the complete circuit is powered up and running. In this state, the microprocessor
has a maximum power consumption of 150 µA/MHz.
A sleep mode, in which all digital blocks are powered up, but the processor core is in sleep mode. Clocks
are generated and distributed to peripherals. The microprocessor core can be waken-up on an interrupt
request (e.g., from the Real-Time Clock (RTC) or from an external event). The microprocessor has a
power consumption in the order of 10 µA.
An hibernation mode, in which all the digital blocks, except the RTC, are powered off and the system
can be woken up at a predetermined date by the running RTC or by an external signal through a GPIO.
At wakeup time, the Random Access Memory (RAM) will have to be re-loaded from the external
Electrically Erasable Programmable Read-Only Memory (EEPROM) during a standard boot sequence.
The power consumption in this state is on the µA range.
Table 5.2 summarizes the power consumption of the different blocks and the main characteristics of the
icyflex device.
5.4.5 Memory
The data storage chosen is a FRAM device, developed by Ramtron International (Colorado Springs,
CO, USA) [81]. A large spectrum of possible sizes and power consumption levels are available, thus
allowing an optimum trade-off according to the application needs. Power consumption can be as low
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Table 5.2: Main characteristics of the icyflex microprocessor.
Parameter Comments Value Unit
Voltage supply
Alkaline cell supply 1-1.8 V
Using step-ups 2.7-3.6 V
Hibernation mode Only RTC active, for wake-up 5 µA
Normal mode 32-bit processor, max 3.4 MHz, 1.0 V 120 µA/MHz
High-current Step-up 95% current efficiency 4-13 mA
Low-current Step-up 50% current efficiency 10 µA
as 20 µA @ 1 MHz. Ramtron devices can withstand up to 1016 write/erase cycles while operating at
3.3 V. Finally, FRAM devices by Ramtron are gamma-ray tolerant, thus compatible with this specific
sterilization method.
5.4.6 Sensor
To complete the device, a sensor and its interface to the Transponder electronics would need to be
integrated in the implant.
For the targeted application, the impedance of the heart is measured. The sensor consists of four
electrodes placed on the heart. Two electrodes inject a current, and the two others collect the resulting
voltage, thus measuring the tissue impedance. The electrodes are a modified form of the Model 3889
leads, connected to the Extension Kit for Deep Brain Stimulation (Model 7482A), both manufactured by
Medtronic (Figure 6.5).
The analog signal sensed by the leads needs to be converted into a digital data and stored into
the memory. An ADC, custom made by IMST GmbH (Kamp-Lintfort, Germany), was connected
in between the leads and the icycom unit. The microprocessor drives and controls the ADC actions
through a Serial Peripheral Interface. The sensor and its ADC interface have been assessed within the
ULTRAsponder project by IMST and Medtronic research groups. However, the sensor was not integrated
in the demonstrator manufactured, and therefore no data are presented in this work.
5.4.7 Backscattering modulation switch
A very important point of the project is the data communication by backscattering modulation. This
technique allows the data transfer with minimal energy consumption. In analogy with RF backscattering,
the "0" and "1" logic levels are communicated by varying the acoustic impedance of the piezoelectric
element. A switch is used to alternatively connect the transducer to a capacitor of high value, which
increases the acoustical impedance and makes the transducer stiff (i.e., reflective, backscattering a "1"
level), or to an inductor, which lowers the acoustic impedance, allowing energy absorption and thus
backscattering a "0" level.
5.4.7.1 Subcarrier generator
The electronics show a strong crosstalk, i.e., the 1 MHz excitation carrier, which is much stronger than
the backscattered signal, causes saturation problems in the receiver and reduces the modulation depth
of the resulting AM signal, thus making the demodulation more difficult. In order to increase the
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3 Vpp
0.2 ms10 µs
Figure 5.11: Resulting signal of a subcarrier at 100 kHz and a modulating signal at 5 kHz.
modulation depth and allow an efficient demodulation, the system takes advantage of the subcarrier
modulation technique. Instead of directly modulating the data, the transponder modulates the data bits
over a subcarrier. The new modulating signal, which drives the backscattering switch, is composed of
the actual modulating signal (the data coming from the microprocessor) multiplied with the subcarrier,
e.g., a 100 kHz square wave of amplitude 3 Vpp and 1.5 V DC offset. The resulting modulated signal is
shown in Figure 5.11.
Exploiting the subcarrier, the modulated signal is shifted in frequency away from the carrier, which
results in lower ratio between amplitude of the modulated signal and amplitude of the subcarrier (higher
modulation depth) and therefore easier demodulation.
It was chosen to exploit a 90% AM subcarrier instead of a 100% AM, in order to avoid that no energy
at all would be backscattered when in "0" state. Otherwise, the receiver would see only noise during that
period, and this would disturb the modulation.
In a first moment, the subcarrier and the modulating signal have been implemented by an external
waveform generator (HP33120A). In the final demonstrator, the generator of subcarrier was integrated
on the CU electronics.
5.4.8 Phantom material
To facilitate the assessment of the ultrasonic transmission in conditions close to in vivo, a phantom
material was manufactured by the Institut National de la Santé Et de la Recherche Médicale (INSERM)
(Lyon, France), which mimics the properties of soft body tissues. It is composed of an Oil-Styrene
polymer and has the form of a 16 cm diameter cylinder. Its acoustic attenuation is 0.3 dB/cm/MHz,
close to that of soft tissues. Small plastic tubes were inserted in the mold, in order to mimic a blocking
structure, for example ribs. Figure 5.12 shows the ready phantom.
5.5 Means of verification
In order to assess the functionality of the proposed device, and to validate the choices of technology,
materials and methods, it is necessary to define the parameters according to which the system should be
evaluated, and the tests and simulations to be performed for that purpose.
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Figure 5.12: Phantom material mimicking a soft tissue and ribs.
Simulation of Ti influence: as a first test on the system, the effect of titanium casing on the acoustic
link must be assessed. It is expected that titanium will attenuate and disturb the ultrasonic transmission.
As described in Chapter 4, the TR sandwich is modeled and the transmission of the maximum acoustic
intensity level allowed by the FDA for this application (0.7 W/cm2) is simulated. The material properties
are described based on the KLM model [55].
The goal is to define the maximum thickness of titanium through which the acoustic transmission can
be established, in order to plan the thinning needed to improve the transmission. It is not possible to
progressively test the acoustic transmission and thin down the titanium material. The optimum thickness
needs to be determined in simulation, the casing thickness must be adjusted if required, and finally the in
vitro assessment can be performed.
Energization possible within FDA limits: once the optimal casing thickness has been established,
the casing is adjusted to that thickness. A second key factor of the system is the compliance with the
regulation. This depends on the carrier parameters used (frequency, duty cycle, intensity), and on the
efficiency of the electronics on both CU and TR side. Given a set of parameters of the CU electronics,
the emitted signal along the path can be calculated, and it can be verified whether or not it complies
with the regulation. Once the best trade-off is found, which gives the more powerful signal at the TR
within the limits set by the regulation, those parameters should be verified in vitro and the recharge of the
battery on the TR must be assessed.
Energization and Communication in vivo: finally, the system should be evaluated in conditions
close to the target application. An in vivo measurement set is required, in which both energization of the
TR and communication from the TR to the CU is successfully shown.
5.6 Conclusion
This chapter presented the ULTRAsponder project, to which the author of this thesis contributed. An
IMD was conceived, which addresses several technological challenges in state-of-the-art devices.
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It is proposed to exploit ultrasound as a carrier for both energy and data transfer between a CU and one
or more implanted TRs.
Data transfer can be performed using very low power, due to the backscattering technology.
The electronics of the system are carefully chosen among commercial off-the-shelf components, or
custom designed within the project. A FRAM device is chosen for data storage, in order to achieve
long device life and MRI compatibility. Thin-film, solid-state batteries are exploited, which carry an
integrated power management unit. Custom ADC and microprocessor modules are designed.
A commercial titanium housing is taken into consideration, mostly because of its biocompatibility. A
region of the casing is thinned down by laser ablation.
A phantom material is manufactured, which mimics real test conditions.
A test procedure is established, in order to verify the good behavior of the demonstrator.
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6.1 Introduction
Within the ULTRAsponder project, several demonstrators were designed, in order to validate the
components and strategies chosen at different stages of the concept development.
The first demonstrator presented in this chapter aimed to prove the concept of an energy transfer
through acoustic waves between an external CU and a TR. The two transducer devices were held at
about 15 cm distance in a testbed filled with water, in order to mimic a deep implantation, but avoiding at
first the attenuation of soft tissues.
In a second step, the phantom material described in Chapter 5 was inserted in the ultrasonic chain.
The transducers and the electronics on both CU and TR side were refined based on the different tests
and on the evolving specifications.
As a support for the improving implant two casings were provided, each of them adapted to the tests
intended and the geometry of the electronics manufactured.
The final demonstrator of the complete system could be used for real-conditions assessment of both
energization and data communication, performed by in vitro and in vivo tests.
A real sensor for the intended application, i.e., monitoring of the heart impedance, and its ADC
were successfully manufactured and tested within the project, but could not be integrated in the final
demonstrator due to time constraints.
6.2 Testbed
A platform was built to study ultrasound propagation and test the demonstrators produced [63] all along
the development of the device. A cubic plexiglas tank of edge 50 cm is used as a container for a pair
of electro-acoustic transducers, where a CU is fixed to one wall of the tank and a TR can be manually
moved in three axes and rotated using a mechanical system. The tank is filled with water to allow acoustic
energy and data transfer, and the system is optimized to avoid parasitic effects due to cables, reflection
paths and cross talk problems. Fig. 6.1 shows the in vitro platform. In order to reduce standing waves
and echoes, an absorber material made of silicone is placed all around the two transducers (Aptflex F28
by Precision Acoustics, Dorchester, Dorset, UK). In the CAD rendering, the absorber material is only
present behind the CU transducer in order to clearly show the Transponder transducer. The mechanical
system is used to move the piston transducer inside the tank along the x, y and z axes with a resolution of
50 µm, also having the possibility to be rotated ±25° along the x axis.
6.3 Housing
6.3.1 Aluminium casing for electronics development
In the development of the project, a prototype casing has been manufactured, which hosts the TR
electronics under development. The casing was designed and fabricated by the transducer manufacturer,
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CU
TR
(a) CAD rendering of the testbed. (b) Mechanical table to move the transponder.
Figure 6.1: Testbed developed for the demonstrator assessment.
for optimal integration of the transducer itself. It is made of aluminium and composed of a bulk part,
holding the transducer and a cable bunch, and two lids to hermetically close the housing. Connector
CLP-105-02 manufactured by Samtec (New Albany, IN, USA) is soldered on the transducer, and its
complementary connector FTSH-105-01-X-DH is mounted on the demonstrator electronics. Signals
from the electronics or from the transducer can be transferred to the external world by a bunch of
coaxial cables (PC 64 Y manufactured by Axon’ Cables SAS, Montmirail, France), which is hermetically
clamped into the prototype housing.
The design of the housing and the connection between transducer and electronics are shown in
Figure 6.2.
6.3.2 Titanium casing for in vivo measurements
Within the ULTRAsponder project, a commercial casing is chosen, in order to prove the acoustic link
through an homologated housing. The casing of the Kinetra® neurostimulator is chosen. Its dimensions
offer enough space for the expected size of the final electronics, while still allowing good implantability
in pigs for in vivo tests.
6.3.2.1 Casing thinning
The Kinetra® casing chosen has a thickness of 300 µm. According to the simulations performed on
the transducer (Chapter 4), it is decided to thin a region of the casing down to 100 µm, in order to
allow a good transmission of the ultrasonic wave while keeping a good structural integrity. Among
different options to machine titanium, laser ablation is chosen, performed by LaserJura (Rossemaison,
Switzerland).
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(a) Geometry of demonstrator casing. (b) Connection to the electronics.
Figure 6.2: Aluminium demonstrator casing.
Figure 6.3 shows the geometrical plans for the thinning of the half casing. The shape of the thinned
region is specified by the manufacturer of the transducer based on the transducer geometry and of the
gluing method.
6.3.2.2 Connection to electronics
During the first steps of the electronics development, the electric signal from each transducer element are
connected to the eight feedthroughs available on the casing, and from there to the external electronics.
In the final version of the TR electronics, the PCB is placed inside the casing, which provides better
connection and more reliable signal transmission. In order to achieve an efficient acoustic coupling
between the transducer and the titanium layer, the glue joint must be as thin as possible. A 10 µm
thick epoxy joint is used. In order to avoid harmful strain on the piezoelectric elements, a connector
(Micro-MaTch, by TE Connectivity Ltd., Schaffhausen, Switzerland) is glued next to the transducer and
the TR’s PCB connects to it, as shown by Figure 6.4.
6.3.2.3 Sealing method
In a first step, the new demonstrator has to be tested in vitro, to assess energy and data transfer through
the titanium barrier. After the tests with the aluminium casing, the TR boards are assembled into the
Kinetra® casing and the same energization and communication tests are performed. Proper casing
sealing should be avoided at this moment, as it may be necessary to adjust the electronics inside the
casing.Therefore, a sealing method must be developed, which ensures waterproofness during roughly a
day, is reversible with as few as possible residual glue on the casing, and is possibly easy and quick to
apply. Several sealants have been tested to this end on an empty casing, without connectors. Both the
feedthrough locations and the joint between the two halves of the casing must be covered and sealed.
Silicone-based sealant Dow Corning 734 has been applied on the joint. It proved to effectively adhere to
the titanium surface, which has been previously cleaned with acetone.The glue layer could be removed by
manual pulling off the layer, then with acetone solvent. Where needed, a cutter was used to remove glue
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Figure 6.3: Geometrical plans for the thinning of a region on the Kinetra® housing.
from the joints. Cleaning with acetone was performed prior to further gluing tests. Dow Corning 734 is a
solvent-less silicone elastomer in the form of a flowable liquid. It has been chosen because of the easy
application method and ability to cure at room temperature. It is chemically not dissimilar to medical
silicone glue, routinely used in implants. As the feedthrough connector was not used for this sealing test,
a generous amount of silicone sealant is applied on the feedthrough pins on the casing, in order to protect
them and ensure waterproof protection at that level. The glue was cured 24 hours at room temperature.
The casing was then put into water for 3 hours to check waterproofness.
This sealing method was sufficient to perform the tests over several days in vitro, as well as in vivo
conditions for few hours.
Figure 6.5 shows the sealed Kinetra® casing. Custom modified leads are attached to the feedthroughs.
6.4 Characterization of the TR transducer array
Prior to integration in the casing, the transducer for the TR was characterized according to its electrical
impedance, sensitivity, directivity, and angular acceptance.
6.4.1 Method
The electrical impedance of each element of the transducer array was measured by a network analyzer.
The array was coupled to water and connected to the analyzer through a 1 meter multicoaxial cable,
which impedance was compensated for a precise result.
For each element, the sensitivity (peak-to-peak voltage) to a mechanical input, the fractional bandwidth,
and the central frequency at −6 dB were deduced from pulse-echo measurements on a brass target in
water.
The directivity in emission was measured in water with an hydrophone turning around the transducer
in the far field region (14 mm from the transducer). The measurement was performed for each element
using a sinusoidal excitation of period 1 MHz.
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(a) Kinetra® casing hosting the transducer array (brown) and the
Micro-MaTch connector (red).
(b) Connection to the electronics.
Figure 6.4: Connection strategy in the Kinetra® housing: the transducer array is glued on the casing and
soldered to the Micro-MaTch connector, on which the PCB is then connected.
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Figure 6.5: Kinetra® casing with modified leads.
Table 6.1: Electrical impedance, sensitivity, and central frequency of TR transducer.
Element number Average Simulated1 2 3 4 5 6
Zr @1MHz [Ω] 937 806 778 825 825 855 838 732
Zi @1MHz [Ω] 346 310 342 297 294 673 310 349
Voltage [mVpp] 162 159 180 167 170 165 167 -
Fc [kHz] 943 956 969 957 964 950 957 947
BW/Fc @ -3dB [%] 17 13 15 14 16 18 16 15
The angular acceptance of the TR in reception was measured in water with one element on the CU
emitting and one element on the TR receiving.
The CU was excited with a burst of 25 periods of sine 1 MHz and the generated voltage on the
transponder was measured on an oscilloscope on 50 Ω. The TR was placed at 16 cm from the CU on the
wave propagation axis. It was aligned with the CU array along both the elevation and the lateral axis, in
order to maximize the reception. Afterwards the CU was turned around the lateral axis.
6.4.2 Results
Table 6.1 gives the characterization results for the electrical impedance, the sensitivity, central frequency
and bandwidth. Simulation results are also given for comparison.
The electrical impedances is close to the ideal value (750 + 750j)Ω for each of the 6 elements in the
array. It is interesting to note that the imaginary part is positive. This is due to the ringing behavior
linked to the titanium presence. For a well damped transducer, the imaginary part is usually negative.
For the present case, the positive imaginary part should be helpful for the power transmission efficiency,
because it compensates the transponder PCB, which has a capacitive behavior due to the battery.
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Figure 6.6: Frequency spectrum of a single flat array element in emission-reception.
Directivity [°]
Element # @ -3 dB @ -6 dB
1 37 53
2 34 52
3 34 52
4 36 54
5 35 54
6 38 54
Figure 6.7: Characterization of the effect of tilting on the TR transducer in emission.
The 6-elements arrays exhibits a good homogeneity (between 150 and 180 mV). The central frequency
is close to 1 MHz and the sensitivity homogeneity is about 1.1 dB. The bandwidth is approximately
16%. The relatively narrow bandwidth is due to the big mismatch in acoustic impedance between the
titanium and the transmission medium. The presence of an adaptation layer, which is not feasible in the
device proposed, would extend the transmission peak over a larger bandwidth. Figure 6.6 gives a typical
spectrum obtained for one element.
There is a good matching between experimental results and simulations. The differences are due to the
variability of properties of the transducer materials among samples, mainly resulting from layer effects
in the sandwich and from fabrication-induced stress and heat.
Figure 6.7 shows the directivity of the transducer elements in emission. The directivity in emission
exhibits a good homogeneity for all the elements: it was about 35 ° at −3 dB and 55 ° at −6 dB.
The angular acceptance (Figure 6.8) is about 40 ° at −3 dB and 60 ° at −6 dB along the lateral axis,
and about 15 ° at −3 dB and 25 ° at −6 dB in the elevation direction. This gives a good flexibility for the
system with regard to the TR motion.
The relative voltage is plotted in dB versus the angle θ between the transducer and the hydrophone as
20 log V(θ)Vmax , Vmax being the maximum voltage obtained for θ = 0.
In order to further enlarge its angular acceptance, the transponder could be divided into elements in
the elevation direction, similar to the division into six elements along the lateral axis.
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(a) Directivity along lateral axis. (b) Directivity along elevation axis.
Figure 6.8: Characterization of the effect of tilting on the TR transducer in reception.
6.5 First proof of concept
In a first step of the ULTRAsponder project, preliminary demonstrators of the CU and of the TR have been
designed and produced. Commercially available components have been used, while custom components
were under development by the partners of the consortium. The functionality of the demonstrator has
been tested, to prove the concept and to estimate the link budget between the CU and the TR. Key
numbers on that stage are the efficiency of the power link and the power levels to be transmitted. Similarly,
the data transmission from CU to TR and vice-versa were assessed. Key numbers are data rates and
reliability of link. The test bench allows investigating the influence of the movement of transducer
(translation and rotation) and the influence of CU and TR location on the above parameters.
The transducers used with this first demonstrator are the 64-channel array on the CU side, and the
6-element transducer, mounted in the aluminium prototype box, on TR side.
6.5.1 Electronics description
The system demonstrator manufactured is composed of three PCBs (namely TRANS, CU_base and
CU_RX), which connect to the transducers. This prototype is intended to be extensively assessed and
characterized in vitro. An external filter and a subcarrier generator have been added during the test
evolution, to improve the performances of the signal received. No sensor is included in this demonstrator,
the data message to be transferred is predefined and do not depend on the external environment. The
block diagram of the demonstrator including the different elements is depicted on Figure 6.9, while
Figure 6.10 depicts the manufactured circuits.
The components used in the demonstrator are commercially available but not necessarily optimized for
the target application. This in order to prove the concept with a simple architecture and well established
components.
6.5.1.1 CU baseboard
The interface between the transducer of the CU and the power generator is provided by the CU_base PCB.
Eight elements of the transducer are reserved for reception, evenly distributed among the 64 available
(elements 8, 16, 24, 32, 40, 48, 56 and 64); all the other elements are dedicated to ultrasonic emission.
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CU baseboard
(CU_base)
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(CU_RX)
TR baseboard
(TRANS)
CU TR
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Figure 6.9: Block diagram of the first demonstrator.
(a) Control Unit. Baseboard CU_base. (b) Control Unit. Receiver circuit CU_RX. (c) Transponder.
Figure 6.10: First system demonstrator.
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Figure 6.11: Detail of CU_base. Choice of reception elements.
The circuit responsible for the emission is divided in seven identical parts, each of them driving eight
elements of the transducer. A manual switch allows connecting or disconnecting each element to the
power generator. That is useful to shape the acoustic beam transmitted by the CU. The eight reception
elements are connected to another switch (S2 in Figure 6.11), so that it can be decided whether or not to
add the contribution of each single element to the total reception signal.
An input Transistor-Transistor Logic (TTL) signal is fed into the PCB and gives the form to the final
wave transmitted. The amplitude of the wave is given by an external voltage generator Vdriver, regulated
into VDR. A filtering stage has been foreseen but proved not necessary.
6.5.1.2 CU receiver and filter
The signal backscattered by the TR device is collected from elements of the CU reserved to this aim and
redirected to CU_RX. This PCB is responsible for demodulating the received signal. Between CU_base
and CU_RX there are a filter stage and an attenuator, which improve the signal transfer. The filter should
remove the main carrier at 900 kHz on which the energy is transferred from CU to TR. The remaining
signal will present the modulated message and the subcarrier. The attenuator may be placed on the
coaxial connector of CU_RX, in order to reduce the power injected which could saturate the PCB.
6.5.1.3 TR baseboard
This PCB is a first prototype of the implanted transponder. It contains the circuitry for the energy
harvesting from the transducer, and the electronics needed for the communication of the data. It does not
contain yet the interface to the sensor, nor the sensor itself. Similarly to the choice of receiving elements
implemented on CU_base, two switches on TRANS allow choosing which of the six elements are
devoted to collect the energy received from the CU, and which elements will be used for communication.
The energization circuitry is essentially composed of three integrated circuits, manufactured by Linear
Technologies (Milpitas, CA, USA) and Texas Instrument (Dallas, TX, USA): the LTC3588-1 rectifier
combines the electrical wave of all contributing elements and outputs a 3.3 V DC voltage. The boost
converter TPS61220 steps up that voltage to the 4.2 V level needed to recharge the thin film battery.
Finally, a regulator (TPS78001) converts the battery voltage to power the microprocessor, which requires
a 1.8 V voltage level.
The backscattering circuitry relies on an electronic switch performing the change in impedance. It is
driven by the microprocessor signal. A series of diodes limits the voltage of the transducer elements
dedicated to backscattering between −0.7 V and 3.6 V, in order to protect the switch from the incoming
energization wave.
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6.5.2 Test performed
The aim of the preliminary tests is to prove the concept of the system, i.e., to use an ultrasonic wave
to recharge a thin film battery that will power an electronic circuit containing a microprocessor, and
to establish a communication between the CU and the TR. All along the process of mounting the
components, the different PCBs were checked against short circuits. The functionality of the system was
assessed, starting from the single, separate functions of each bloc and evolving towards the behavior of
the complete system.
In the energization tests, the transfer of energy from the generator, through the CU, through the
acoustic link to the TR is assessed. In the backscattering tests, the aim is to evaluate the transfer of the
wave carrying the information stored in the implant. The wave travels from CU to TR and back, so its
transfer is affected twice by the medium and by the reflection on the TR interface.
6.5.2.1 Functional test of the CU baseboard
The circuit CU_base, connected to the two external power supplies Vdriver and Vlogic, creates the signal
to be delivered to the transducer elements chosen. The switches drive the signal to the correct elements.
The input to CU_base is a TTL signal, that is a 1 MHz square wave, with an amplitude of at least 2.4 Vpp
and an offset of half the amplitude. An arbitrary voltage level is chosen for Vdriver, and the necessary 9 V
are set for Vlogic.
The resulting wave on each pin of the connector is observed on the oscilloscope. The excitation
wave will have the form of the input TTL signal, and the amplitude of Vdriver. Then, the CU transducer
contained in the tank is connected to CU_base, and the power required to drive all elements or a subset
of the transducer is monitored.
6.5.2.2 Functional test of the TR baseboard
The electronics of the implant are assessed without the transducer. When a power supply is plugged on
the transducer connector, the circuit must rectify the wave supplied and use that power to recharge the
battery and start the microprocessor. The excitation is provided by a signal generator plugged on the
connector hosting the transducers. On each of the six pins connected to the PCB a resistance of 1.2 kΩ is
connected, to model the impedance of the transducer element as characterized by the manufacturer. In
reality, the impedance of the element also presents a reactive part of about −1.5 kΩ at 1 MHz (equivalent
to a capacitance in series). It is very important to have a high impedance at the input of TRANS, because
of the backscattering switch: its power supply being at 3.3 V, it cannot withstand the high voltage
obtained by the energization (up to 25 V). For this same reason, the backscattering switches are protected
by a series of diodes.
The signal is supplied in parallel to all resistances, and a 1 Ω resistance is connected in series to allow
the measurement of the power consumption. The small value of this resistance is negligible with respect
to the transducer impedance: the total impedance of the transducer varies between 200 Ω (parallel of six
resistances of 1.2 kΩ) and 1.2 kΩ (only one element connected). The error is therefore smaller than 0.5%.
The ground of the signal is connected to the appropriate pins on the connector. The power is measured
indirectly: the voltage drop across the 1 Ω resistance is measured with a differential probe, while another
probe measures the amplitude of the wave injected into the PCB (VIN). Two measurements are relevant
at this stage:
Minimum voltage to be provided to the PCB in order to obtain the necessary voltage level to recharge
the battery (4.2 V DC) and to switch on the microprocessor (at least 2.7 V DC);
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Variation of the voltage level depending on the amount of elements dedicated to energization.
6.5.2.3 In vitro energization
Both TRANS and CU_base are now connected to their respective transducers, placed in the test bench.
The battery and the microprocessor are connected, but not the receiver CU_RX. Aim of the measurement
is to assess the minimum power to be supplied on CU so that its transducer is able to recharge the TR
battery and that the microprocessor is switched on. To this aim, the supplied current will be read from
the DC power supply.
In addition to these measurements, similar to those performed on TRANS alone, the influence of the
alignment of the transducers on the ultrasonic transfer is estimated. Different positions, rotations and
tilting of the TR are explored, and different sets of CU transducer elements are used in emission. As
a starting position, the transducers are aligned by eye, at a distance of about 11 cm, which is the focal
distance according to the characterization performed by the manufacturer.
6.5.2.4 Functional test of the CU receiver
Supplying a modulated electrical wave at the input, the correctness of the demodulation and the mini-
mal/maximal amplitude of the carrier wave are evaluated. The RF_IN input of CU_RX is connected to
the signal generator through a 2.5 MHz low pass filter stage. The RSSI wave and the demodulated logic
signal are monitored on the oscilloscope. The RSSI level is also checked on a multimeter. It should not
exceed 4 V DC, which would indicate a saturation of the demodulator circuit.
6.5.2.5 In vitro backscattering
Finally, the CU_RX can be connected to the rest of the setup and the whole energization-backscattering
chain can be performed: the power generator feeds the CU_base with an electrical wave and the
resulting backscattering signal received by the CU elements dedicated to reception is observed. Like
for the energization tests, several positions, rotations and tilting of the TR, and different sets of CU
emitting elements are explored. The TRANS elements dedicated to backscattering and those dedicated
to energization are defined by the previous tests.
6.5.3 Results
The equipment used for the tests are the following:
• Waveform generators: TG4001, HP33120A
• Modulated signal generator: Agilent MGX N5181A
• Power supplies: ranging 20 V DC, 1 A
• Oscilloscope: Tektronix MSO4034
• Spectrum analyzer: Agilent E4402B
All measurements in vitro are performed using water as a conductive material, no phantom materials are
inserted at this stage.
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(a) Setup schematic.
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900 kHz
(b) Signal emitted on connected CU elements when
Vdriver = 15V.
Figure 6.12: Functional test of CU_base.
80 mVpp
60 mVpp
2 MHz
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(b) Six adjacent elements are ON.
Figure 6.13: Crosstalk on CU element #4 dedicated to energization.
6.5.3.1 Functional test of the CU baseboard
At first, the energy transfer on the PCB, without the load of the transducer, is assessed. To this end,
a square wave at 900 kHz, 3 Vpp, 1.5 V DC offset is applied on the PCB input IN. The level Vlogic is
fixed to 9 V DC and Vdriver is swept between 0 and 15 V. The wave produced on the enabled transducer
elements is, as expected, a square wave at 900 kHz, whose amplitude nicely follows Vdriver as shown in
Figure 6.12.
On the elements switched off, a 0 Volt signal can be observed, as foreseen, but also peaks at various
frequencies. There is a clear correlation between the amplitude of the peaks and the state of the adjacent
transducer elements. More elements emitting around the element under test result in higher peaks, as
well visible in Figure 6.13.
Also on channels dedicated to reception (each 8th element), a square wave at 900 kHz can be observed,
which amplitude depends on the state of the other elements: when all elements are switched off, the
wave is less than 60 mVpp, while it is about 1.2 Vpp when seven energization elements on each side of
the observed element are switched on (Figure 6.14).
It can be therefore concluded that a non negligible crosstalk occurs on the CU_base PCB, and that
a signal is present on the receiving elements even when no element of the transducer is excited. This
93
6 Demonstrators produced
55 mVpp
900 kHz
(a) All elements are OFF.
1.14 Vpp
900 kHz
(b) Seven elements on each side of element 8 are switched ON.
Figure 6.14: Crosstalk on CU element #8 dedicated to backscattering.
Figure 6.15: Linear increase in power consumed with respect to the amount of elements.
contributes to the saturation of the demodulator (in CU_RX) and should therefore be corrected. The
crosstalk level slightly vary according to the position of the element observed: central elements show
higher amplitude than side ones, which is very well explained by the quantity of adjacent elements.
In a second step, the transducer is plug to the circuit. Because of the current limitation at 1 A imposed
by the commercial power supplies, a voltage of about 17 V DC on Vdriver when driving all 56 elements
cannot be exceeded. The higher the voltage applied, the higher the current drawn by the transducer,
which acts like a resistance of about 20 Ω. Figure 6.15 shows the power consumption as a function of the
voltage and of the number of elements driven. As expected, the increase is clearly linear. The power
provided by Vlogic is not relevant, due to the low power of the commercial components chosen.
6.5.3.2 Functional test of the TR baseboard
In order to assess the energy transfer inside the implant, a sinusoidal wave of amplitude Vgen at 1 MHz is
applied through 1.2 kΩ on each input of TRANS and the resulting voltages in the circuit are monitored:
• Vin: the amplitude of the electrical wave when connected to the TRANS PCB. A small voltage
drop occurs due to the relatively low input impedance of the elements.
• Vr: the rectified voltage, at the input of the regulator. It saturates at 20 V.
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Table 6.2: Voltage levels on TRANS when supplying a sinusoidal wave at 1 MHz.
Vgen [Vpp] Vin [Vpp] Vr [V] Vcc [V] Vbat [V]
20 17 8.1 OK OK
17 14.4 6.9 OK OK
15 12.8 6.1 OK OK
13 10.8 5.22 OK OK
11 9.4 4.4 OK OK
TRANS
Connector 
H18
.
.
J19
To battery
To µP
Diff. 
Probe
Probe
1Ω
AC
1.2 kΩVIN
Vgen
Vbat
Vcc
(a) Setup schematic. (b) Power consumption of TRANS, with 3 elements dedicated
to energization.
Figure 6.16: Functional test of TRANS.
• Vcc: the supply voltage for the microprocessor. It is regulated to 3.3 V.
• Vbat:the voltage on the battery. It is regulated to 4.2 V.
Table 6.2 shows the different voltages. All measurements have been done without connecting the battery
and the microprocessor.
Applying an input amplitude lower than 11 V does not allow obtaining enough rectified voltage to drive
the device. Applying a square wave at the input, instead of a sinusoidal wave, gives of course a higher
rectified voltage. In a further step, the input amplitude is fixed at 20 Vpp and the number of elements
dedicated to energization is changed. The elements switched off for energization will be switched on for
backscattering and vice-versa. Three TR adjacent elements are dedicated to reception (energization) and
the other three are dedicated to emission (backscattering). The power consumed by the circuit in this
configuration is shown in Figure 6.16. A part of this power is used to recharge the battery, that is to say it
is stored in the device.
6.5.3.3 In vitro energization
Finally, TRANS and CU_base can be connected to their respective transducers, and the battery and the
microprocessor can be plugged into the system. On the contrary, the receiver CU_RX is not connected.
The TR is put in front of the CU and at an approximate distance x3 = 11 cm. This is the focal distance
according to the manufacturer datasheets. The transponder is then moved along the three Cartesian axis
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Figure 6.17: In vitro energization.
and the rotation axis, in order to obtain the maximum of transfer. Providing Vdriver = 9 V a rectified
voltage Vr > 20 V was obtained, which is the saturation limit due to the Zener limiting diode in the
LTC3588-1 rectifier chip. The supplied voltage must be reduced down to Vdriver = 8.5 V to obtain
VIN = 23.6 Vpp and therefore Vr = 19.2 V (Figure 6.17). This is at a distance x3 = 11.2 cm.
6.5.3.4 Misalignment
From the optimal position previously found, on which the highest transfer is achieved, the TR is
misaligned first along the x2 axis (lateral misalignment), then along the propagation axis x3. A constant
CU emission is set, and the rectified voltage on TR is observed. According to the data shown in
Figure 6.18, the system can accept a maximal displacement of 20 mm on the x2 axis and still provide
a sufficient transfer to power up the microprocessor. The red box indicates a condition in which no
sufficient energy is transferred to achieve the good levels of Vbat and Vcc. The maximum distance between
the transducers for which energy transfer can occur is about 11.15 cm, which is about 0.5 mm from the
focal point. On the contrary, placing TR at a distance smaller than the focus always results in a sufficient
transfer, because the TR will be in the acoustic beam.
Now, the influence of the amount of emitting elements is observed: the emission of some elements of
the CU is disabled, starting from the most peripheral ones. As an effect, the beam will be less focused,
i.e., the area of maximal intensity on the focal plan will be larger. A sufficient transfer is possible with as
few as 14 elements over the 56 available, as shown on Figure 6.19.
6.5.3.5 Functional test of the CU receiver
Once the energization has been proved, the data communication can be assessed. The input signal is a
square wave at 1 MHz modulated by 5 kHz at a modulation depth of 90%. The attenuation of the signal
was changed and the resulting RSSI signal was monitored (Figure 6.20). Ideally, its AC part should be
as high as possible, in order to be easily recognized by the data slicer, and its DC part should not exceed
4 V, the level of saturation of the CU_RX. According to the measurements shown in Table 6.3, a signal
with a level up to −30 dBm can potentially be exploited. Higher amplitude than that will saturate the
CU_RX. The minimum amplitude allowed for the signal depends on the demodulator stage.
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Figure 6.18: Displacement of TR from optimal point.
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Figure 6.19: Effect of the amount of CU elements emitting on the rectified voltage in the TR.
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Figure 6.20: Setup schematics for the functional test of CU_RX.
97
6 Demonstrators produced
Table 6.3: Efficiency of the CU_RX.
Attenuation [dBm] RSSI level AC [mVpp] RSSI level DC [V]
-70 520 2.8
-60 900 3.13
-50 1080 3.53
-40 1080 4
-30 800 4.2
-25 560 4.34
Figure 6.21: Modulated signal at the output of CU_RX.
6.5.3.6 In vitro backscattering
The circuit CU_RX can finally be connected to the system tested for the energization test and the
backscattering can be assessed.
The excitation applied on the CU is exactly the same used for energization assessment: the TTL signal
on CU_base is a square wave at 900 kHz (3 Vpp, 1.5 V offset), Vdriver = 8.5 V, Vlogic = 9 V. All CU
elements are used and the reception of the backscattered wave is enabled only on the middle receiving
element (PZ_32). The signal generator drives the backscattering switches with a modulated signal at
5 kHz superposed with a subcarrier at 100 kHz. The incident wave on CU_RX (RF_IN, connector P1) is
visualized on the spectrum analyzer.
The signal delivered on the input of CU_RX is shown in Figure 6.21: it has a component at the
combined frequency of carrier and subcarrier fC+S C = 1 MHz and two side bands at ±5 kHz. The
modulation depth is very high: the difference between the amplitude of the carrier and the amplitude of
the modulation signal is only 4 dBm. The signal amplitude (−50 dBm) is acceptable.
6.5.3.7 Misalignment
The displacement along x2 is repeated and the selection of different amounts of emitting CU elements.
The amplitude of both the carrier and its side bands (modulated signal) are monitored on the spectrum
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(a) Misalignment along x2 axis. (b) Variation of amount of CU elements emitting.
Figure 6.22: Effect of side displacement on data communication.
analyzer. Ideally, both the attenuation and the difference between the two amplitudes should be as small
as possible (high RSSI level, high modulation depth). Figure 6.22 shows the effect of a side displacement
and of the amount of elements used for emission from CU_base. Green circles indicate the best results
concerning communication.
6.6 Final electronics
6.6.1 Electronics description
An improved circuit for the TR has been designed and manufactured, based on preliminary tests in vitro.
Major advantages are a better charge and discharge management of the local battery, an integrated and
stable backscattering technique and a shape adapted to the Kinetra® casing.
On CU side, two major improvements have been performed, namely the Data Slicer and the GUI.
Also, the power levels provided by the driver can be adjusted.
Figure 6.23 shows the final CU board and the final TR electronics in the biocompatible casing. The
connections between the PCB and the feedthroughs are not performed.
The TR baseboard is composed of different blocs.
Thin film battery: two 0.4 mAh batteries, manufactured by Infinite Power Solutions (IPS).
FRAM: a ferro-electric non-volatile memory (e.g., FM25V10, 128 kB, manufactured by Ramtron).
Transducer modulator: Two backscattering switch ADG719 from Analog Devices Inc. (Norwood,
MA, USA), performing dual modulation with a 100 kHz subcarrier.
Voltage multiplier: in order to increase the voltage level coming from the transducer elements, and to
overcome the threshold at the input of the battery recharge circuit, a voltage tripler was developed, which
needs a minimum input amplitude of 650 mVpp to work (corresponding to two Schottky diode drops).
The correct behavior of the stage was verified by simulation: a Vac input level of 1.7 Vp is successfully
rectified into a 5.6 V DC Vtrip.
MAX17710 chip: the power management of the battery occurs through this chip, which was custom
designed by Maxim Integrated (San Jose, CA, USA) for the IPS battery chosen. It replaces a big part of
the energy harvesting circuit previously designed. It contains an on-chip voltage boost converter, which
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(a) TR electronics in the Kinetra® casing. Micro-
processor submodule on the right.
(b) CU electronics.
Figure 6.23: Final CU and TR electronics. Not at scale.
will be used after the tripler. It allows a better management of the recharge of the battery, the control the
power consumption of the electronics, and the protection of the battery from deep discharge.
Two submodules complete the baseboard: an Icycom daughter board, containing the microprocessor,
and an ADC submodule, designed to host the custom ADC, which converts the data collected by the
sensor leads. The ADC submodule was designed and manufactured, but not yet integrated in the PCB.
As no data can be sensed in real time, the Icycom submodule continuously sends a fixed hexadecimal
message, i.e., “ABBA DADA ADDA”.
An oscilloscope powered by USB on a laptop is exploited (Picoscope® by Pico Technologies, Cam-
bridgeshire, UK), in order to insulate the system from the AC power line, thus avoiding parasitic
signals.
Wires give access to AC signals from 2 transducer channels (backscattering and communication),
regulated voltage for Icycom (3.3 V nominal), and Vchg voltage (output of voltage booster circuit, input
to battery charger).
On CU side, the Data Slicer circuit converts the received analog backscattered signal into a tidy
square signal representing the signal series of bits. Four threshold levels are programmed, which identify
the minimum high level (Lo+), the maximum high level (Hi+), and the minimum and maximum low
levels (Lo- and Hi-, respectively). A “peak-to-peak” input signal is interpreted based on the crossing of
those levels. The output gets high when the input crosses the Hi+ threshold upwards, and it gets low
when the input crosses the Lo- threshold downwards.
In the current application, the thresholds are set on the peak signal amplitude, the top threshold is set
at 96%, and the bottom threshold is set at 89%. This ensures good decoding.
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6.6.2 Tests performed
With this latest version of TR and CU electronics, both the energy transfer from the CU to the TR and
the data transmission from TR to CU are tested. The first assessment is performed in the test bench, then
in a surgical facility, in conditions close to real implantation in humans.
6.6.2.1 In vitro test
The developed electronics board, containing a power management and a backscattering circuitry, is
inserted into the casing and connected to the TR transducer. Among the six transducer elements, one is
used for energy harvesting (acoustic wave from CU to TR) and another for backscattering (reflection of
the wave from TR to CU). The 14 central elements of a flat, 32-elements transducer are used for emission
from the CU, using a carrier at 900 kHz. Pulses of an electrical power equal to 82 mW are injected on
each element, for a total 1.15 W electrical power emitted. Given the efficiency of the transducer (58%), it
results in 0.67 W acoustic power emitted. Under those conditions, according to the Rayleigh propagation
model , the incoming power on the Transponder is equal to 0.64 W, which is 1.8 W/cm2. Being the
CU emission duty cycle 5%, this corresponds to about 0.1 W/cm2 in average. The tests are performed
in a custom testbed, described by Mazzili, Peisino et al. [63]. Energization and communication are
performed both in water and through the custom phantom material, whose attenuation has been assessed
by pulse echo acquisition to be close to the attenuation of a body soft tissue [63].
To avoid ground loops and parasites on the transmission, an oscilloscope powered by USB and
connected to a portable PC is used.
6.6.2.2 In vivo test
The same casing and the same TR electronics are used for in vivo assessment. Tests are performed at
the University Hospital of Oslo on a Norwegian pig of about 35 kg. The test underwent usual ethical
approval according to the regulation.
An incision is first done in the abdomen (laparotomy), the excitation transducer is applied on the
abdominal skin, and the Kinetra® is placed at subcutaneous distance (about 1 cm), medium distance
(3-5 cm), and longer distances (10 cm).
During the operation, the surgeon tries to keep as much parallelism and alignment as possible between
the planes of the two transducers.
In a second step, the demonstrator is placed inside the rib cage (thoracotomy) and the transmission
trough the ribs is tested. In this case, the communication and recharging distance is limited to a couple of
centimeters. Acoustic gel is copiously used in the cavity to ensure the best possible acoustical contact
with the demonstrator.
For the energization assessment, the Control Unit presents the same configuration as for in vitro tests:
the central 14 channels are used and a pulsed power of 1.8 W on a 5% duty cycle is sent. On TR side,
one element is dedicated to reception and energization, and another to backscattering communication.
For the communication assessment, continuous emission from the CU is used, injecting approximately
the same amount on average power as in the pulsed case.
In order to protect the CU from over-heating, all the tests are done using acoustic gel, and excitation is
always cut before lifting the transducer from the skin. Displacement between two locations is done by
sliding the CU, leaving as much as possible the transducer in contact with the skin.
Figure 6.24 visualizes the setup used for the in vivo tests and the manual placement of the transducers
at a distance of about 4 cm.
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(a) Setup. (b) Test at ∼4 cm.
Figure 6.24: In vivo test of the final demonstrator.
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Figure 6.25: Acoustic pulse received on transducer element.
6.6.3 Results
Using the optimal casing thickness previously determined by simulation (100 µm), the system is assem-
bled and tested in vitro. As a first test, the peak response of the system is evaluated, by emitting in burst
mode at 5% duty cycle. The TR is placed at about 11 cm distance in water, and the signal received on
a single transducer element is monitored. The incoming power intensity is approximately 0.1 W/cm2.
Emitting with the 14 central elements of the CU in pulse mode, a maximum amplitude of 3.4 Vpp at
about 11 cm (Figure 6.25) can be obtained.
Emitting with two more elements shows no noticeable effect.
For the next tests, continuous mode is always used. The relatively small amplitude received is treated by
the voltage multiplier and fed into the booster stage of the battery recharge regulator chip (MAX17710).
As expected by simulations, the voltage multiplier proves to be able to rectify the amplitude Vac = 3.4 Vpp
into a 5.6 V DC level (named Vtrip), which has previously proven to be sufficient to recharge the battery.
Figure 6.26 shows the incoming signal Vac and the rectified voltage Vtrip.
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Figure 6.26: Treatment of the incoming voltage Vac (red) into a DC level Vtrip (blue).
As a result, current is periodically drawn from the regulator chip and used to recharge the battery.
Figure 6.27 shows the behavior of the booster stage when collecting Vac from only piezo element 1,
piezo 1 and 2, or piezo 1 to 5. Corresponding to each voltage drop (red) on the buffer capacitor on the
booster input, there’s current (blue) flowing into the battery and recharging it. The period between peaks
depends on the power provided by the transducer elements, while the duration of the peak depends on
the battery state only, and the current level injected is fixed. For this reason, continuous mode of CU
emission is more efficient than pulse mode, because it allows more frequent peaks, thus quicker recharge
of the battery. It can be noticed that using more elements in reception does not necessarily improve the
recharge time. In the example shown, using both element 1 and 2 is beneficial, but using elements 1 to 5
is not. This basically depends on the differences between power levels on the elements used.
The energy stored in the battery can be then used to produce a fixed message and accordingly modulate
the acoustic wave backscattered to the CU.
Figure 6.28 presents the digital message (blue) produced by the microcontroller and driving the
backscattering switch, and the actual backscattered signal (red) as seen on the TR transducer elements.
The amplitude of the “high” bit is about 700 mVpp, while the amplitude of the “low” bit is 50 mVpp.
The message is sent through the phantom material developed by INSERM, and the wave on the CU
transducer is monitored.
Figure 6.29 shows the message as received on the CU, at different stages of the demodulation.
Important to notice are: the turquoise signal, which is the analog signal arriving on the CU transducer
elements, and the corresponding green digital signal, fully demodulated by the CU circuit.
The same device assessed in vitro is used for in vivo tests. The TR is placed at different locations in the
pig’s body and transmission from and to the CU is assessed. Figure 6.30 shows the incoming acoustic
signal Vac (blue) and the voltage Vchg at the input of the battery charger (red). Whenever Vchg exceeds
4.1 V, its level drops again shortly after.
The backscattered signal is observed on the CU transducers and is shown in Figure 6.31. The amplitude
of the “high” bit is about 500 mVpp and the “low” bit is about 450 mVpp.
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Figure 6.27: Battery charging using different sets of piezoelectric elements. Voltage drop on the buffer
capacitor on the booster input (red); current flowing into the battery (blue).
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Figure 6.28: Backscattering of a fixed message created by the microcontroller. The analog signal Vbsk is
observed on one transducer element dedicated to backscattering.
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Figure 6.29: Backscattering and demodulation of a message (violet) through a custom phantom material.
Incoming wave (turquoise), level recognition (orange), resulting digital signal (green).
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Figure 6.30: Energy harvesting in vivo at subcutaneous distance. During Vchg peaks (red) the battery is
recharged. The corresponding acoustic signal Vac (blue) is also shown.
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Figure 6.31: Backscattered acoustic signal from subcutaneous implant, to be demodulated by the CU.
The signal is modulated in amplitude.
6.7 Discussion
After refinement of the system electronics, and assessment of the system through in vitro and in vivo
tests, the suitability of the manufactured system can be evaluated.
In particular, it is interesting to assess if energization of TR is possible within the FDA limits, and if
energization and communication can be efficiently performed in vivo.
6.7.1 Energization simulation and in vitro assessment
The energy received by the TR, which is well below the limit of 720 mW/cm2, proved sufficient to start
the battery recharge, to switch on the microprocessor, and thus allow communication between the TR
and the CU by backscattering.
It has to be noted that the battery is recharged only during the small periods in which current is drawn
from the Vchg signal at the input of the booster stage of the power management.
The demodulation strategy on CU is efficient for the backscattered message type received, both in
water and through an attenuating phantom.
6.7.2 In vivo energization and communication
Energization and communication were tested in vivo at about 1 cm, 4 cm, and 10 cm (deep implantation).
From Figure 6.30 it can be seen that the voltage Vchg on the buffer cyclically rises to 4.1 V and drops:
the battery is indeed absorbing energy in order to recharge.
Energization could be assessed up to 4 cm, while bigger distances resulted in insufficient amplitude of
Vac. Good communication between TR and CU was obtained at 1 cm (Figure 6.31).
6.8 Conclusion
The system manufactured and tested within the ULTRAsponder project proved the concept of an energy
and data transfer based on ultrasound.
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Successful in vivo operation could be only assessed in subcutaneous range. This is not sufficient for
the applications addressed in the ULTRAsponder project. One of the key reasons for using ultrasound
as a carrier was its ability to reach deeply IMDs. Based on the current state of tests, the feasibility of a
system based on ultrasonic energy and data transfer cannot be proven.
Longer distances could be achievable sending more energy, up to the FDA limit. To this end, a
more powerful CU transducer has already been manufactured within the project, but unfortunately not
exploited for the tests due to a lack of resources. The electric power delivered by the CU could be
automatically adjusted according to a feedback on the acoustic intensity received on the TR, in order
to send the maximum acoustic power allowed. From the perspective of better power management, the
impedance of the TR electronics can be further matched to the transducers, and the microprocessor use
can be optimized.
Outlook for the proposed system would include the integration of the heart impedance sensor into the
implant, in order to address a real application and test the real readings.
Also, the TR electronics must be miniaturized and fitted in a custom casing, much smaller than the
Kinetra®. In order to do this, a flexible PCB support could be necessary.
From an industrial point of view, the robustness of the system needs to be increased, in order to handle
real-life conditions.
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This thesis work describes the contribution of the author to the development of a new generation of
Implanted Medical Devices, which addresses a certain amount of technological challenges present
in today commercial devices. IMDs are very promising tools for further development of minimally
invasive medicine. They allow conceiving new applications and performing therapies better adapted to
the patient’s needs.
Despite intensive research and development in the field during the last few decades, current IMDs
suffer from limitations concerning their size and their interaction with the external world. Several
technical challenges still need to be overcome towards a new generation of IMDs.
Within the European FP7 project ULTRAsponder, a generic IMD platform and its external CU were
developed, manufactured, and tested. The target implant identified is a trade-off among small size,
long-term autonomous operation, and deep implantation capability. Particular focus is put on the device
compatibility with MRI procedures and external electromagnetic wave sources (e.g., mobile phones and
medical equipment). This generic device can be combined with several sensors and actuators, making
it a precious tool for a multitude of applications. The longer-term vision is a BSN, in which several
implanted nodes are devoted to different sensing/actuation tasks and a central CU manages the operations.
The nodes should work autonomously, but wirelessly connect to the CU on a regular basis for recharging
and in order to exchange data.
The main novelties proposed by the project are the exploitation of ultrasonic waves as a carrier for
both energy and data transfer, and exploitation of backscattering technique for data communication.
The ultrasonic carrier allows reaching deeply implanted devices, outperforming techniques based on
electromagnetic waves in case of small transducers with respect to the implantation depth. Moreover,
ultrasound is intrinsically compatible with MRI and does not suffer from interference with external
radiators. The backscattering method reduces to the minimum the needed power consumption to transmit
data from the TR to the CU, because the sent data travels on a carrier generated by the CU, where power
consumption is not critical. Also, the proposed system is aimed to be industrially exploited. Therefore, it
must comply with current regulation and standards in the medical domain. An important constraint on
the proposed device is the exploitation of titanium for the casing: titanium keeps indeed its place as the
most suited material for IMD housing, due to its excellent characteristics and biocompatibility.
The contribution of the author to the device design covers different domains. It includes:
• Choice and assessment of components and technologies adapted to the target device: MRI
compatible, long-life FRAM memory devices; ultra-thin, long-life, all-solid-state battery, with an
integrated power management unit (Chapter 5).
• Development of SPI communication among the microprocessor, the ADC device, and the FRAM
memory device (Chapter 5).
• Development of the firmware for the microprocessor on TR side: managing the power received by
the CU, creating the message to be sent and driving the TR electronics.
• Design of a testbed for the in vitro assessment of the demonstrator (Chapter 6).
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• Modeling of the reception of an acoustic power on the receiving transducer, its propagation through
the different layers of the transducer sandwich and its translation into electrical power. Assessment
of the influence of the titanium casing on the ultrasonic transmission. Simulation of different
thicknesses of the titanium layers, and for different geometrical configurations of the transducer.
Definition of a suitable titanium thickness for acceptable transmission (Chapter 4).
• Choice of a micro-machining strategy (laser ablation) for the local thinning of the titanium casing,
design of the region to be thinned down (Chapter 5).
Together with the design of custom ADC device, microprocessor, transducers, and electronics, which
were performed by other consortium members within the project, the author’s work led to demonstrators
of the intended system. A working frequency of 1 MHz was chosen, because the wavelength in the
mm range is advantageous for beam shaping, and the relatively high frequency minimizes the biological
effects.
Simulations of the titanium barrier and in vitro verification showed that ultrasonic transmission through
a titanium barrier of 100 µm is feasible.
Tests in vitro and in vivo have been performed and proved the ability of the system to transfer energy
to an implant placed up to 4 cm into soft tissues and to establish data communication with subcutaneous
implants. Longer distances may be achievable by sending more energy from the CU, up to the FDA
limit.
As an outlook, the system manufactured could be optimized in several ways: the electrical impedance
of the TR electronics could be better matched to the transducer, thus improving the power transfer; better
power management could be obtained by optimizing the use of the microprocessor; finally, both the TR
and the CU should be made more robust, and the TR must be miniaturized. To this end, a flexible PCB
support might be necessary.
The designed ADC and sensor device, which were absent from the demonstrator, should be integrated
in the system, in order to substitute the fixed message to send with real sensing data. This would allow
assessment of the system on a real application and tests on some real readings.
On the theoretical level, the acoustic power transfer between the CU and the TR should be better
estimated by simulations and assessed, in order to refine the CU emission settings. The electric power
delivered by the CU could be even automatically adjusted according to a feedback on the acoustic
intensity received on the TR, in order to provide at any time the maximum energy allowed by the
regulation.
With a refined system, chronic in vivo assessment could be performed.
Although the absence of a sensor in the implant, and despite the limited spatial range in which the
demonstrators proved efficient, the concept of the target system could be proven: energy and data transfer
based on ultrasound can be exploited to implement a deep IMD. In particular, an important result emerges
from the simplified simulations presented in this thesis work: titanium encapsulation can coexist with
ultrasonic propagation, given an appropriate coupling with the piezoelectric element, an appropriate
design of the piezocomposite, and a locally thinned layer of titanium. This opens the way to a new
generation of long-term biocompatible IMD, based on ultrasonic power transfer and communication.
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research in Europe.
Summer 2006 Internship,
Institut für angewandte Nano- und Optische Technologien (iNano), Hochschule Niederrhein,
Krefeld, Germany.
Organization of a grey-room facility for Scanning Electron Microscopy; Development of Fresnel microlenses.
I had the opportunity to practically use nano patterning in not optimal conditions.
Language and technical skills
Italian: mother tongue; Proficient in German, French, and English (European level C1).
Computer competences: Macintosh, Windows and Unix environments; Good command of MS Office
and OpenOffice; Good knowledge of C and LATEX; Average knowledge of Java and Visual Basic.
Average knowledge of engineering and CAD tools: MATLAB, LabVIEW, Visio, Solidworks, IPE.
Extracurricular activities and soft skills
I have a good ability to perform in teams. In particular, I was involved in organizing social events
and representing Ph.D. students as a member of the executive board of the EPFL Association of
Research Scientists and Lecturers (ACIDE), from 2009 to 2013.
I am a well-organized, analytic person, with good ability in leadership and communication.
Several experiences abroad, starting with an Exchange year in Germany during high school, made me
independent and open-minded.
I enjoy exercising my creativity, mostly by painting and reading. I am very enthusiastic about travel
and culture, which has led me to learn constructed language Esperanto.
Recent discovery of Scuba diving has allowed me to develop my ability to deal with stress.
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in Biomedical and Communication Technologies (ISABEL) , Rome, 2010.
2. F. Mazzilli, M. Peisino, R. Mitouassiwou, B. Cotté and P. Thoppay Egambaram et al. In-Vitro
Platform to study Ultrasound as Source for Wireless Energy Transfer and Communication for
Implanted Medical Devices. 32nd Annual International Conference of the IEEE Engineering in
Medicine and Biology Society, Buenos Aires, 2010.
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